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The response to oxidative stress, a process that can lead to genotoxic injury, is 
thought to involve the abundant cellular antioxidant, glutathione, and the stress 
response transcription factor, p53. Glutathione (GSH) biosynthesis occurs through a 
two -step pathway, the first reaction of which is rate limiting and is catalysed by the 
enzyme gamma glutamylcysteine synthetase (yGCS). yGCS is a heterodimer, 
composed of a heavy (yGCSh) and a light ( yGCS1) subunit. The heavy subunit 
contains the active site, whereas the light performs a regulatory function on the 
heavy by means of a redox -sensitive inter- subunit disulphide bridge. 
The hypothesis that GSH mediates protection against oxidative stress was 
investigated by gene targeting of yGCSh in murine embryonic stem (ES) cells. 
Mouse yGCSh cDNA sequence was isolated by RT -PCR, cloned, characterised and 
used to screen a mouse genomic ? library. Characterisation of the resultant clone 
confirmed that it contained yGCSh gene sequences. This information was used to 
design and construct a replacement targeting vector which was subsequently 
electroporated into ES cells to delete a segment of the endogenous locus. A total of 
285 clones were isolated and analysed for a correct gene targeting event. 
Unfortunately, no positive clones were identified. 
The role of GSH and p53 in the response of ES cells to oxidative stress was also 
examined via a series of in vitro assay strategies measuring cellular viability, 
apoptosis and intracellular GSH levels. ES cells were shown to express yGCSh. 
Agents known to induce oxidative stress or lower GSH levels in other cell lines were 
then tested for toxicity and their potential to modulate GSH levels in ES cells. On the 
basis of these experiments, the quinone menadione (MQ) and the yGCS inhibitor, 
buthionine sulphoximine (BSO), were investigated further. Treatment with MQ was 
associated with a transient elevation of GSH, a strong apoptotic response and 
reduced clonogenic survival. Addition of BSO depleted GSH levels and prevented 
the MQ- induced increase in GSH, sensitising cells to oxidative insult. In order to 
x 
address the role of p53 in the response to oxidative stress, karyotypically normal 
p53 -/- ES cells were compared to wild -type cells. This showed that both maintenance 
of basal GSH levels and MQ- induction of GSH were independent of p53 status. 
However, a role for p53 in this response was demonstrated as the kinetics of MQ- 
induced apoptosis were delayed in the absence of p53. Taken together, these findings 
suggest that the pathways involving p53 and GSH act independently to protect 
against the deleterious effects of oxidative damage. 
Consistent with studies using a wide spectrum of other DNA damage inducing 
agents, loss of p53 conferred an immediate survival advantage post oxidative stress. 
However, the long -term clonogenic survival of p53 -/- ES cells was found to be lower 
than cells with an intact p53 pathway. This suggests that compensatory mechanisms 
exist to ensure that, in the absence of functional p53, cells bearing genetic lesions are 
less likely to be propagated, and furthermore that the ability to engage apoptosis does 
not necessarily predict long term clonogenic survival. 
In summary, an attempt was made to address the in vivo significance of GSH by 
creating a ,GCSh null strain of mice. To this end a targeting vector was generated 
and used in ES cells, but unfortunately this failed to produce a mutant ),GCSh allele. 
This thesis has also explored the relationship between oxidative damage and the 
cellular responses of GSH and p53 in vitro. Evidence is presented to demonstrate 
that, within embryonic tissues, multiple pathways operate in response to oxidative 




1.1 ROS and Oxidants 
Oxygen is essential to aerobic life, though respiration of oxygen to water gives rise to 
reactive, toxic intermediates. These oxidants, or free radicals, are defined chemically 
as molecules that can lose electrons. Such umbrella descriptions cover a 
kaleidoscope of structurally heterogeneous pro- oxidative compounds that have in 
common an ability to exist independently for a period of time with one or more 
unpaired electrons in their outer orbital. Molecular oxygen can be considered as a bi- 
radical, because it has two unpaired electrons. They are relevant to the spheres of 
biology and medicine, since they are tissue damaging molecules implicated in a 
variety of human conditions ranging from developmental abnormalities to natural 
ageing. 
The term reactive oxygen species (ROS) was originally employed to designate a 
group of oxygen- centred radicals and several non -radicals derived from oxygen such 
as hydrogen peroxide (H202) (Halliwell et al., 1992). However sulphur or nitrogen - 
based radicals are also referred to as ROS by many researchers (table 1.1), as long as 
they exist with an incomplete or excessive electron quota. 
ROS and free radicals can be harmful due to their reactivity towards nearby cellular 
molecules. To complement the unpaired electron in their outer orbit a ROS may 
remove an electron from a cellular molecule, or join that molecule to form a stable 
bond. Alternatively, a ROS may donate its unpaired electron to a biological 
nonradical. A nonradical with an additional electron becomes a radical, thus ROS 
chemistry can, on such occasions, proceed as chain reactions. Only when two 
radicals meet, or when an electron is donated from an external system does the 
reaction terminate. Highly reactive radicals, such as the hydroxyl radical (OH.) 
frequently attack cellular components. Peroxynitrite (ONOO.), superoxide (02. -) and 
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Table 1.1 Types of endogenously produced radicals 
An example of biologically relevant ROS, adapted from (Woods et al., 1998). The 
dot designates the presence of unpaired electrons, nomenclature recommended by 
(Pryor and Davies, 1993). * Indicates reactive non -radicals derived from oxygen. 
Chemical symbol Chemical name 
02- Superoxide 
HO- Hydroxyl radical 
RS- Sulphur- centred radical (thiyl) 
CC13. Carbon -centred radical (trichloromethyl) 
NO Nitrogen -centred radical (nitric oxide) 
ONOO Peroxynitrite 
HOC! * Hypochlorous acid 
'02 * Singlet oxygen 
H202 * Hydrogen peroxide 
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H202, although less reactive, still have biologically sensitive targets (Halliwell et al., 
1992). 
1.1.1 The generation of ROS 
Radicals are produced by accepting or losing an electron. Within cells this can occur, 
for the most part, by four major processes. (1) By normal aerobic respiration. The 
sequential reduction of oxygen to water in the mitochondrial electron transport chain 
generates ROS by- products (figure 1.1a), of which approximately two per cent leak 
to the cytosol. During infection, exposure to X -rays, irradiation, exogenous toxins or 
other stress- inducing factors, mitochondrial respiration accelerates, oxygen 
consumption and leakage of ROS to the cytoplasm escalates (Ames et al., 1993; Park 
et al., 1998; Woods et al., 1998). (2) By degradation of fatty acids in peroxisomes. 
Degradation products include H202 that, under certain conditions, may leak from the 
organelle to other cellular compartments. (3) By cytochrome P450 activation. While 
many toxins are directly harmful, the toxicity of others is due to activation by 
metabolic conversion. The induction of P450 enzymes constitutes a primary defence 
system against naturally occurring toxins, but it can also yield metabolic 
intermediates bearing defective electronic arrangements (Ames et al., 1993). (4) By 
the actions of polymorphonuclear cells as they engulf and consume bacteria. 
Although the exact mechanism is not clear, phagocytes are thought to employ an 
oxidative burst of NO., 02.-, H2O2 and OC1. to help destroy bacteria or virus - 
infected cells. This potent bactericidal cocktail protects against death from infection 
at the expense of localised oxidative injury (Ames et al., 1993; Woods et al., 1998). 
Whilst these endogenous processes routinely generate ROS, exogenous sources of 
ROS are the predominant mediators of oxidative injury. Two exogenous sources may 
increase the endogenous oxidant burden: (1) ROS- generating chemical and physical 
agents that cause oxidation of macromolecules and depletes antioxidant levels, and 
(2) dietary iron salts which promote release of hydroxyl radicals (Ames et al., 1993). 
The mechanism of oxidant production varies between the mode of induction. 
Ionising (y) and ultraviolet (UV) irradiation initiate an ROS burden through direct, 
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Figure 1.1 Generation of ROS 
A, Normal metabolism produces of ROS. Electrons (e) are sequentially added by 
mitochondrial oxidases in the aerobic respiration of oxygen to water (de Groot and 
Littauer, 1989). B, Under circumstances of excess H2O2 production, H202 can be 
cleaved in transition metal (iron or copper) ion -catalysed reactions to produce the 




O2' HO H2O 
OXIDATION OF CELLULAR COMPONENTS 
(1) Fe2+ + H2O2 Fe3+ + HO- + HO- 
Fe 
(2) 02: + H202 -> 02 + HO" + HO. 
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high- energy electron displacement from cellular molecules (Stadtman and Levine, 
2000), while many phenolic compounds and quinones are thought generate radicals 
by "redox cycling ". In this process, radicals typically transfer their extra electron to 
oxygen, forming a superoxide anion radical and regenerating the parent donor, which 
is ready to gain a new electron (Figure 1.2). Through this "redox- cycling ", one 
electron acceptor molecule can generate many superoxide anions (Klassen, 1996). 
H2O2 and alkylperoxides are the most common end products of oxidative stress. 
These peroxides by themselves are relatively unreactive compounds. However, in the 
presence of transition metals ions, at physiological concentrations, a limited amount 
of H2O2 is converted to the highly reactive hydroxyl radical (Stadtman and Levine, 
2000). The reactivity of HO. is such that it does not diffuse more than two molecular 
diameters before reacting with a cellular molecule (Pryor, 1986). 
1.1.2 Oxidative injury 
Under normal physiological conditions, reactive species are produced at low levels 
and efficiently removed. Oxidative stress results when the rate of oxidant production 
greatly exceeds the rate of removal. Oxidative stress is a factor implicated in cell 
injury and death in many human diseases. This area has been the focus of a wealth of 
research that has shown the interaction of ROS with cellular molecules can 
precipitate both their dysfunction and destruction. Biomolecules subject to reactivity 
with ROS include lipid, protein, carbohydrate and nucleic acids. 
ROS can activate proteins or, more commonly, inhibit their function. These 
processes are predominantly localised to the iron- or copper- binding sites on 
proteins, resulting in localised OH. generation which selectively modifies adjacent 
amino acids residues (Levine et al., 1981; Stadtman, 1990; Neuzil et al., 1993; 
Stadtman and Levine, 2000). Therefore, it is thought that protein oxidation is, under 
physiological conditions, a site -specific process. Reaction with critical protein 
sulfhydryls (SH- groups) usually impairs catalytic activity of enzymes, especially 
those dependent on metal ions for activity (Fucci et al., 1983). A similar end result 
can occur through arylation of protein sulfhydryls (van Ommen et al., 1988; Brown 
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et al., 1991). With particular compounds, including many quinones, this direct 
covalent binding between ROS and sulfhydryl groups is considered as toxic as the 
effects of oxidation (Nicotera et al., 1990b; Stone et al., 1996; Qiu et al., 1998). 
Arylation of cellular SH- groups results in the deleterious formation of MQ- protein 
adducts (Qiu et al., 1998). ROS can also generate conformational changes that inhibit 
assembly into macromolecular complexes (Stadtman and Levine, 2000), and 
fragment carbohydrate groups (Woods et al., 1998). Through both oxidation and 
arylation mechanisms ROS are thought to block receptors, ion channels and ablate 
the catalytic activity of enzymes. 
The sensitivity of biolipids to oxidation resides in their esterified lipid residue 
(Porter, 1986). This group, found at the tip of polyunsaturated fatty acid tails, has an 
unpaired electron that represents a prime target for reaction with ROS. This 
phospholipid species is present in very high concentrations in all cell membranes and 
enables them to participate in long free radical chain reactions (Marnett, 2000). A 
single reaction with the lipid bilayer can initiate a cascade that consumes up to 200 
molecules of fatty acid (Awad et al., 1993). The major products of lipid peroxidation 
are malondialdehyde (MDA) and 4- hydroxynonwnol (HNE) (Schauenstein and 
Esterbauer, 1978). MDA is directly mutagenic, while FINE has powerful effects on 
signal transduction pathways, the phenotypic effects of which appear independent of 
DNA damage (Basu and Marnett, 1983). 
Though ROS can attack most biomolecules, DNA probably represents the most 
important biological target (Berlett and Stadtman, 1997; Henle and Linn, 1997). The 
injuries inflicted by ROS on DNA are almost exclusively small, but their 
accumulation is suspected to be carcinogenic (Bohr and Dianov, 1999; Akman et al., 
2000; Marnett, 2000) and represent a major contribution to the development of a 
variety of other pathologies. Intercalation of compounds in the double helix push 
adjacent bases apart causing shifts in reading frame (Klassen, 1996), whilst covalent 
binding of oxidants to DNA can cause nucleotide mispairing during replication 
(especially the G ->T transversion) (Wang et al., 1998a; Marnett, 2000). Some ROS- 
inducing compounds, including quinones, can also arylate DNA to produce modified 
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Figure 1.2 Quinone -based redox -cycling 
Quinones (Q) can be metabolised intracellularly (within circle) by either a one or a 
two step reaction. One -step reaction: 2e- are donated by quinone oxidoreductase 
NQO1 (b) to directly form a less reactive hydroquinone (HQ) product. Two step 
reaction: sequential addition of single electrons by individual flavoenzymes (a) 
generates a semiquinone (SQ.) intermediate that readily reacts with cellular oxygen 
to produce 02 -, regenerating the parent molecule. Subsequent production of H202 
and OH occurs as indicated (adapted from Thor et al., 1982). 
HQ- conjugate 
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bases known as adducts. Adducts slow replication, which can arrest cell division or 
generate chromosomal alterations (Woods et al., 1998; Sharma and Slocum, 1999). 
Quinones can also initiate single -strand breaks, the effects of which may be 
compounded by the incorporation of damaged nucleotides during DNA repair 
(Zastawny et al., 1998). The reaction of OH. radicals with DNA can induce 
depurination, as well as strand scission caused by interaction with the phosphodiester 
bond (Klassen, 1996). Tissue culture data regarding ROS- inflicted DNA damage 
indicates that the lesions induced are mutagenic and reflect mutations commonly 
observed in human genes (Marnett, 2000). Last, and in addition to reaction with 
individual classes of biomolecules, ROS can cross -link proteins, DNA, or DNA with 
proteins: imposing structural and functional constraints on coupled molecules. 
1.2 Antioxidants and repair 
1.2.1 Prevention of ROS -induced injury 
To allow survival in an oxygen environment, many cellular defence mechanisms 
have evolved to limit the levels of ROS within the organism and the damage they 
inflict. There are guards that work to prevent ROS production: structural defences, 
such as sequestration of H2O2 generating enzymes in peroxisomes. By 
compartmentalising ROS produced by respiration in the mitochondria, oxidant 
species are prevented from interacting with vulnerable cell structures. Furthermore, 
transition metal ions are effectively sequestered and any free iron or copper ions can 
be removed from solution by metal chelators such as the glycoprotein transferrin. 
Though 020- can promote release of iron from such molecules, chelation suppresses 
the net rate of OH. formation (Biemond et al., 1984). After ROS have been 
produced, a wide spectrum of antioxidants with overlapping specificities has evolved 
to limit the injury induced by ROS. The heterogeneity in their structure reflects the 
diversity of the oxidant species neutralised, but the mode of their operation may be 
drawn into two broad categories: enzymatic and chemical. In the first group, 
enzymes metabolise ROS or prevent transition into more unstable intermediate 
molecules, and in the second, molecules react directly with ROS to neutralise them 
(Woods et al., 1998). 
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Catalysed removal of ROS includes the structurally unrelated and intracellular 
enzymes superoxide dismutases (SOD), catalase, thioredoxin reductase and 
glutathione peroxidases (GPx) glutathione S- transferases (GST). Different isoforms 
of SODs are found in cytosol, nucleus, mitochondria and plasma though all eliminate 
ROS by reducing (adding an electron to) superoxide to form hydrogen peroxide, 
which in turn is removed by other enzymes (editorial, 1993). Catalase and GPx are 
responsible for reducing H2O2 to H2O and 02 (Warner, 1994), while thioredoxin 
reductases maintain proteins in their reduced state (Mustacich and Powis, 2000) and 
GSTs eliminate a wide variety of foreign compounds. 
In addition to the major antioxidant enzymes, many low molecular weight chemical 
antioxidants such as ascorbate (vitamin C), a- tocopherol (vitamin E), E3-carotene 
(vitamin A), thioredoxin (Deneke, 2000), uric acid, urate (Ames et al., 1993), 
carnosine, ubiquinol (Podda et al., 1998) and possibly bilirubin operate to preserve 
cellular redox balance (Stocker and Peterhans, 1989; Minetti et al., 1998). a- 
tocopherol, an essential vitamin, is lipid soluble and can integrate into membranes 
where it is thought to break the chain reaction of lipid peroxidation. I3-carotene, 
another dietary antioxidant, is also lipid soluble and can scavenge 026-. Ascorbate 
also neutralises 02- and H2O2, but is water soluble and is located both in intra and 
extracellular spaces. Interestingly, both ascorbate and [3-carotene can have pro - 
oxidant capability. However, the most abundant intracellular antioxidant is the 
tripeptide glutathione (GSH), L- y- glutamyl -L- cysteinylglycine. GSH carries a reduced 
SH -group (termed "thiol ", to distinguish it from protein SH- "sulfhydryl" groups) 
that acts as a non -specific reducing site with either free ROS or cellular compounds 
with an incomplete electron compliment. In both cases a hydrogen atom, which has a 
single unpaired electron, is transferred from the thiol group to the recipient radical 
(Bergendi et al., 1999). 
1.2.2 Repair of ROS damage 
These elaborate antioxidant defences do not provide complete protection from 
oxidative stress however, as residual ROS are often free long enough to interact with 
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cellular architecture. As such, other systems are dedicated to the removal of damaged 
cellular components. 
Toxic lipid by- products are removed by glutathione peroxidase and oxidised proteins 
are degraded by proteases. Most oxidised base damage in DNA is repaired rapidly, 
within several hours of oxidant exposure, though repair of single or double strand 
breaks is considerably slower (Akman et al., 2000). Repair of the majority of ROS- 
induced DNA damage occurs via the BER (base excision repair) system, a conserved 
and intricate process. This utilises DNA glycosylases to excise oxidised base 
residues (Bhagwat and Gerlt, 1995), which are then excreted in the urine. The 
resulting nucleotide gap is filled by synthesis with DNA polymerase p and concludes 
with a complex assembly including DNA Ligase III to complete repair (Cappelli et 
al., 1997). To assist in the annealing of complimentary strands, the stress response 
regulator p53 (section 1.5) is thought to bind single -stranded DNA ends (Yokote et 
al., 1998). More recently, in vitro studies showed nuclear extracts overexpressing 
p53 exhibited an augmented BER activity, whilst p53 depletion abolished this 
enhanced activity (Offer et al., 1999). To a lesser extent, oxidative DNA damage is 
repaired by restitution via hydrogen donation from an SH -group (section 1.3), 
nucleotide excision (section 1.5.4.3), and recombination (Henle and Linn, 1997). 
In the absence of cell division, oxidative lesions are removed quite rapidly and the 
mutation rate effectively repressed. However, from a cellular perspective the 
optimum strategy would be to neutralise ROS prior to damage infliction, and in this 
regard GSH plays a central role. 
1.3 Glutathione 
GSH was originally discovered in 1888 and the structure resolved in 1929 (figure 
1.3). The peptide has a stable structure, resistant to most peptidases due to the strong 
glutamyl -cysteine bond (Anderson et al., 1989). GSH is synthesised by virtually all 
eukaryotic cells and participates in a myriad of biological processes, including 
cellular defence against oxidative stress by scavenging ROS or by reducing 
disulphide linkages in proteins and other cellular molecules. GSH also protects 
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Figure 1.3 Structure of GSH and GSSG 
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against other toxic insults such as heavy metals, xenobiotics and radiation either 
through direct conjugation or in enzyme- catalysed reactions as a co- factor for GPx 
and GST ( Rahman et al., 1996; Sagara et al., 1998; Shimizu et al., 1998). Image 
analysis with the fluorescent compound monochlorobimane, which binds specifically 
with GSH, has shown GSH is concentrated in the cell nucleus of hepatocytes. This 
pool of GSH is more resistant to GSH depletion agents and reinforces the hypothesis 
that GSH is important in guarding against oxidative damage to nuclear components 
(Bellomo et al., 1992). The physiological role of GSH as an antioxidant has been 
described in numerous disorders reflecting increased oxidation as a result of 
abnormal GSH metabolism. 
1.3.1 Maintenance of GSH homeostasis under oxidative stress 
A plethora of chemical, physical and biological agents are known to alter GSH 
levels. An increase in oxidative stress can lead to the oxidation of GSH to GSSG 
(figure 1.3) the net result of which is a lowering of intracellular GSH. However, 
many stresses lead to a transient elevation of intracellular GSH over the steady -state 
level after an initial depletion. Since this event is associated with increased cellular 
survival it is considered to perform a protective function. Two main enzyme systems 
mediate this elevation and sustain intracellular GSH in its reduced form within 
normal physiological concentrations. One route is through a recycling of GSSG and 
the other de novo biosynthesis of GSH. 
1.3.1.1 Cyclical regeneration 
The levels of reduced (GSH) and oxidised glutathione (GSSG) are regulated, in part, 
by a series of reactions shown in figure 1.4a. GSH can reduce oxidised protein 
residues, ROS or lipid peroxides by oxidising its own thiol group via the GSH 
peroxidase -catalysed reaction, forming GSSG. NADPH is the ultimate source of 
reduced hydrogen and reduces the GSSG via the glutathione reductase (GR)- 
catalysed reaction, reconstituting GSH. NADPH is re- supplied by a reduction of 
NADP+ via the pentose phosphate pathway. Under normal conditions the balance of 
the equation is far in the direction of maintaining cellular glutathione ( >90 %), 
however, GSSG can accumulate in situations of rapid GSH oxidation or limited 
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Figure 1.4 Regeneration and synthesis reactions of GSH 
Enzymes catalysing each stage are highlighted in grey. A, Cyclical depletion and 
regeneration of GSH. Glutathione peroxidase uses GSH as a co- factor to convert 
H202 to water and oxygen. This reaction and spontaneous ROS scavenging oxidises 
GSH to GSSG: the substrate for glutathione reductase to reform GSH. The hydrogen 
ion used for this reaction is abstracted from NADPH, in turn maintained by 
conversion of G -6 -P (glucose -6- phosphate) to 6 -P (6- phosphoglucono -lactone) via 
the pentose phopsphate shunt (Deneke et el., 1989). B, De novo biosynthesis of GSH 
from its constituent amino acids. The two sequential reactions are catalysed by 
gamma -glutamylcysteine synthetase (yGCS) and glutathione reductase (GR). 
Lipid-OOH 
or H202 GSH NADP+ G-6-P 
Glutathione peroxidase Glutathione Reductase G-6-P Dehydrogenase 
Lipid-O GSSG NADPH ` 6-P 
or H20 
B 
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NADPH availability. GSSG generated has several possible fates, namely intracellular 
regeneration back to GSH or ATP -dependent exportation from the cells. If not 
removed by regeneration or efflux, GSSG may react with protein sulfhydryls 
according to the following reaction (Thomas and Sies, 1991): 
GSSG + Protein -SH Protein -S -SG + GSH. 
Formation of protein -GSH mixed disulfides (PrSSG), though reversible, is thought to 
impair protein function (Bannai, 1984; Rahman et al., 1995). 
1.3.1.2 de novo biosynthesis 
The second mechanism to maintain GSH homeostasis involves endogenous synthesis 
of GSH from its three constituent amino acids, shown in figure 1.4b. The production 
of GSH involves two ATP -dependent and Mgt + -sensitive enzymatic reactions: the 
formation of y- glutamylcysteine from addition of glutamate to cysteine and 
formation of GSH from the addition of glycine to y- glutamylcysteine. The first step 
of GSH biosynthesis is rate limiting and catalysed by y- glutamylcysteine synthetase 
(yGCS), the second by glutathione synthetase (GS). The catalytic mechanism of 
yGCS is reviewed in depth by Griffith and Mulcahy (1999). 
1.3.1.3 GSH metabolism 
Figure 1.5 details the global metabolic reactions that utilise and resupply GSH. The 
availability of cellular substrates is a limiting factor in the synthesis of glutathione. 
Although a few epithelial cell lines can uptake intact GSH directly from plasma, 
most cell types rely on importing the constituent amino acids of GSH prior to 
intracellular synthesis. This occurs by direct transport into cells. Cysteine is the most 
limiting substrate, is present in very low concentrations in plasma and is imported by 
multiple transport systems (Bannai, 1984; Deneke and Fanburg, 1989). However, the 
oxidising environment of plasma favours the oxidised form of cysteine, termed 
cystine. Cystine is imported predominantly through the X-c transport system, 
whereupon the reduction reforms cysteine and generates an intracellular equilibrium. 
Another route for cells to obtain the substrates for GSH synthesis is via the 
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Figure 1:5 Global metabolism of glutathione 
Pathways catalysed by enzymes are indicated by a yellow circle. Letters refer to the 
following enzymes: (A) y- glutamyl transpeptidase; (B) y- glutamyl cyclotransferase; 
(C) oxoprolinase; (D) y- glutamylcysteine synthetase; (E) glutathione synthetase; (F) 
glutathione peroxidase; (G) glutathione S- transferase; (H) glutathione reductase; (I) 
dipeptidase and (K) X-c transporter. Red circles correspond to spontaneous 
pathways: (1) scavenging free ROS. Excess GSSG is either transported from the cell 
or reacts with reduced sulphydryl groups of cellular proteins to generate PrSSG (2). 
PrSSG not reduced by GSH is targeted for degradation (adapted from Griffith et al., 
1999, and Deneke et al., 1989). 
GSH or amino acid 
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breakdown of circulating GSH. Liver is the main source of plasma GSH and its half - 
life is less than two minutes (Morris and Bernard, 1994). y- glutamyl transpeptidase 
(y -GT) is a transmembrane enzyme which transfers the y- glutamyl moiety from 
extracellular GSH to an amino acid, which is then imported into the cell. If resulting 
the dipeptide is y- glutamylcysteine, it could be utilised directly for GSH synthesis in 
reaction E. Other y- glutamyl -amino acid complexes can be converted by y- 
glutamylcyclotransferase to glutamate by reactions B and C. 
GSH interacts non -enzymatically with free ROS or as a co- factor in GPx- catalysed 
hydrolysis of H202. GSH is also utilised via the GSH transferase reaction (GST). 
GSH is a strong nucleophile (a molecule containing an extra electron in its outer 
orbit), and conjugation of GSH with a large number of unstable foreign compounds 
with electrophilic (electron deficient) centres stabilises them. This reaction, which 
depletes total cellular GSH, is catalysed by GSTs found in many tissues. 
Cells can respond to oxidative stress by upregulating the activity of one or more 
enzymes of that act to sustain GSH (yGT, GR and yGCS) and utilise GSH (GST and 
GPx). However, there are large species and cell -type differences in the response of 
the GSH system to oxidative stress. The mechanism controlling the net GSH level is 
clearly complex and not fully elucidated, though it is likely to involve all these 
factors in different degrees. 
1.3.2 yGCS 
Since the first step in GSH synthesis is rate limiting, this reaction and the catalytic 
machinery driving it are of primary interest. yGCS is responsive to an extraordinary 
variety of physical, biological and chemical stimuli, detailed in table 1.2. 
yGCS was first purified from rat kidney over twenty years ago (Orlowski and 
Meister, 1971). The enzyme is a heterodimer comprised of a "heavy" and a "light" 
subunit which play different roles in the catalysis of glutathione synthesis. The two 
subunits are coded for separately by single copy genes. The heavy subunit is located 
in the human chromosome 6p12 and mouse chromosome 9D -E and the light subunit 
27 
Table 1.2 Stimuli known to modulate yGCS and GSH levels 
Abbreviations: H202 (hydrogen peroxide); LDL (low density lipoprotein); CSC (cigarette 
smoke condensate); MQ (menadione); DMNQ (dimethoxy naphthoqunione); tBHQ (tert- 
butylhydroqunione); ACNU ( aminomethylpyrimidinyl- methylchloroethyl nitrosourea); 
TNF -a (tumour necrosis factor); IL -1 (interlukin -1); TGF -ß (transforming growth factor); 
BHT (butylated hydroxytoluene); BSO (buthionine sulphoximine); DEM (diethyl maleate) 
and NO (nitric oxide). * This information refers to the levels of GSH during the response 
phase (post any initial GSH depletion), except the GSH -depleting factors BSO, DEM and 
dexamethasome, which refer to the time at which those agents were withdrawn from cells. 
Stimuli 
Effect on 
GSH levels * 
Effect on 
yGCS levels References 
Physical shock 
ionizing radiation T T (Morales et al., 1998; Iwanaga et al., 1998) 
y- irradiation t t (Kojima et al., 1998a; Kojima et al., 1998b) 
Pro -ROS and alkylating agents 
H202 1' T (Rahman et al., 1996) 
LDL T t (Cho et al., 1999) 
CSC 1' T (Rahman et al., 1998; Rahman et al., 1996) 
T t (Shi et al., 1994; Rahman et al., 1998) 
DMNQ t t (Shi et al., 1994b; Shi et al., 1994a) 
tBHQ T T (Galloway et al., 1997) 
ACNU 
cytokines 
t T (Gomi et al., 1997b) 
TNF-a T T (Urata et al., 1996; Morales et al., 1997a) 
IL-1 T T 
(Urata et al., 1996) 
TGF-ß 
hormones 
1, 1, (Arsalane et al., 1997) 
Insulin T T (Cai et al., 1995) 
hydrocortisone 
antioxidants 
T T (Cai et al., 1995) 
BHT 1' T (Borroz et al., 1994; Tu and Anders, 1998c) 
Glutamine analogues 
BSO t T (Aliosman et al., 1996; Tanaka et al., 1998) 
GSH conjugating agents 
Dexamethasone t J, (Rahman et al., 1998; Rahman et al., 1999) 
DEM t T (Kitteringham et al., 2000) 
NO T T (Moellering et al., 1998; Moellering et al., 
1999) 
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gene in human chromosome 1p21-p22 and mouse chromosome 3H1-3 (Tsuchiya et 
al., 1995; Walsh et al., 1996). The heavy subunit, yGCSh, has a molecular weight of 
73 kDa. Data on the macromolecular structure is limited, although it is known the 
heavy subunit contains the sites for catalysis which harbour a vital sulfhydryl moiety 
(Simondsen and Meister, 1986; Tu and Anders, 1998b; Tu and Anders, 1998a). The 
recent discovery of sequence homology between yGCS and GS led to the 
identification of two candidate yGCS metal biding sites, each chelated by three 
amino acids (Abbott et al., 2001). Replacement of these residues by site -directed 
mutagenesis indeed lead to a large reduction in yGCS catalytic efficiency, confirming 
a critical role in the yGCSh active site. Furthermore, mutation of ligands 
individually suggests one site is involved in binding glutamic acid and stabilisation 
of its transition state, while the other is responsible for binding and orienting MgATP 
(Abbott et al., 2001). 
The human light subunit, yGCSI, migrates at 31 kDa (Gipp et al., 1995). Alignments 
between light subunit cDNA and amino acid sequences from rat, human and mouse 
reveal extensive homology among these species. Mouse cDNA shares 95% (rat) and 
91% (human) identity, while mouse amino acid sequence is 99% and 96% similar to 
rat and human sequences, respectively (Reid et al., 1997). However, there are 
species differences. For example, rat kidney and E. coli yGCS have very similar Km, 
turnover and specificity, but E. coli GCS is composed of a single polypeptide (Huang 
et al., 1993b). 
1.3.2.1 Regulation of holoenzyme activity 
The activity of yGCS is regulated at multiple levels. In 1975 it was shown that GSH 
inhibited rat yGCS in a competitive fashion with glutamate (Richman et al., 1975). 
Later experiments with GSH analogues such as ophthalmic acid suggest that this is 
mediated via the GSH glutamyl moiety while, for optimal inhibition, the GSH thiol 
group interacts with the enzyme at a site distinct from the glutamate binding domain, 
reviewed in Griffith and Mulcahy (1999). These studies lend support for the concept 
that feed back inhibition of yGCS occurs by an excess of GSH. This theory certainly 
fits with a transient decrease in GSH often observed prior to an increase. 
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Another fundamental level of regulation is the generation of the holoenzyme. While 
the heavy subunit contains all the substrate binding and catalysis sites, it is now 
widely accepted that the light chain exerts an important regulatory function on the 
catalytic activity of the heavy chain, in two ways. First, the recombinant holoenzyme 
and isolated holoenzyme show similar Km values for yGCS substrates, whereas the 
heavy subunit alone shows a markedly increased Km value for glutamate (table 1.3). 
Hence formation of the holoezyme is held to elevate catalytic activity. Second, 
association of the subunits raises the apparent Ki for GSH. Such is this effect Huang 
et al argue that, under physiological conditions, the catalytic activity of the heavy 
chain alone is effectively zero due to binding GSH (Huang et al., 1993b; Huang et 
al., 1993a). In these respects, the ratio of the heavy: light subunit represents an 
important level of control in the overall GSH- synthetic capability of a cell. 
In addition to the feedback loop and generation of the holoenzyme, it is possible the 
enzyme is controlled by the reversible formation of redox- sensitive disulphide bonds 
between cysteine residues (Ochi, 1995; Tu and Anders, 1998b; Soltaninassab et al., 
2000). In 1993 Huang et al. proposed that intersubunit di- sulphide bridge formation 
produces a steric alteration that increases the affinity between glutamate and the 
binding site (Huang et al., 1993b). In this model, yGCS "senses" oxidative stress and 
"reacts" to increase GSH synthesis. However, anomalies that are inconsistent with 
this model should be noted. In particular, inhibition of yGCS by the GSH analogue 
ophthalmic acid occurs via a non -competitive route. Further, the Ki value measuring 
yGCS inhibition is 1.8 mM for GSH, whilst ophthalmic acid is 12.5 mM. Such 
conspicuously distinct properties between these related compounds suggests 
regulation may not be a simple as previously imagined. Nevertheless, a similar 
system of control has become apparent in the regulation of tyrosine phosphatases, 
receptor tyrosine kinases, NF -KB (see section 1.3.5), GSTs, thioredoxin and PKC 
(Bauskin et al., 1991; Knebel et al., 1996; Gopalakrishna et al., 1997a; Denu and 
Tanner, 1998). For example, under oxidative conditions, disulphide bridge formation 
in an autoinhibitory domain of PKC is associated with enhanced activity, whereas 
antioxidant activity upon catalytic cysteine residues correlates with depressed 
activity (Gopalakrishna et al., 1997b; Gopalakrishna and Jaken, 2000). Huang and 
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Table 13 Comparative affinity of substrates and GSH for yGCSh and 
holoenzyme 
All kinetic values are expressed as mM. Data derived from rat (Huang et al., 1993; 
Tu and Anders, 1998). 
Km Km Ki 
Enzyme status L -Glu L -Cys GSH 
yGCS holoenzyme -1.6 0.2 8.2 
yGCSh alone -18 0.2 1.8 
Figure 1.6 Proposed redox structures of the yGCS holoenzyme 
Scheme to account for the reversible regulation of yGCS holoenzyme activity, by the 
redox environment of the cell. Blue indicates yGCSh; green yGCS1. yGCS contains 
20 protein sulfhydryl groups (SH). Under conditions of GSH depletion, at least one 
intra- and one inter -disulphide bridge (S -S) form. This correlates with an optimal 
affinity between glutamate (Glu) and its binding site, possibly via alteration of yGCS 
tertiary conformation. Upon re- establishing physiological concentrations of GSH, S- 
S linkages are reduced back to individual SH groups. Text and figure based on 












colleagues' proposal, modified in light of recent data, is outlined in figure 1.6. 
In addition to disuphide regulation, the activity of yGCS may be under 
phosphorylation control. Three serine- threonine residues in the heavy subunit are 
subject to reversible phosphorylation by protein kinase (PK -A), protein kinase (PK- 
C) Cat + /Calmodulin- dependent kinase in vivo (Sun et al., 1996) and the enzyme can 
autophosphorylate (Sekhar and Freeman, 1999). The degree of phosphorylation 
correlated with loss of yGCS activity without altering gross structure of the 
holoenzyme, so inactivation occurs by unidentified mechanism. Treatment with 
agonists of signal transduction pathways, such as cAMP (cyclo adenosine 
monophosphate), significantly increased the phosphorylation suggesting a tentative 
physiological role where phosphorylation status may regulate GCS activity (Sun et 
al., 1996). However, PKC activation in a neuronal cell line prevents, rather 
thanenhances oxidative -induced cytotoxicity (Davis and Maher, 1994), and others 
show many oxidative -stress inducing agents do not activate PKC (Devary et al., 
1992). Clearly, further work is needed to confirm whether this potential mechanism 
of mammalian regulation is relevant in vivo. 
1.3.2.2 Transcriptional regulation 
yGCSh and yGCS/ can be induced by a striking variety of external stumuli, though 
the majority of studies have tended to focus upon yGCSh regulation. Detail of cis - 
acting componentry helped to identify putative trans- acting factors that execute 
expression. 
Sequencing the human yGCSh 5' regulatory region ( -3802 to +547) has revealed 
multiple promoter motifs and transcription start sites, the former shown in figure 1.7. 
In addition to a variety of standard regulatory motifs, the yGCSh upstream sequence 
contains consensus AP -1 (activator protein -1) sites, an NF -KB (nuclear factor -KB) 
binding region, a consensus MRE (metal response element), XRE (xenobiotic 
response element) and four potential ARE's (antioxidant response elements) 
(Griffith, 1999; Tsuboi, 1999). The ARE was first identified as an enhancer element 
involved in the induction of the rat GST A2 gene (Rushmore et al., 1991) and 
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Figure 1.7 Potential transcription control elements in yGCSh 
Schematic map of 5' flanking region of human yGCSh gene (orange) showing some 
identified nuclear protein binding sites and transcription start site (bent arrow). 
Numbers indicate distance from ATG in bp. Sequences thought to play vital roles in 
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consists of a core sequence 5'- RTGACnnnGC -3' that can contain an internal AP -1 
and /or an adjacent AP -1 motif. An AP -1 -like sequence is located adjacent to the 
yGCSh ARE4 sequence, and is thought to regulate yGCSh similar fashion to others 
detected in the promoter region of several P450 phase II and antioxidant enzymes (Li 
and Jaiswal, 1994; Mulcahy and Gipp, 1995; Xie et al., 1995). 
The AP -1 transcription factor is a dimeric complex, usually composed of Fos and Jun 
proteins, though other transcription factors, including Fra, Maf, Nrfl and Nrf2 may 
form heterogeneous complexes with Jun proteins. Induction of mRNA for the 
components of AP -1 (c -fos and c-jun) has been described in cells exposed to CSC 
(Muller, 1995; Rahman et al., 1996). AP -1 indeed mediates, at least in part, yGCSh 
upregulation induced by cadmium (Wu and Moye -Rowley, 1994), cisplatin (Yao et 
al., 1995), phenolic antioxidants (Choi, 1993) and phosphatase inhibitor, okadaic 
acid (OA) (Sekhar et al., 1997). Nrf2 has been shown to bind the yGCSh ARE 
element in response to extracellular stimuli (Moinova and Mulcahy, 1998; Wild et 
al., 1999; Moinova and Mulcahy, 1999; Jeyapaul and Jaiswal, 2000). Such variation 
is thought to modify the transcriptional activation of yGCSh (Abate et al., 1990). 
A large volume of literature is dedicated to understanding the sequences mediating 
yGCSh upregulation under oxidative stress. Deletion mutagenesis studies using 
reporter plasmids in human hepatoblastoma (Hep G2) cells show the oxidant ß- 
naphthoflavone (3 -NF) exerts induction of yGCSh through activation of ARE4. In 
contrast, ARE3 does not direct increased expression in response to I3-NF nor does it 
significantly modify the magnitude of induction directed by ARE4 (Tsuboi, 1999). 
Further work showed constitutive and inducible expression was eliminated by 
introduction of a single base mutation in the either the ARE4 core sequence 
(Mulcahy et al., 1997) or terminal GC box (Wild et al., 1998). This contrasts with the 
dependency of y- irradiation- induced upregulation of yGCSh by NF-KB in the 
malignant glioblastoma cell line T98G. Moreover, the GC -rich fragment -108 to 
+91 (containing only housekeeping promoter elements) is sufficient for cisplatin- 
induced yGCSh upregulation in lung cancer SBC -3 (Tomonari et al., 1997b). 
Heterogeneity in cis -acting factors employed for yGCSh induction suggests multiple 
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signalling pathways may operate to elicit a GSH- mediated response to diverse 
sources of stress. 
Deletion and binding studies have also revealed that the constitutive expression of 
the human heavy subunit gene is mediated by the TATA box -containing fragment - 
202 to +22, and both distal ARE3 and ARE4 sequences at -3093 to -3103 in Hep G2 
cells (Tomonari et al., 1997a). Full basal expression also requires the embedded AP- 
1 site be intact (Wild et al., 1998). As in inducible expression, AREs are not a 
ubiquitous requirement for constitutive expression of the yGCSh gene. COST cells 
require only a proximal -108 to -28 GC -rich region (containing multiple promoter 
elements but lacking any AP -1 consensus) for basal transcription (Tomonari et al., 
1997a), although the -269 to -263 AP -1 site also has a marginal positive regulatory 
effect, whereas the critical site in lung epithelial cells is the same -269 to -263 AP -1 
motif ( Rahman et al., 1998). The biological importance of such heterogeneous 
sequences controlling basal transcription is also unclear. It is possible that exposure 
of particular tissues to high levels of oxidative stress, such as liver and lung, may 
require local variations in the strength of basal expression may account for the 
differences in promoter elements utilised. 
In addition to these elements driving expression, yGCSh contains a putative silencer 
region containing NF -1. sites (Imagawa et al., 1991; Osada et al., 1997). Interaction 
of the NF -1 transcription factor with similar motifs in the GST -P gene suppresses 
transcription. Whether this system is functional in the yGCS genes remains to be 
resolved. Of note however, NF -1 - like yGCS, contains redox- sensitive cysteine 
residues which modulate its activity (Novak et al., 1992; Bandyopadhyay et al., 
1998). 
Analysis by Galloway et al and Moinova et al revealed many potential promoter 
elements in the human light subunit promoter region, shown in figure 1.8 (Galloway 
et al., 1997; Moinova and Mulcahy, 1998). yGCSI can also be repressed by 
transforming growth factor (TGF 3) (Arsalane et al., 1997). Moinova et al., 1998, 
investigating 3.3Kó of known upstream sequence in HepG2 cells, demonstrated a 
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Figure 1.8 Potential transcription control elements in yGCSI 
Schematic map of 5' flanking region of human yGCSI gene showing identified nuclear 
protein binding sites (not to scale). The area covered indicates the total area analysed 
to date, numbers indicate approximate distance from ATG in bp. Sequences thought to 
play vital roles in ),GCS/ transcription are highlighted in red. 
yGCSI 
-1260 -1150 -620 -460 -490 -303 -290 ó 
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fragment only -344 to -242óp 5' of the transcription initiation start site is required 
for constitutive and (3-NF induced expression. This DNA contains a consensus ARE 
with internal AP -1 site and an adjacent AP -1 site. Subtle deletion studies 
demonstrate the adjacent AP -1 site alone is capable of driving full basal yGCS/ 
transcription in HepG2 cells, and contributes to and I3-NF induction. However, 
removal of both ARE and adjacent AP -1 is necessary to eliminate yGCS/ 
upregulation (the embedded AP -1 motif performs no function here). Cloned ARE, 
isolated from native promoter sequence, is sufficient to drive I3-NF-mediated yGCS1 
induction, so represents the dominant enhancer element (Moinova and Mulcahy, 
1998). Table 1.4 summarises the operative transactivation elements of yGCSh and 
yGCS1 genes in response to particular environmental signals. 
As for the heavy subunit, there is diversity in the elements mediating promotion of 
the light subunit gene. For example, 6.7Kó of yGCS/ promoter sequence analysed in 
response to tBHQ confirmed a prominent role for the proximal AP -1 site in basal 
expression. However, induction by tBHQ was dependent upon the presence of 
unknown element adjacent to the AP -1 site (Galloway et al., 1997). While these 
studies have provided insights into the control of yGCS gene expression, it is 
possible other transcription factors, and their cognate elements, remain to be 
identified. Elucidation of such factors and their signal pathways should help to 
unravel the full complexity of yGCS heavy and light subunit gene expression. 
1.3.2.3 Posttranscriptional regulation 
In addition to GSH negative feedback, yGCS redox- sensitivity and transcriptional 
control of constituent subunits, yGCSh and yGCS1 are regulated posttranscriptionally. 
Incubation of rat lung cells with the deleterious lipid peroxidation product HNE 
(section 1.1.2), which is neutralised by conjugation with GSH, was found to increase 
the half -life of yGCSh mRNA (Liu et al., 1998). Similarly human glioma cells 
exposed to a pro- oxidant induced yGCSh via an increase in message stability (Gomi 
et al., 1997) and, interestingly, the presence of ROS also initiates the stabilisation of 
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Table 1.4 Comparison of promoter elements controlling induced and 
constitutive yGCSh and yGCS /transcription 
yGCSh expression 
INDUCED CONSTITUTIVE 
















TNF-a! IL -ß 
Ionizing radiation 
ARE4/ AP -1 HepG2 (1) ARE4 and TATA HepG2 (1) 
AP -1 HepG2 (2) AP -1 A549 (7) 
AP -1 HepG2 (3) Proximal GC -rich COS 7 (5) 
AP -1 HepG2 (4) 
AP -1 Lung tunour SBC3 (5) 
AP -1 A549 (6) 
AP -1 A549 (7) 
AP -1 Endothelial: 
Human vascular (8) 
AP -1 Endothelial: 
Human vascular (13) 
AP -1 Mouse liver (12) 
AP -1 A549 (9) 
AP -1/MRE Rat hepatocytes (10) 
not NF-kB Rat hepatocytes (11) 
NF -kB Rat hepatocytes (11) 
NF -kB Mouse liver (12) 
NF -kB Endothelial: 
Mouse glycemic (14) 
NF -kB Glioblastoma: 








ARE -AP -1 
unknown element 
Cell type & Ref. No. Promoter Cell Type & Ref No. 
HepG2 (16) AP-1 HepG2 (17) 
HepG2 (17) 
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a GST transcript (Chen et al., 1995; Ming et al., 1998). However, the mechanism 
mediating these increases in message stability is presently unclear. 
1.3.3 Co- ordination of 7GCSh with other genes 
Cells co- ordinate yGCSh expression with other proteins under particular conditions. 
yGCSI is one obvious and important candidate. Comparison of the light with the 
heavy chain promoter region has revealed several common putative enhancer 
elements: ARE, XRE, AP -1 and AP -1 -like sites, each of which could initiate yGCS 
transcription in response to chemical and oxidative stress (Galloway et al., 1997). 
Clearly, it is conceivable that common cis -acting sequences between light and heavy 
subunit promoters co- ordinates expression to maximise holoenzyme formation. 
However, northern analysis of yGCSh and yGCS/ in multiple tissues indicates this is 
not always the case (Gipp et al., 1995). Indeed, many stimuli increase only the heavy 
subunit, while others do advance a dual response. Thus the two genes can be subject 
to co- ordinate or independent regulation. In addition to yGCSI, GSH -cycle 
components, the transmembrane MRP (multidrug resistance protein) and 
detoxification enzymes such as SOD and catalase are documented examples (table 
1.5). 
Constitutive upregulation of yGCS activity has been previously noted in many drug - 
resistant tumour cell lines. The relevance of this to carcinogenesis has been attributed 
to a protective effect either mediated by an enhanced detoxification capacity or 
resistance to cell death, reviewed by (Hall, 1999). Since GSTs are dependent on GSH 
as a co- factor, it is perhaps not surprising that yGCS is jointly upregulated with GSTs 
in cisplatin- resistant bladder cancer cells (Kotoh et al., 1997). Indeed, a variety of 
transformed cell lines (Ishikawa et al., 1996; Kuo et al., 1996) and normal mouse 
tissue (Kuo et al., 1998) co- ordinate transcriptional upregulation of yGCSh with 
MRP. Individual stimuli upregulate a pattern of enzymes from a bank of 
detoxification genes, the permanent over -expression of which may confer a survival 
advantage. 
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Table 1.5 Co- ordination of yGCSh with GSH- metabolism and 
antioxidant enzymes 
Summary of a representative cross -section of literature regarding the co- expression of 
yGCSh with related GSH factors and antioxidants. Abbreviations: TRX (thioredoxin) 
and CTX (catalase). For other compounds, refer to table 1.3. 






Hep G2 tBHQ yGCS1 (Galloway et al., 1997) 
Hep G2 f3-NF yGCS1 (Wild et al., 1999) 
Hep G2 PDTC yGCS1 (Wild et al., 1999) 
Rat lung L2 DMNQ yGCS1 (Li et al., 1996) 
Rat retinal rMC -1 tBHQ yGCSI (Lu et al., 1999) 
Rat fibroblasts Ionizing radiation yGT (Sierra-Rivera et al., 1994) 
Mouse liver y -rays GPx, GR, TRX (Kojima et al., 1998a) 
Human lung Heavy metals MRP (Ishikawa et al., 1996) 
Mouse Nerve HT -22 Glutamate- resistant GR, GST, CTX (Sagara et al., 1998) 
GST 
Bladder cancer Cisplatin- resistant GST (Kotoh et al., 1997) 
Mouse liver CC14 GPx, GR (Kojima et al., 1998b) 
Leukaemia Cisplatin MRP (Ishikawa et al., 1996) 
Colorectal cancer none yGCSI, MRP (Kuo et al., 1996) 
172 Glioblastoma ACNU MRP (Gomi et al., 1997) 
Hep G2 DEM yGCSI (Sekhar et al., 1997) 
Lung carcinoma, A549 TGF -ß GR, CTX (Arsalane et al., 1997) 




(Thanislass et al., 1995) 
Lung carcinoma, A549 Dexamethasone yGT (Rahman et al., 1998) 
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1.3.4 ROS and GSH in gene activation and cell cycling 
GSH is thought to be intimately involved in the regulation of stress -induced gene 
expression. Shifts in the intracellular redox potential, largely initiated by excess 
production of ROS, are increasingly correlated with a change in the activity of signal 
transduction and transcription components (Choi, 1993; Yao et al., 1995; Rahman et 
al., 1996; Sekhar et al., 1997; Arsalane et al., 1997). GSH, by its capacity to 
scavenge ROS and regulate the redox status of cellular proteins, was therefore 
proposed to regulate the activity of such redox- sensitive factors (Gipp et al., 1995). 
One response of mammalian cells to diverse chemical and physical agents is the 
activation of a global regulon known as the UV or stress response. To date, all 
stimuli that elicit the stress response share in common the ability to alter the balance 
of the intracellular redox potential, reviewed in Adler et al., 1999. The response 
includes activation of a battery of genes involved in repair and ROS scavenging that 
include, amongst others, genes regulating GSH metabolism. This transactivation is 
dependent, at least in part, on the transcription factors AP -1 and NF -KB. NF -KB 
normally resides in the cytosol as an inactive dimer bound to the inhibitory subunit I- 
KB. Activation requires phosphorylation of I -KB to dissociate the NF- KB:I -KB 
complex. Devary et al., 1993, showed NF -KB activation, when by stimulated by UV, 
depends upon a redox- sensitive tyrosine kinase to recognise and to initiate 
transduction of the stress signal. Indeed, oxidative stress induced by H2O2, diamide 
and IL -1 has also been shown to activate tyrosine kinases (Heffetz et al., 1990; 
Bauskin et al., 1991; Munoz et al., 1992). This is thought to occur via modifications 
to kinase conformation enforced by the formation of di- sulphide bridges between 
native sulfhydryl groups. This regulatory mechanism, introduced in section 1.3.2.1, 
is well characterised for the bacterial transcription factors OxyR and SoxR (Bessette 
et al., 1999; Gonzalez -Flecha and Demple, 2000; Zheng and Storz, 2000). 
ROS also activate NF -KB by inhibiting the activity of tyrosine phosphatases (Knebel 
et al., 1996). Dephoshorylation enzymes all share a common amino acid motif at the 
active site. This includes a catalytically important cysteine (Barford et al., 1995), the 
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reversible oxidation of which is thought to lead to a loss of function (Denu and 
Tanner, 1998; Herrlich and Bohmer, 2000). A last mode of NF-KB oxidoreductive 
control is the direct interaction of ROS with NF-KB peptides. This redox sensitivity 
is also attributed to the reversible oxidation of cysteine residues in NF -KB DNA 
binding site, an event purported to modulate DNA recognition (Hayashi et al., 1993; 
Gaiter et al., 1994). 
The antioxidant N- acetylcysteine (NAC), a precursor of GSH, can inhibit tryosine 
kinase- dependent UV- triggered induction of NF-KB (Devary et al., 1993). GSH 
depletion has also been implicated in the regulation of stress kinases JNK (c -Jun N- 
terminal kinase), p38 (Wilhelm et al., 1997) and PKC ( Gopalakrishna et al., 1997a; 
Gopalakrishna et al., 1997b). Indeed, a variety of antioxidants can suppress NF-KB 
activation by a great variety of pathogenic stimuli, including H202, cytokines, TNF, 
viruses, double stranded RNA, endotoxins, phorbol esters, UV and ionising radiation 
(Schreck et al., 1992). That antioxidants can prevent NF-KB activation by a wide 
repertoire of agents is further evidence that ROS are intracellular messengers that 
channel disparate stresses into a common cellular response (Schreck et al., 1991). 
Reprogramming of stress -response genes by factors that modulate the redox potential 
can conclude in cellular consequences that include mitotic arrest, cell death and 
division. Recently, low level oxidation induced by H202 in human lymphoid cells 
reversibly activated p38 cascade, an event that directly induced an aberrant cell cycle 
(Kurata, 2000). This stimulus did not produce NF-KB activation, though different 
levels of oxidation appears to activate discrete signal transduction pathways and 
nuclear factors (Su and Karin, 1996). In agreement with this, other oxidants can 
induce apoptosis or necrosis- depending on the concentration of the oxidant 
(Dypbukt et al., 1994; Sata et al., 1997; Vayssier et al., 1998), or the level of cellular 
GSH (Fernandes and Cotter, 1994). In contrast, the presence of other pro -oxidants 
can induce cell proliferation (Duhe et al., 1998). These effects of ROS on cell 
behaviour points toward an oxidant- effect dependency on dose, antioxidant status 
and cell type. 
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1.3.5 Role of GSH in Development 
The blood in the decidua surrounding the early mammalian embryo contains 5% 
oxygen (New et al., 1976). Low oxygen is necessary for normal development of the 
neural tube, whereas atmospheric oxygen concentrations (20 %) are essential for 
subsequent development (Akazawa et al., 1994). The levels of GSH and ROS vary 
in a dramatic and controlled fashion during embryogenesis. The GSH content of 
mouse oocytes falls by nearly a quarter at fertilisation, nearly by half between the 
two- and four -cell stages (days 1 -2.5) and ten -fold at the stage of the blastocyst (day 
4) (Nasr -Esfahani and Johnson, 1992; Gardiner and Reed, 1994; Gardiner and Reed, 
1995b). 
Several studies have attributed the cause of drug -induced birth defects to oxidative 
DNA damage (Slott and Hales, 1987; Winn and Wells, 1995; Winn and Wells, 1997; 
Baek et al., 2000). Indeed, at both the two -cell and blastocyst stages, incubation with 
the pro- oxidant tBHQ depletes the embryo of GSH and reduces the number of 
embryos with normal developmental features. The loss of GSH was accounted for by 
increases in GSSG and PrSSG, indicating that the embryo was undergoing oxidative 
stress (Gardiner and Reed, 1994). Recently, yGCS was shown to be expressed 
throughout development to adult tissues (Levonen et al., 2000). However, recovery 
of basal GSH levels in two -cell embryos is dependent upon cyclical regeneration 
with GR, although blastocyst recovery is dependent upon a combination of 
regeneration and de novo synthesis (Gardiner and Reed, 1995a). 
At day 5 of mouse development, a burst of 02. correlates with hatching from the 
zona pellucida. This is thought to be vital since hatching was successfully induced in 
vitro, without loss of viability, by treatment of embryos with 02: (Thomas et al., 
1997). At neuralation (9 -10 days), embryos remain entirely dependent on anaerobic 
glycolysis. When efficient oxygen delivery is established on day 11, the TCA cycle 
begins and mitochondrial morphology matures. In rat embryos exposed to 20% 
oxygen at day 9 -10, prematurely developed mitochondria are visible and ROS 
production is increased, indicating the initiation of the tricarboxylic acid cycle. This 
correlated with a subsequent manifestation of an array of embryonic defects, 
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including stunted growth and a reduction in GSH. Culturing embryos in 2mM GSH 
reduced 11202 formation, prevented the acquisition of embryonic malformations and 
restored growth (Ishibashi et al., 1996). Neuralation -stage rat embryos derived from 
streptozotocin- induced diabetic rats or embryos exposed to hyperglycemic conditions 
(66.7mM glucose) displayed similar lesions, also reversible by GSH (Trocino et al., 
1995; Sakamaki et al., 1999). 
In consideration of the total developmental data, it was predicted GSH has a central 
role in normal embryogenesis and in the embryonic response to oxidative stress. The 
former proposition was recently verified by the lethal phenotype of 2,GCSh null 
('GCSh -I -) mice. These mice die at E 8.5, associated with a massive increase in 
apoptotic cell death in distal regions, suggesting GSH may also be involved in the 
signal transduction of embryonic remodelling events (Shi et al., 2000). A further 
study showed (yGCSh -/ -) embryos die before day 13 post gestation (Dalton et al., 
2000). This work also revealed that heterozygotes show an approximate 30% 
increase in ascorbate levels, showing a role of GSH in modulating alternative 
antioxidants. 
1.4 Apoptosis 
The removal of specific cells from the surrounding population is a biologically 
essential and highly controlled process. The first recognition of it, then termed 
"necrobiosis ", was in 1858 and was described as "a shrinkage being where the cell 
vanishes and can no longer be seen in its previous form" (Virchow and Chandler, 
1859). This was also the first differentiation from necrosis, later shown as a 
predominantly uncontrolled process of cell death where, after membrane collapse, 
the cellular content is dispersed into the extracellular mileu. In humans a local 
discharge of the cellular content causes unfavourable inflammation, though recent 
work shows necrosis sometimes has important functions in the normal life cycle of 
lower organisms (Cornillon et al., 1998). Over a century later, ultrastructural detail of 
the controlled process was revealed by electron microscopy and in 1972 the term 
apoptosis was coined (Kerr et al., 1972). More recently, an explosion of biochemical 
and genetic information has led to an appreciation of the mechanisms underlying the 
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original morphological observations. Apoptosis is a phenomena now observed 
universally in both the plant and animal kingdoms, and dysfunction of it is 
recognised as a major contributory factor in many human diseases. 
Reflecting the occurrence of its dysregulation in disease, apoptosis is critical in the 
implementation of many normal physiological processes. In addition to a host of 
functions throughout development (section 1.4.1), apoptosis is critical for immune 
system turnover and killing. Apoptosis mediates T- and B -cell removal once their 
purpose has been served (Miller and Heath, 1993; Russell et al., 1995), whilst 
cytotoxic T lymphocytes and natural killer can destroy target cells by initiating their 
apoptosis via CD95 (surface determinant 95) receptor signalling (Rouvier et al., 
1993; Darmon et al., 1995). Other prominent roles include involution of the 
mammary gland during lactation (Walker et al., 1989; Strange et al., 1992), 
regression of the adrenal cortex following adrenocorticotrophic hormone withdrawal 
(Wyllie et al., 1973) and breakdown of the uterine endometrium during the menstrual 
cycle (Hopwood and Levison, 1976). 
The apoptotic process can be broken into four discrete stages, the first of which is 
receipt of a potentially lethal stimulus. Second, this signal is internalised by binding 
of external ligands to specific cell receptors and relayed to a checkpoint where, third, 
the information is "processed" to decide whether to proceed or not. If the decision is 
to terminate the cell, the final stage is effecting the apoptotic programme. 
1.4.1 Apoptosis in development 
From the earliest stages, apoptosis has a role in development. For example, ovulated 
eggs in the mammalian oviduct are destined for apoptosis if unfertilised (Morita and 
Tilly, 1999). After fertilisation, it is thought embryos that fail to achieve early 
developmental progression undergo apoptosis by default (Jurisicova et al., 1996; 
Jurisicova et al., 1998a; Jurisicova et al., 1998b). Later, at the blastocyst stage, 
apoptosis occurs as a normal part of development (Mohr and Trounson, 1982; Brison 
and Schultz, 1997), though the function of this is presently unknown. 
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A study of apoptosis throughout embryogenesis was undertaken in the nematode 
worm Caenorhabditis elegans, revealing the striking control of the process. During 
development, 131 cells die by apoptosis in a precise temporal fashion, leaving a 
mature worm of 1090 cells (reviewed in Metzstein et al, 1998). In higher organisms 
apoptosis is not so defined but appears essential in many developmental processes. 
For example, apoptosis mediates digit and palette formation by deleting interdigital 
membrane and midline epithelium, respectively (Pratt and Greene, 1976; Garcia - 
Martinez et al., 1993; Mori et al., 1994). 
1.4.2 Apoptosis in cellular injury 
In addition to the role of apoptosis in mediating physiological processes in 
development and adult life, apoptosis can be vital in the response to pathological 
stimuli. Apoptosis triggered by physical or chemical insults is not reliant upon cell - 
surface ligand- receptor binding, though some in systems transmembrane receptors 
are activated internally (Caricchio et al., 1999; Gonin et al., 1999). The majority of 
cytotoxic agents enter the cell directly, causing internal damage, which activates the 
apoptotic pathway in the absence of specific cell -surface receptors. Examples of such 
agents include heat shock (Thompson, 1995), UV light, y- irradiation (Corbet et al., 
1999), numerous drugs, synthetic peptides (Schwall et al., 1993) and toxins (Sachs 
and Lotem, 1993). 
1.4.3 Biochemical and morphological changes 
After commitment to the apoptotic programme, cells complete a repertoire of defined 
structural changes that are mediated by particular biochemical effectors. A pivotal 
intracellular event prior to the physical manifestation of apoptosis is an alteration in 
the function of the mitochondrial membrane. Escalation of mitochondrial activity 
precedes collapse of the transmembrane potential. This correlates with leakage of 
mitochondrial cytochrome c, AIF (apoptosis- inducing factor), calcium ions and a 
cellular depletion of ATP (Fernandez -Checa et al., 1997). This is probably mediated 
by opening of the mitochondrial transmembrane megachannel PT (permeability 
transition) pore (Kroemer et al., 1995; Zamzami et al., 1995; Zamzami et al., 1996), 
which allows free passage of solutes <1500 Da (Zoratti and Szabo, 1995). In 
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agreement with this, inhibition of the PT pore prevents apoptotic activation (Kroemer 
et al., 1997; Kroemer, 1997). Loss of mitochondrial membrane integrity is an event 
widely accepted to have critical and irreversible downstream effects on the process 
of cell death. 
Morphologically, an apoptotic cell initially retreats from neighbouring cells and an 
involution of the plasma membrane, termed blebbing, occurs. Next, chromatin 
condense and migrate towards the nuclear envelope. This is usually associated with 
disintegration of nuclear DNA into 50 -300kb fragments by the action of specific 
endonucleases (Bustamante et al., 1997). Finally, the plasma membrane begins to 
bud off to form a cluster of cytoplasmic apoptotic bodies that encapsulate 
degenerated organelles. This event parallels an increase in transglutaminase activity, 
which cross -links adjacent cytoplasmic proteins (Piacentini et al., 1992). 
Remarkably, the entire process of apoptosis is completed within a few hours (Kerr, 
1971; Wyllie et al., 1980; Allen, 1987; Lazebnik et al., 1993). 
An important phase of apoptosis not formally included in the morphological 
definition is the ensuing phagocytosis of apoptotic bodies. Apoptotic cells, if not 
consumed by surrounding cells or the immune system, can eventually assume 
necrotic morphology in vivo (Dong et al., 1997). In agreement with this, apoptosis 
can be triggered by low concentrations of a pro- oxidant, whilst the same compound 
at higher concentrations causes necrosis (Sata et al., 1997) (and expanded in section 
5.8.3). In consideration of this and other data, it is argued there is more crossover 
between apoptosis and necrosis than previously imagined (reviewed in Kroemer et 
al, 1997). 
1.4.4 Genetic regulation of apoptosis 
Each cell of the C. elegans that dies by apoptosis during development does so under 
the command of genetically pre -determined programme. Investigation of this 
pathway has lead to the identification of a host of factors that encode the apoptotic 
machinery. Because the process of apoptosis appears highly conserved between 
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disparate cell types (Frade and Michaelidis, 1997), mammalian homologs of many of 
these and other factors have been isolated, summarised in table 1.6. 
The first family to be characterised was the Caspases, a group currently comprising 
13 individual members. These encode cysteine proteinases that differ in size and 
substrate specificity though appear essential effectors of the apoptotic cascade. 
Activated caspases execute apoptosis by cleaving factors involved in cellular 
homeostasis, repair and the maintenance of cell structure (reviewed in Wolf et al, 
1999). By forming a signalling cascade that activates transcription factors caspases 
are also thought to play a role in the initiation of apoptosis (Hofmann et al., 1997; 
Buckley et al., 1999). 
The Bc1-2 superfamily represents a critical apoptosis -regulating family, encoding 
proteins that promote or suppress cell survival. Bc1-2 forms heterodimers with other 
bc1-2 superfamily members, including Bax (Oltvai et al., 1993), Bel-xi, Bcl -xs (Boise 
et al., 1993), Bad (Yang et al., 1995) and Bak (Chittenden et al., 1995), which differ 
in their structure and pattern of expression. This heterodimer acts as an inhibitor or 
promoter of apoptosis. The bc1-2 protein co- localises with the PT pore in the outer 
mitochondrial membrane (Zoratti and Szabo, 1995; Kroemer et al., 1997), a site that 
appears necessary for bc1-2 function (Tanaka et al., 1993; Hockenbery et al., 1993). 
Gene knock -out studies have shown some bc1-2 members are essential for early 
development, by repressing excessive thymus, spleen, nervous and haemopoetic 
apoptosis. Consistent with this, over -expression of bc1-2 protects most cells from 
apoptosis induced by a variety of stimuli (Okazawa et al., 1996). 
The Bax subfamily, comprising the Bak, Bax and Bok proteins appear to promote 
cell death. The BH3 subfamily, a group of posttranslationally activated proteins that 
include Bad, Bik, Bid and Blk, share a motif common to bc1-2 members. Bid can 
modify the conformation of Bax, an event correlating with apoptosis (Wang et al., 
1996) and cytochrome c release (Desagher et al., 1999). BH3 peptides can also 
interact with death suppressers such as Bcl -xL to block their activity (Sailer et al., 
1997). 
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Table 1.6 Genes that regulate apoptosis 
Adapted from Afford et al., 1999. 
Genes Effect on cell survival 
Bd-2 family 
Bc1 -2 Positive 
BcI -xl Positive 
Bcl -w Positive 














Caspases 1 -13 Initiate and execute vital aspects of the apoptosis programme 
p53 Effects bc1 -2 and Bax directly, has a critical role in determining either 
growth arrest or apoptosis. 
IRF -1 critical role in determining either growth arrest or apoptosis. 
Rb Modulates exit from cell cycle- inhibition causes apoptosis 
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Once the mitochondrial gradient is lost and cytochrome c released, the caspase 
effector pathway may be activated via the Apafl (apoptotic protease activating factor 
1) gene product (Zou et al., 1997). This molecule, with ATP and a caspase cofactor, 
can bind cytochrome c and activate the caspase cascade. Bc1-2 is thought to regulate 
the activity of Apafl by controlling the flow of mitochondrial cytochrome c through 
the PT pore (reviewed by (Morita and Tilly, 1999). In agreement with this, release of 
cytochrome c in response to pro -apoptotic stimuli is blocked in cells over -expressing 
bc1-2 (Kluck et al., 1997; Yang et al., 1997). Thus, the members of the Bc1-2 
superfamily appear to fit into the apoptotic sequence upstream from caspase 
activation but downstream from initial signalling molecules, and are thought to 
integrate cell survival and death signals (Lutz, 2000). 
Other important apoptotic genes include genes implicated in cell cycle progression. 
The tumour suppressor genes p53 and IRF1 can signal either growth arrest or 
apoptosis (Canman et al., 1995; Tamura et al., 1995). P53 is known to transactivate a 
variety of apoptotic factors and directly modulate bc1-2 and bax activity (see section 
1.5.3). Rb (Retinoblastoma), another tumour suppressor gene, encodes a product that 
determines exit for the cell cycle into Go. Inactivation of Rb by a variety of different 
factors prevents cell cycle exit and causes apoptosis (Debbas and White, 1993; 
Slebos et al., 1994). Ultimately, the fate of the cell is controlled by a complex 
balance of pro- and anti -apoptotic factors that is poorly understood. 
1.4.5 Role of ROS in apoptosis 
ROS are implicated in the initiation the implementation of the apoptotic programme 
(Buttke and Sandstrom, 1994). Radicals themselves, including H2O2 and lipid 
peroxides induce apoptosis (Bladier et al., 1997; Hockenbery et al., 1993; Ratan et 
al., 1994). Furthermore, cytotoxic physical and chemical agents that exert oxidative 
stress activate apoptosis in manifold cell types. Similarly apoptosis induced by 
physiological stimuli, such as TNF -a or glucocorticoid, also induces an alteration in 
the redox state prior to the morphological features of apoptosis becoming apparent 
( Bustamante et al., 1997; Pierce et al., 2000; Jiang et al., 2000). Consistent with this, 
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Laster and collegues observed that culture in oxygen -free conditions can inhibit 
TNF -a- induced death (Laster et al., 1988). 
There is evidence that ROS are also required for the execution phase of apoptosis. 
For example, after the apoptotic signal is triggered many cells sustain lipid 
peroxidation (Amstad et al., 1994; Czene et al., 1997; Dimmeler et al., 1998). Since 
antioxidants (Johnson et al., 1996), including NAC, GSH (Jiang et al., 2000) and 
yGCS (Manna et al., 1999) can rescue cells from apoptosis ROS are, in some 
circumstances, implicated as downstream effectors in the execution phase of cell 
death. However, caution should be exercised in interpreting the effects of 
multifunctional antioxidants. 
Other evidence for a role of ROS in the regulation of apoptosis comes from a 
comparison of apoptosis- resistant (LYar) and apoptosis- sensitive (LYas) mouse 
lymphoma lines. Voehringer and colleagues initially demonstrated that LYar cells 
have elevated bc1-2 and GSH levels (Voehringer et al., 1998). Subsequent gene 
microarray analysis of 11,000 mRNA transcripts revealed LYar cells constitutively 
upregulate two genes thought to boost the level of GSH, via the GR- catalysed 
GSSG -recycling reaction and yGT- catalysed GSH- scavenging reaction (Voehringer 
et al., 2000). 
Interestingly, over expression of bc1-2 can abrogate lipid peroxidation (Hockenbery 
et al., 1993) and block apoptosis- at least in part by inhibiting the production or 
effects of ROS (Kane et al., 1993). Thus, Bcl -2 is thought to function in an anti- 
oxidant pathway. Since depletion of LYar GSH levels reverses the bcl -2- mediated 
block of apoptosis, the redox state and not bcl -2 per se has been proposed to account 
for the resistance to apoptosis (Voehringer et al., 1998; Voehringer et al., 2000). 
Consistent with this, the PT pore has redox- sensitive sulfhydryl groups that may 
regulate its activity (Petronilli et al., 1994; Chernyak and Bernardi, 1996), a 
mechanism thought to override the effect of bcl -2 (Zamzami et al., 1998). 
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However, there are some contradictory observations regarding the importance of 
ROS in apoptosis. Of particular note, some cell types under anaerobic conditions can 
undergo apoptosis (Shimizu et al., 1995). This casts some doubt over a universal role 
for ROS in apoptosis. Within this study, expression of bc1 -2 prevented hypoxia- 
induced apoptosis, a phenomenon associated with no increase in oxidation of lipid, 
DNA or protein. This opens a potential mechanism of bc1-2 action that does not 
depend upon the modulation of ROS. It should be borne in mind that multiple 
divergent pathways leading to cell death exist and further work is required to clarify 
the significance of ROS in the execution phase. 
1.5 p53 
Unlike yGCS, which is primarily monofunctional, the 53kDa nucleoprotein p53 is 
highly pleiotropic. P53 is a stress -surveillance factor and tumour suppressor, drawing 
international attention since the finding that it is the gene most commonly mutated in 
human cancer (Caron and Soussi, 1992; Hollstein et al., 1994; Hollstein et al., 1996). 
In response to a variety of stress signals, including oxidative stress, p53 co- ordinates 
the cellular processes of cell cycle arrest, DNA repair and apoptosis (Lane, 1992; 
Clarke et al., 1993; Smith et al., 1995) (Levine, 1997). 
1.5.1 Functional domains and structure 
The p53 protein is divided into five functional domains, I -V, which display a high 
level of sequence conservation (Soussi et al., 1990). The N- terminal region, spanning 
amino acids 1 -42, embodies the activation (1) domain (Fields and Jang, 1990; Unger 
et al., 1992), though neighbouring sequences are probably required for optimal 
performance (May and May, 1999). As with all transactivators, p53 binds both DNA 
sequences and other components of the transcription machinery. Currently, these 
include the TBP (TATA box binding protein), TBP- associated proteins of the 
transcription factors TFIID (transcription factor IID) (Lu and Levine, 1995; Thut et 
al., 1995), TFIIH (He et al., 1993), TFIIIB (Chesnokov et al., 1996), Sp -1 (Borellini 
and Glazer, 1993) and the single- stranded DNA -binding protein RP -A (Duna et al., 
1993). The amino- terminal region also mediates interaction with the p53 negative 
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regulator, mdm2 (discussed in section 1.5.2.3) and various viral proteins all of which 
repress p53 transcriptional activation (May and May, 1999). 
Adjacent to the N- terminus resides a proline -rich linker region (amino acids 63 -97), 
containing a motif found in the SH3 (Src homology 3) domain. This sequence is 
thought necessary for interaction with SH3- containing regulatory proteins, for 
example the gas -1 (growth arrest specific) which blocks GO /S phase transition (Del 
Sal et al., 1995; Ruaro et al., 1997). The proline -rich region has been shown to play a 
role in growth suppression by influencing p53- mediated apoptosis (Sakamuro et al., 
1997). Subsequent deletion of it appears not to affect p53 transactivation, though it 
can release transrepression (Venot et al., 1998). 
The p53 core, covering amono acids 102 -292, contains the functional domains II -V. 
These areas comprise the DNA binding region (el -Deiry et al., 1992) which permit 
interaction with target DNA motifs, and the transcriptional activity associated with 
p53 activation in response to a stimulus. Consistent with the importance of this 
function, this area is highly conserved and is also the site in which 80 -90% of p53 
tumour mutations occur (Hollstein et al., 1994). The crystal structure of the core 
domain bound to its promoter sequence has revealed a 4 loop arrangement that binds 
a major and minor DNA groove (Cho et al., 1994). The tertiary configuration is 
stabilised by a zinc ion, chelation of which alters the structure and reduces DNA 
binding in vitro (Hainaut and Milner, 1993b). The valence of the zinc ion is 
dependent on the prevailing redox potential and this bestows a degree of ROS 
sensitivity on p53, expanded in section 1.5.2.3. In addition to DNA binding, the core 
domain mediates a limited protein binding function and 3' -5' exonuclease activity 
associated with the "latent" form of p53 (Mummenbrauer et al., 1996), outlined in 
section 1.5.2.1. 
The principal provinces of the carboxy terminus are the oligmerisation and 
regulatory domains (amino acids 363 -393 and 323 -356, respectively). The former 
region permits aggregation into di- or tetrameric complexes (Stenger et al., 1992), 
partial deletion of which prevents tetramer formation and reduces the affinity of p53 
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for cognate DNA sequences (Milner et al., 1991; Hainaut et al., 1994). The latter 
domain, though relatively short, has several distinct functions assigned it. In 
particular, three nuclear localisation signal have been discovered within, mutagenesis 
of which can generate either an entirely cytoplasmic protein, or one that resides in 
both the cytoplasm and nucleus (Dang and Lee, 1989; Shaulsky et al., 1990). In 
addition an autoinhibitory function has been ascribed to this domain, discussed in the 
next section. 
1.5.2 Regulation of p53 function 
One theory advanced to explain the regulation of p53 activity advocates an 
interaction between the carboxy terminus and another region in the p53 tetramer 
which prevents sequence specific binding of DNA (Hupp and Lane, 1994; Hainaut et 
al., 1994). This inactive, or "latent" form is the predominant species within normal 
cells and is now widely accepted to have a discrete function from activated p53. In 
particular, latent p53 is implicated in proofreading and repair of low -level DNA 
damage (see section 1.5.4.3). Latent p53, present at low concentrations, is subject to 
highly efficient degradation via the ubiquitin- dependent pathway and has a half -life 
measured in minutes (Haupt et al., 1997; Kubbutat et al., 1997). Upon DNA damage 
the latent form switches to the active form, capable of transactivating target genes. 
Activation is predicted to require a steric modification of the tetramer that releases 
the association between the autoinhibitory C- terminal domain from its partner(s). 
This view is supported by the finding that deletion of the C- terminus (Okorokov et 
al., 1997) or the C- terminal recognising monoclonal anitobody, Pab421, can activate 
specific DNA binding (Hupp and Lane, 1995; Abarzua et al., 1996; Shaw et al., 
1996; Selivanova et al., 1999). Physiologically, p53 activation is associated with C- 
terminal phosphorylation (Ko and Prives, 1996) and acetylation (Sakaguchi et al., 
1998) (enlarged in section 1.5.2.2). Activation also correlates with an extension of 
the half -life, elevating p53 protein levels (see next section). Thus, activation - 
stabilisation events are critical in the p53 response to stress, and occur via a series of 
highly regulated, predominantly posttranscriptional pathways that modify the p53 
protein. 
55 
1.5.2.1 Protein -protein associations 
p53 is regulated by interactions with cellular and non -cellular peptides. In particular, 
the mdm2 protein was demonstrated to bind p53 in vitro and in vivo (Barak and 
Oren, 1992; Oliner et al., 1992), a consistent event that inactivates p53 (Momand et 
al., 1992; Oliner et al., 1993). This p53 inhibitor appears to function in two ways. 
First, mdm2 binds the N- terminal transactivation domain which prevents p53- 
dependent transcription (Momand et al., 1992; Oliner et al., 1993) and second, mdm2 
targets nuclear p53:Mdm2 complexes to the cytoplasm for rapid ubiquitin 
degradation (Haupt et al., 1997; Kubbutat et al., 1997). Disruption of the p53:mdm2 
complex is the principle mechanism for p53 stabilisation (Ashcroft and Vousden, 
1999b). Immediately after genotoxic damage, for example UV irradiation, Mdm2 
messenger RNA and protein levels fall in a p53- independent fashion and free p53 
levels rise (Arriola et al., 1999; Blattner et al., 1999). Subsequent posttranslational 
modifications further adjust p53 activation. With increasing p53 levels, mdm2 
becomes induced and re- establishes the repression of p53, forming a well 
characterised autoinhibitory loop, reviewed by Freedman et al., 1999. 
However, the feedback pathway to promote p53 stabilisation in response to DNA 
damage would require interruption to permit p53 time to complete its functions, thus 
invoking additional control features to regulate the inhibitory effect of mdm2. Both 
phosphorylation of p53:mdm2 and interaction of mdm2 with other factors are 
candidate mechanisms. Indeed, mdm2 can be phosphorylated (Mayo et al., 1997) and 
the tumour suppressor gene product pl9ARF can prevent mdm2- mediated inhibition 
of p53. This occurs through direct mdm2 binding and sequestration in the nucleolus, 
preventing the nuclear export necessary for p53 proteolysis (Honda and Yasuda, 
1999; Weber et al., 1999). 
Furthermore, a p53- binding protein with homology to mdm2, mdmX, has been 
identified (Shvarts et al., 1996). MdmX has also been shown to inhibit p53 
transactivation upon binding though, in contrast to mdm2, it cannot signal nuclear 
export or induce proteolysis. On this basis Jackson and co- workers have proposed 
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that mdmX may function to maintain a nuclear pool of p53 in undamaged cells 
(Jackson and Berberich, 2000). 
p53 can also be modulated by non -cellular proteins. p53 is bound and functionally 
repressed, through different mechanisms, by viral factors such as SV40 T antigen 
(Jenkins et al., 1988; McCarthy et al., 1994), adenovirus E1B (Yew et al., 1994) and 
HPV E6 (Thomas et al., 1995). 
1.5.2.2 Phosphorylation and acetylation 
Eleven major phosphorylation sites have been identified on the p53 protein, clustered 
mostly in the C- and A- terminal regions. Phosphorylation is thought to modulate 
different aspects of p53 activity, namely protein stability (Shieh et al., 1997), DNA 
binding (Takenaka et al., 1995) and transactivation (Jamal and Ziff, 1995) via subtle 
alterations in tertiary structure. Dephosphorylation, induced by ionising irradiation, 
generates a binding site that permits association with other factors that activate 
sequence specific DNA binding (Waterman et al., 1998). In addition, Chemov et el 
report that the stability and activity of p53 are likely to be regulated independently by 
phoshorylation of discrete sites (Chernov et al., 1998). However, mutation of all 
phosphorylation sites does not significantly prevent the ability of DNA damage to 
activate p53 (Ashcroft et al., 1999a). Further, attempts to understand the specific 
biological effects of individual phosphorylation events are limited by the fact that, in 
vivo, p53 may be subject to multiple kinase and phosphatase activities 
simultaneously. 
Acetylation of the p53 molecule also appears to control p53 activity in response to 
DNA damage. An early response to UV or ionising radiation is p53 phosphorylation 
(Shieh et al., 1997), which is then preferentially and acetylated in a site -specific 
manner (Sakaguchi et al., 1998). Furthermore, the acetyl transferase p300 acetylates 
the C- terminus of p53, which enhances sequence -specific DNA- recognition (Gu and 
Roeder, 1997). This may operate by inhibiting the random DNA -binding activity 
associated with latent p53 (Anderson et al., 1997), a theory yet to be tested. Recently, 
the small ubiquitin -like protein SUMO -1 has also shown to interct with p53 in a 
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specific and regulatory manner. SUMO -1 ubiquinates a lysine residue at position 386 
on the C- terminus, initiating transcriptional activation (Gostissa et al., 1999; 
Rodriguez et al., 1999; Muller et al., 2000). 
1.5.2.3 ROS and Ref -1 
In addition to mechanisms controlling p53 activity previously outlined, the redox 
environment appears to a have a significant regulatory effect on p53. First, a host of 
ROS- generating physical and chemical agents induce p53, an event blocked in the 
presence of GSH or NAC (reviewed by Hainaut et al, 2000). Oxidative damage to 
DNA, in particular single and double strand breaks, is thought the major mediator of 
such p53 activation (Nelson and Kastan, 1994). 
Second, the functional capability of p53, like that of an increasing number of stress - 
response transcription factors (such as AP -1 and NF -KB), is subject to the 
surrounding redox milieu. Site specific DNA -binding of p53 requires the central 
domain that holds a zinc ion (Bargonetti et al., 1993; Pavletich et al., 1993; Wang et 
al., 1993) and contains highly conserved cysteine residues at positions 176, 238 and 
242 (Cho et al., 1994). Mutation of these residues abolishes or reduces the sequence - 
specific DNA -binding activity in vitro (Rainwater et al., 1995). 
Oxidising agents and metal chelators were shown to disrupt p53 conformation and 
render p53 incapable of DNA -binding, whereas reductants restored conformation and 
enhanced DNA -binding in vitro (Hainaut and Milner, 1993b; Hainaut and Milner, 
1993a). This effect of metal chelation on p53 conformation and DNA binding were 
later shown reversible in vivo (Verhaegh et al., 1998). Within cells, hydrogen 
peroxide (Parks et al., 1997) or diethyl maleate (Russo et al., 1995) depressed the 
ability of p53 to bind and transactivate, whereas binding to non -specific DNA was 
not altered. Subsequently, residues 176, 238 and 242 were shown to be oxidised in 
vivo, an event that dampened p53 transactivation (Wu and Momand, 1998). 
However, in some instances metal chelation can lead to an increase in p53 DNA - 
binding in vivo (Sun et al., 1997; Chandel et al., 2000). Sun et al propose that metal 
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chelation may release p53 from binding cellular inhibitory proteins. Consistent with 
this, zinc was required for formation of stable p53 -large T antigen complex in vitro 
(Kernohan et al., 1996). Clearly, the conformation, DNA -binding and transactivation 
capacity of p53 is regulated to some degree by ROS and the availability of zinc or 
copper ions. In light of these discoveries, Meplan et al postulate redox events may 
play a role in the "fine tuning" of DNA binding (Meplan et al., 2000). 
Regulators of the intracellular redox and protein cysteine state may then have a 
significant regulatory effect on p53. Ref -1 (redox factor -1) is a potent activator of 
latent p53 that acts via redox dependent and independent mechanisms (Jayaraman et 
al., 1997; Meira et al., 1997). Oxidised Ref -1 is regenerated by direct association 
with the antioxidant thioredoxin, which augments Ref- l-enhanced p53- dependent 
expression of p21 (Ueno et al., 1999). Ref -1, also implicated in BER repair of 
oxidised DNA (section 1.2.2), enhances p53 transactivation when over -expressed in 
vivo. Antisense Ref -1 downregulates p53 induction and correlated with attenuated 
apoptosis (Gaiddon et al., 1999). Interestingly, Ref -1 is co- activated with AP -1 in 
colon cancer cells in response to hypoxia (Yao et al., 1994). 
1.5.2.4 p53 homologues 
A final possible mechanism of control of p53 was revealed when the presence of new 
family members were reported. P73 and p63 both have striking similarity to p53 in 
all domains bar the C- terminus, which is considerably longer (Kaghad et al., 1997; 
Schmale and Bamberger, 1997). Some isoforms of p73 can transactivate p53 targets 
and initiate cell cycle arrest (May and May, 1999) or apoptosis when overexpressed 
(Jost et al., 1997). Therefore, it seemed possible that p73 and p63 compensate for 
p53 in p53 -/- mice. Recently however, functional differences between family 
members are emerging. Notably and unlike p53, p73 cannot interact with oncogenic 
viral proteins, is unresponsive to genotoxic injury (Kaelin, 1999) and shows no clear 
tumour suppressor activity (Lohrum and Vousden, 1999). Moreover, the strikingly 
different phenotypes of the p73 -/- and p63 -/- mice compared to p53 -/- animals would 
suggest the p53 homologues fulfil distinct physiological purposes (Mills et al., 1999; 
Yang et al., 1999; Yang et al., 2000). 
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1.5.3 Molecular outcomes of p53 activation 
After receipt of genetic injury or other cellular stress, p53 becomes stabilised and 
activated by release from inhibitory proteins such as mdm2 (figure 1.9). 
Subsequently, p53 activity may be further adjusted via phosphorylation, acetylation 
and redox processes. Activated p53 performs a variety of functions that have, in 
combination with other molecular responses, defined molecular consequences. The 
characteristic events activated p53 causes are referred to as the "p53 response ", the 
most prominent aspect of which is the impact on gene expression and influence on 
interaction with other proteins. 
1.5.3.1 Increased transcription 
Genes induced by p53 broadly fall into functional categories. In addition to genes of 
uncertain function, p53 upregulates genes directly involved in cell cycle arrest; 
apoptosis; angiogenesis and p53 autoregulation. 
The most characterised p53- transactivated mediator of the cell cycle arrest is p21. 
Elevated p21 levels inhibit G1- active members of the cell -cycle regulatory family, 
CDKs (cyclin- dependent kinases) (Xiong et al., 1993) (Harper et al., 1993) (see also 
section 1.5.4.2). Other genes involved in cell cycle arrest are also transcriptional 
targets of activated p53. These are cyclin G1 (Okamoto and Beach, 1994); cyclin D1 
(Chen et al., 1995); the DNA replication protein, PCNA (proliferating cell nuclear 
antigen) (Morris et al., 1996); GADD45 (growth arrest and DNA damage -inducible 
protein) (Kastan et al., 1992); IGF -BP3 (insulin -like growth factor binding protein 3), 
a factor that suppresses mitogenic stimuli (Buckbinder et al., 1996); the signal 
transduction protein 14 -3 -3a (Hermeking et al., 1997); Siah (Matsuzawa et al., 1998) 
and Rb (retinoblastoma) (Osifchin et al., 1994). 
A second superfamily of genes upregulated by active p53 are those involved in 
promoting apoptosis. The expression of the pro -apoptotic factor bax is elevated in a 
p53- dependent fashion (Miyashita and Reed, 1995). In addition, the Fas gene, which 
encodes a cell surface receptor that internalises an apoptosis signal upon ligand 
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Figure 1.9 Modifications to p53 and the cellular consequences 
Indicated: Latent p53 (asymmetric green tetramer) is bound by mdm2 (purple 
oval), repressing sequence specific DNA binding and targeting p53 for rapid 
cytoplasmic degradation. Receipt of a stress signal (indicated by red explosion), 
such as DNA strand breakage, activates p 19ARF which blocks nuclear export of 
p53. Dissociation of the p53:mdm2 complex follows, possibly by phosphorylation 
of p53 or mdm2, freeing the transactivation domain from mdm2 occlusion. Final 
activation is achieved by the divergent actions of families of kinases, acetyl 
transferases and redox modulators. Active p53 (symmetric green tetramer) 
mediates molecular changes such as altered gene expression and protein -protein 
interactions. The outcome of these, dependent on the level of damage incurred, 
can be cell cycle arrest, DNA repair or apoptosis. Not indicated: Rising levels of 
active p53 increases mdm2 transcription, which shuts down the response. 
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Figure 1.9 Pathways mediating the p53 response to genotoxic stress 
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binding, is also transcribed by p53 in vitro and in vivo (Owen- Schaub et al., 1995; 
Reinke and Lozano, 1997). The SH3- containing kinase regulator, p85 (Yin et al., 
1998) and a novel gene PAG608 (Israeli et al., 1997) may also represent points of 
control. Using differential display, Polyak et al. revealed a battery of genes 
preferentially transactivated by p53 in early apoptosis. Many of the fourteen PIG's 
(p53 inducible genes) identified encode factors related to, or known to be directly 
involved in the maintenance of the redox potential. This has led to the proposition 
that the transactivation of PIG's induces apoptosis by ROS production (elaborated in 
section 1.5.4.1). 
A third class of genes expressed by p53 play a role in impeding angiogenesis. 
Thrombospondin -1 and BAIL both encode inhibitors of vascularisation and are both 
transactivated by p53 (Dameron et al., 1994; Nishimori et al., 1997). Consistent with 
this, p53 deficiency is correlated with elevated angiogenesis. Lastly, as part of the 
autoregulatory loop, p53 can transactivate its own gene (Deft-1e et al., 1993) and that 
of mdm2 (Juven et al., 1993). 
1.5.3.2 Depressed transcription 
The p53 response can also embody abated expression of specific genes. Though the 
mechanism underlying this remains obscure, a cellular significance has been shown: 
proteins that inhibit p53- dependent apoptosis, such as bc1-2, also inhibit the 
transcriptional repression function while unaffecting transactivation (Shen and 
Shenk, 1994). 
Specifically, p53 transrepresses cyclin A (Yamamoto et al., 1994), MRP (Wang et 
al., 1998b), the AP -1 component c-fos (Ginsberg et al., 1991), the pro- antioxidant 
COX2 (cyclooxygenase 2) (Subbaramaiah et al., 1999) and interleukins 2, 4 and 6 
(Santhanam et al., 1991; Pesch et al., 1996). Lowering the rate of transcription 
appears to involve interaction between the N- and C- terminal regions of p53 with 
TBP (TATA- binding protein) (Horikoshi et al., 1995). However, p53 also sequesters 
and inactivates other transcription apparatii, including TFIIIB, and CBF (CCAAT 
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binding factor) (Cairns and White, 1998) and probably operates via other 
unidentified routes. 
1.5.3.3 Translational control 
In addition to modulating transcription, p53 can influence translation of specific 
transcripts. In response to treatment with TGF13, polysomes fail to associate with 
CDK4 mRNA in a p53- dependent manner (Ewen et al., 1995). The mechanism 
underlying this translational block is currently unknown. 
1.5.4 Cellular outcomes of p53 activation 
1.5.4.1 Apoptosis 
An enormous volume of evidence supports a role of p53 in the controlled deletion of 
cells in response to a bewildering variety of stimuli. Exogenous p53, when 
introduced to tumour cell lines activates apoptosis (Shaw et al., 1992; Yonish- 
Rouach et al., 1994). Moreover, a spectra of p53 -/- cell types treated with DNA 
damaging agents display a markedly attenuated level of apoptosis (Clarke et al., 
1993; Strasser et al., 1994; Ziegler et al., 1994; Clarke et al., 1994). The p53- 
dependent apoptotic response also shows a gene -dose effect, with p53 heterozygotes 
exhibiting intermediate levels of apoptosis between that shown by wild -type and p53 
homozygotes (Clarke et al., 1993; Lowe et al., 1993). 
However, in some cell types p53 deficiency results only in an alteration of the 
kinetics of apoptosis (Xia et al., 1995; Aladjem et al., 1998; Frenkel et al., 1999), and 
others contain pathways to apoptosis not dependent on p53. For example, treatment 
of thymocytes with dexamethasome results in p53- independent apoptosis (Clarke et 
al., 1993). 
While the effectors of apoptosis are now quite well understood, the regulation of 
those effectors has been the subject of controversy. Recently, mechanisms of p53- 
dependent apoptosis have become clearer. In one pathway, the transactivation of 
p53- responsive genes is critical for p53- dependent apoptosis (Sabbatini et al., 1995). 
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Intriguingly, many of the p53- inducible genes (PIG) induced prior to the onset of 
apoptosis are involved in the regulation of ROS and include pro- oxidative factors 
(Polyak et al., 1997). Polyak et al postulate that the PIGs, upregulated by a similar 
degree as p21, collectively generate ROS that damage mitochondrial components. 
This, in turn, causes leakage of cytochrome c and pro -apoptotic factors to the cytosol 
which activate the caspase cascade. Indeed, p53 specifically represses expression of 
the antioxidant and anti -apoptotic factor, bc1-2 (White, 1996), the adenovirus- 
mediated forced expression of which inhibits p53- dependent apoptosis (Chiou et al., 
1994). This pathway can be inhibited by the kinase c -KIT, which stabilises the 
mitochondrial electrochemical gradient and inhibits ROS production, suggesting 
redox processes may be critical in p53- dependent apoptosis (Lee, 1998). Consistent 
with this model, p53 sensitises TNF- resistant tumour cells to TNF by increasing ROS 
and depleting GSH (Shatrov et al., 2000). 
In other circumstances, transcriptional activation by p53 is dispensable for the 
initiation of the death program. For example, p53- dependent apoptosis can occur in 
the presence of RNA and protein synthesis inhibitors (Caelles et al., 1994; Wagner et 
al., 1994) and p53 transactivation -mutants are capable of apoptosis, albeit at a slower 
rate than wild type p53 (Haupt et al., 1995; Chen et al., 1996). It is now clear that 
p53 can activate apoptosis via either pathway, and that the route taken is determined 
by the origin of the cell (Haupt et al., 1996). 
Since p53 is able to initiate growth arrest or apoptosis, the question arises over how 
the cell decides its fate. As the level of injury is known to regulate the cellular 
outcome, with minor injuries inducing cell cycle arrest and extensive injuries 
triggering apoptosis, the degree of damage sustained by p53 gene is a candidate 
mechanism (Chen et al., 1996). This model could operate via injury to or mutations 
in the sequence -specific DNA -binding region, yielding a molecule capable of 
transactivating genes only containing strong promoter motifs. Examination of p53 
point mutants showed they were indeed able to differentiate between p53 target 
promoters, remaining active toward p21 (favouring G1 arrest) but became inactive 
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towards bax and IGF -BP3 (disfavouring apoptosis) (Friedlander et al., 1996; Ludwig 
et al., 1996). In support of this, the preferential transactivation of particular genes has 
been reported for wild -type p53 in some instances (Nakano et al., 2000), with a 
tentative role for phosphorylation (Wang et al., 1995; Bouvard et al., 2000). Whether 
this system is responsible for making critical cellular decisions remains to be shown. 
Of note, p21 seems to be transactivated irrespective of the cellular outcome. 
Inhibition of cell death in a variety of cell types leads to G1 arrest, suggesting that 
without downstream prevention, the default outcome is growth arrest. 
L5.4.2 Reversible or irreversible cell cycle arrest 
The p53 -transactivated p21 gene plays a prominent role in the initiation of growth 
arrest following DNA damage. At high concentrations, such as those provoked by 
p53, p21 complexes with and potently inhibits several members of the cdk family, 
including cyclin E /CDK2, cyclinD /CDK4 /6 and cyclinA/CDK2 (Dulic et al., 1994), 
which prevents entry to S -phase via Rb (Slebos et al., 1994). However, fibroblasts 
isolated from p21 -/- embryos have only a partial attenuation of G1 arrest following 
DNA damage (Deng et al., 1995; Brugarolas et al., 1995). Thus arrest of the cell 
cycle is not always wholly dependent on p21. In line with this, p53 has been shown 
to play a role in inhibiting G1 /S transition via direct association with cyclin H/CDK7 
(Schneider et al., 1998). Interestingly, oxidant -induced growth arrest that is 
independent of p53 but directly dependent on p21 has been noted in lung epithelial 
cells (Corroyer et al., 1996; O'Reilly, 2001; Rancourt et al., 2001). 
P53 is also thought to have a limited function in the G2 checkpoint (Guillouf et al., 
1995), G2/M phase transition (Agarwal et al., 1995; Stewart et al., 1995), centrosome 
regulation (Fukasawa et al., 1996) and possibly the mitotic spindle checkpoint in 
cells bearing spindle damage (Lanni and Jacks, 1998). 
Originally, it was believed that the p53 -dependent arrest of the cell cycle opened a 
temporal window for DNA repair to occur. However, distinct from transient G1 
arrest or apoptosis, the response of some cells to genotoxic stress can be an 
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irreversible G1 growth arrest (Toussaint et al., 2000). Non -neoplastic cells naturally 
lose replicative potential after a certain number of cell divisions (Hayflick and 
Moorhead, 1961; Hayflick, 1991), whereby they assume a stable metabolic 
condition, known as replicative senescence, for a period which can run into years. 
Senescent cells are further characterised by an enlarged cell volume (Smith and 
Lincoln, 1984), elevated activity of a unique ß- galactosidase (Dimri et al., 1995), 
upregulated p21 levels (Cristofalo et al., 1992; Campisi, 1992) and resistance to 
physiologic mitogenic (Goldstein, 1990; Campisi, 1996; Smith and Pereira -Smith, 
1996) or apoptotic stimuli (Wang et al., 1995). These characteristic morphological 
and biochemical alterations may, after exposure to oxidants or other cytotoxic 
compounds, be prematurely induced well below the normal number of cell divisions, 
reviewed in Chen et al., 2000. 
Work to elucidate whether p53 functions in senescence has shown that enhanced p53 
proteolytic degradation in normal HDFs (human diploid fibroblasts) can delay 
replicative senescence (Shay et al., 1991). In addition, embryonic fibroblasts derived 
from p53 -/- animals can proliferate for over 50 passages in vitro, whereas 
heterozygote and wild -type fibroblasts enter senescence around passage 20 (Harvey 
et al., 1993). Senescence has also been correlated with increased p53 activity (Atadja 
et al., 1995) and re- introduction of p53 to a previously immortal cell line (Sugrue et 
al., 1997). However, there is contradictory evidence. For example, SV40 large T 
antigen- mediated inactivation of p53 in senescent cells permits some cells to initiate 
DNA synthesis, but these cells fail to replicate (Ide et al., 1983; Gorman and 
Cristofalo, 1985). Furthermore, HDFs cultured in the presence of p53 antisense 
oligonucleotides had a lifespan similar to untreated HDFs (Hara et al., 1991). Clearly 
further research is required to elucidate the role of p53 in senescence. 
15.4.3 DNA repair 
Activation of p53 after genotoxic stress leads to transitory cell cycle arrest, 
senescence or apoptosis. While initiation of the death programme circumvents the 
requirement to maintain the fidelity of the genome, transient growth arrest exists to 
permit the repair of damaged DNA. Logically, p53- dependent transactivation of 
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DNA repair genes could therefore follow. Until recently, no such genes were known. 
However, using differential display, Tanaka et al identified the p53R2 gene as a 
transcriptional target for p53. This encodes a protein closely related to ribonucleotide 
reductases, which are important in DNA repair by providing a supply of 
deoxyribonucleotides (Jordan and Reichard, 1998). p53R2 is upregulated in response 
to diverse stress stimuli (Nakano et al., 2000) and p53R2 inhibition during genotoxic 
stress results in reduced DNA reduced repair and cell survival (Tanaka et al., 2000). 
This data is evidence for a direct link between p53 and the repair of damaged DNA. 
However, other data regarding the involvement of p53 in DNA repair is 
contradictory. Different groups conclude p53 deficiency results in reduced DNA 
repair (Ford and Hanawalt, 1995; Ford and Hanawalt, 1997), no alteration in the rate 
of repair (Ishizaki et al., 1994; Sands et al., 1995) and increased rate of repair (Prost 
et al., 1998). 
In addition to the transcription of genes involved in DNA repair, p53 can directly 
interact with pre- existing DNA repair proteins. In particular, an association between 
p53 and helicase members of the multiprotein TFIIH, which initiates basal 
transcription of RNA polymerase II and couples transcription with NER (nucleotide 
excision repair) has been reported (Xiao et al., 1994; Wang et al., 1995; Leveillard et 
al., 1996). The effect of this interaction is inhibition of helicase activity. 
Furthermore, p53 is known to bind DNA strand breaks (Bakalkin et al., 1995), 
mismatches (Lee et al., 1995) and the Rad51 protein, a RecA homolog purported to 
constitute part of the cellular recombination machinery (Buchhop et al., 1997) 
(discussed in section 4.2.2). Consistent with this, p53 is also known to catalyse DNA 
renaturation and strand transfer (Brain and Jenkins, 1994; Yokote et al., 1998). 
Even in its latent form, p53 may have a role to play in DNA repair. P53 can bind 
single strand nucleotides, anneal DNA or RNA (Oberosler et al., 1993) and recognise 
1 -3bp mismatches (Lee et al., 1995). Exonuclease activity is central to the 
recognition of damage prior to restoration via the mismatch repair pathway. The 
intrinsic 3' -5' exonuclease activity of unactivated p53 may link it with the tumour 
suppressor Msh2 (Janus et al., 1999). Circumstantial evidence to support this comes 
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from mouse models: loss of either p53 or msh2 results in increased incidence of 
colon carcinomas (reviewed in (Bodmer et al., 1994), and Msh2 -/- p53 -/- mice 
develop tumours significantly earlier than either of the single mutants (Cranston et 
al., 1997). 
Furthermore, overexpression of p53 with nuclear extracts in vitro enhanced the BER 
pathway (outlined in section 1.2.2), an effect nullified by p53 depletion (Offer et al., 
1999). Lastly, p53 has been demonstrated to bind RPA (replication protein A) in 
vitro and in vivo, a DNA unwinding and synthesis factor required for NER (Li and 
Botchan, 1993). Formation of the p53 -RPA complex also inhibits p53 sequence 
specific DNA binding (Miller et al., 1997) by effectively sequestering p53, though 
UV treatment has been demonstrated to dissociate the p53 -RPA complex in vivo. Via 
this route DNA damage can increase the levels of free p53 (Abramova et al., 1997), 
then able to participate in transactivation and protein -protein associations. Further 
investigation should reveal whether these are important events in the repair of 
genome injury. 
1.5.5 Role of p53 in development 
Considerable attention has been focused on the contribution of p53 in embryonic 
development. Undifferentiated ES (embryonic stem) cells express high levels of p53 
and respond to UV- induced damage by undergoing apoptosis, whereas differentiated 
cells have lower levels of p53 and are relatively UV resistant. Indeed, a number of 
studies closely correlate p53 activity with the degree of differentiation (Louis et al., 
1988; Sabapathy et al., 1997). 
The generation of p53 -/- mice permitted analysis of p53 function throughout 
embryogenesis. Unexpectedly these mice were viable, though close inspection 
revealed an increased incidence of exencephaly and associated defects in neural tube 
closure. This suggests a role for p53 in neural tube development (Armstrong et al., 
1995; Sah et al., 1995). p53 also functions in the reproductive potential of offspring, 
as male mice show defective spermatogenesis (Rotter et al., 1993) and females a 
lower fertility than wild -type littermates (Armstrong et al., 1995; Donehower, 1996). 
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Finally, delayed cartilage maturation is observed in p53 -/- embryos, identifying a p53 
function in skeletal regulation (Ohyama et al., 1997). 
In contrast to p53, embryos deficient for the p53 negative regulator, mdm2, are non- 
viable at an early stage. Significantly, viability of mdm2 null mice is fully restored in 
the absence of p53. P53 overexpression is similarly detrimental to development (Li 
and Jaiswal, 1994; Jones et al., 1995; Nakamura et al., 1995; Godley et al., 1996). 
Together these findings suggest that a correct balance of p53 activity is critical for 
embryogenesis. 
Finally, p53 is implicated in the embryonic response to genotoxic stress. A role for 
p53 as a teratological suppressor was suggested on the basis of the ability of p53 to 
inhibit the effects of the teratogens benzo[a]pyrene or y- irradiation on mouse 
embryonic development (Nicol et al., 1995; Norimura et al., 1996), possibly by 
protection against ROS- induced DNA damage (Winn and Wells, 1995; Liu and 
Wells, 1995). As with most other aspects of p53 function, there are exceptions. 
Wubah and colleagues demonstrated the genotoxic agent 2- chloro -2- deoxyadenosine 
caused a 73% incidence of eye abnormalities in wild -type embryos, compared with 
52% and 2% in p53 + /- and p53 -/- embryos, respectively (Wubah et al., 1996). 
Overall however, there is robust evidence that p53 efficiently deletes embryo cells 
with DNA -damage. Indeed, it has been predicted over 50% of foetuses do not 
survive to childbirth due to p53- dependent mechanisms resulting in unrecognisable 
spontaneous abortions (Boue et al., 1985; Gilbert, 1991; Hall and Lane, 1997). This 
would make good evolutionary sense, if failure to abort foetuses bearing DNA 
damage generated progeny with compromised reproductive potential (Choi and 
Donehower, 1999). 
1.6 Rationale of the thesis 
Many disparate factors are orchestrated to protect mammalian cells from endogenous 
and exogenous oxidative injury. The GSH- mediated response constitutes a broad, 
potent and inducible antioxidant screen that is likely to play a pivotal role in 
protecting against oxidative injury and maintaining cellular redox homeostasis. It is 
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primarily executed through the transcriptional control of yGCSh and related genes, to 
effect an increase in GSH, though the mechanisms underlying this response are 
complex and only partly elucidated. A variety of studies point toward a critical role 
for GSH during normal development (Nasr -Esfahani and Johnson, 1992; Gardiner 
and Reed, 1995a; Shi et al., 2000), in addition to protecting the foetus from stress - 
induced oxidative damage (Trocino et al., 1995; Ishibashi et al., 1996; Sakamaki et 
al., 1999). Despite being implicated in the earliest stages of embryogenesis, the 
functional consequences of a constitutive GSH depletion on development were not 
conclusively known at the outset of this project. 
The correct kinetics of cell death, in addition to growth, are central to normal 
development. It is here hypothesised that absence of the GSH- system would impact 
upon the capacity to recover and continue cycling. Additionally it is proposed that, 
subsequent to redox alterations within cells caused by GSH loss, the ability to enter 
apoptotic pathways will be affected. If either of these processes were disrupted, 
subsequent analysis of the mechanism underlyling them may yield information on 
how to limit abnormalities arising in utero. 
To test these hypotheses, two strategies were employed. First, a gene targeting 
strategy was adopted to generate a murine ES (embryonic stem) cell line bearing a 
deleted yGCSh allele. Prior to attempting to complex tissue specific or inducible 
targeting technology, a replacement approach was chosen to constitutively delete 
yGCSh in all tissues. 
To understand the effects of constitutive yGCSh and GSH deficiency, it is necessary 
to first understand the normal situation. To date, the majority of studies investigating 
the cytotoxicity of oxidative stress have utilised the culture of primary or 
transformed cell lines for limited periods of time ( <48 hours). ES cells, the 
pluripotent progenitors of all subsequent development, proliferate continuously in 
culture (section 4.4). However, ES cells are non -transformed and exhibit normal 
growth and responses to damage characteristic of that in vivo. These traits permit 
analysis of the long -term effects of oxidative stress on healthy mammalian cells. 
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Second, therefore, unmodified ES cells - a cell type in which very little oxidative 
stress work has been carried out, were used to investigate the response to oxidative 
stress induced by the pro- oxidant menadione (MQ). MQ can introduce DNA strand 
breaks, though this damage has been dissociated from immediate cell death in 
hepatocytes (Coleman et al., 1989) and fibroblasts (Renzing et al., 1996). In 
embryonic development, however, such damage to DNA propagated through 
successive rounds of replication may accumulate to the long -term detriment of the 
organism. 
Factors involved in the maintenance of cellular integrity ultimately act to preserve 
the well being of the organism. p53, by delaying DNA replication until DNA repair 
is complete and eliminating heavily damaged cells from the population, similarly 
acts to safeguard the integrity of the cell. In addition to its role as a tumour 
suppressor gene there is evidence that p53 also plays a significant role in promoting 
normal embryogenesis. How p53 performs this function is unclear. Several studies 
have attributed the cause of drug- induced birth defects to oxidative DNA damage 
(Winn and Wells, 1995; Baek et al., 2000; Liu and Wells, 1995) and here it is 
proposed that p53 is a major factor in deleting cells injured by oxidative stress during 
development. 
Oxidative stress can activate the p53 response in a wide repertoire of cell lineages of 
normal and neoplastic origin. ROS can also operate as downstream effectors in 
apoptosis, via p53- dependent upregulation of redox -related genes. In light of this, a 
possible functional relationship between GSH and p53 is hypothesised. If p53 
modulates the GSH response directly via yGCS transactivation or indirectly by other 
mechanisms, then p53 deficiency would attenuate the GSH response. Furthermore, if 
embryonic cell death is indeed due to oxidative stress- induced p53- dependent 
apoptosis, then a deficiency in p53 would be expected to increase resistance against 
oxidative injury. These suppositions are directly tested in this thesis by the use of 
gene targeted p53 -/- cells. 
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This thesis explores the relationship between oxidative stress, p53 status and 
glutathione levels, and directly tests whether p53 mediates resistance to oxidative 
stress through regulation of GSH levels in ES cells. 
1.6.1 Specific aims 
This thesis sets out three main objectives. (1) To isolate, clone and characterise both 
novel mouse yGCSh cDNA, and a large (10 -20kb) portion of mouse gene sequences. 
(2) Analyse the impact of a permanent GSH deficiency, using gene targeting 
technology. To achieve this, the gene sequences generated will be used for the design 
and construction of a targeting vector. Electroporation of this plasmid into mouse ES 
cells is anticipated to deactivate the endogenous yGCSh gene. Culture of 
heterozygotes in high G418 is a technique used routinely to render cells 
homozygous. Comparison of the survival, GSH levels and apoptotic rates between 
yGCSh -/- and unmodified ES cells would show the impact of GSH loss (3) To 
characterise the role of GSH and p53 in response of ES cells to oxidative stress. 
Initially, to determine baseline responses of genetically normal ES cells to GSH 
depleting agents and pro- oxidative compounds to isolate suitable agents for further 
study. Use of the selected compounds will allow investigation of the cellular 
responses of cell proliferation, death and GSH levels to redox imbalance. 
Comparison of the responses made by wild -type and p53 -/- ES cells will reveal any 
role of p53 in these parameters, and show whether a causal association between these 
factors and viability exist in early embryogenesis. 
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Chapter 2 
Materials and Methods 
2.1 Manipulation of RNA 
2.1.1 Extraction of RNA from fresh tissue 
Following removal from the host animal, samples of fresh tissue were immediately 
frozen in liquid nitrogen, then rapidly transferred to -80 °C storage prior to use. 1 ml 
TRIZOL was added per 100mg fresh tissue and homogenised thoroughly using a 
"drill -bit" homogeniser. For subsequent treatment, see section 2.1.2. 
2.1.2 Extraction of RNA from cultured cells 
Cell cultures had media aspirated and were washed xl in PBS. 1ml of TRIZOL 
Reagent (Gibco -BRL) was added per 10cm2 of culture dish and left at room 
temperature for approximately 2 minutes. The resulting whole cell lysate was passed 
several times through a blue (p1000) pipette tip, transferred to a RNase -free 
eppendorf tube and the RNA cleaned as described (section 2.2.4). 
RNA was washed by removal of supernatant from the pellet, and addition of 1 ml 
70% ethanol per 1ml of TRIZOL reagent used. Samples were vortexed thoroughly 
and centrifuged at 10,000 rpm for 5 minutes at 4 °C. Ethanol supernatant was 
discarded and the RNA pellet briefly air -dried for 5 to 10 minutes. Pellets were 
resuspended in an appropriate volume of RNase -free water by passing the solution 
several times through a yellow (p200) tip and incubating at 55 °C for 10 minutes. 
2.1.3 Generation of cDNA from RNA template with reverse transcriptase 
For first strand cDNA synthesis 1111 Oligo (dT)15 at 100ng, 1 -5µg total RNA and 
12111 DEPC treated dH2O were added to PCR tubes. Samples were mixed, incubated 
at 70 °C for 5 minutes and left to slowly cool to ambient temperature. The contents of 
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tubes were collected by centrifugation and placed on ice. 441 5X First Strand Buffer 
(Gibco BRL; supplied with enzyme), 241 0.1M, DTT 141, 10mM and dNTP mix 141 
(200 units) of Superscript II (Gibco BRL) were added to the tubes. The contents were 
mixed and subjected to the following cycle: 37 °C for 10 minutes; 42 °C for 60 
minutes and 50 °C for 10 minutes. 801.41 sterile H2O was added and the reaction 
inactivated by incubation at 94 °C for 10 minutes. 5 -2041 of the sample was used as 
template in conventional PCR reactions (see section 2.2.1). 
2.2 Manipulation of DNA 
2.2.1 PCR amplification of DNA 
Two types of PCR reactions were employed, "standard" and "Hi- Fidelity ", 
distinguished by the type of polymerase and contents of reaction buffers. All 
standard and high Hi- Fidelity PCR reactions were performed in a Hybaid Omni Gene 
DNA thermocycler and only cycle conditions were varied to enable optimisation of 
specific template amplification for each individual primer pair (detailed at each 
relevant section throughout thesis). 
Primers and PCR conditions used for the amplification of 7GCSh sequences are 
shown in table 2.1. All reactions were subject to an initial cycle of 3 minutes at 94 °C; 
1 minute at 57 °C and 72 °C for 2 minutes. A final extension step of 72 °C for 10 
minutes was also included. For intermediate cycle conditions refer to relevant PCR 
reaction in table 2.1. 
Once prepared, individual standard or Hi- Fidelity PCR reaction tubes were 
transferred to a dedicated template loading area where 141 of template was added to 
each sample, excepting negative control (approx. 300ng genomic DNA or 141 of a 
10-6 plasmid dilution). 6041 of paraffin oil was overlaid to reduce sample evaporation 
during thermocycling. 
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Table 2.1 Amplification of yGCSh sequences 
Up- indicates upstream primer, Rev -indicates downstream primer. The same 








5' RT -PCR 
no product 
5' Up - ATGGGGCTGCTGTCCCAGG 
Rev 3- CATTTTGAGAATATTCAGTC 
94 °C 30s 
57 °C 30s 
72 °C 120s 
MgZ+ @ 1, 1.5 and 2mM 
Annealing @ 59, 55 and 
53 °C 
Central RT -PCR 





Up2 - AGGAGAAAAGGTTGTCATCA 
Rev2 - ATGTACCTACGGTACCCTA 
Up3- TGCTCATCTCTTTATTAGAGA 
Rev3- TCGAGTAGAGAAATAATCTCT 
Up4 - ATCCTGACTACAAGCAAGACA 
Rev4 - TAGGACTGATGTTCGTTCT 
Up2 +Rev4 
94 °C 30s 
57 °C 30s 
72 °C 30s 
as above 
as above 
94 °C 30s 
57 °C 30s 
72 °C 90s 
MgZ' @ 1.5Mm 
Mgt+ @ 1.5mM 














94 °C 30s 
57 °C 30s 





MgZ` @ 1.5mM 
Mgt, @ 1, 1.5 and 2mM 





RevB- CJIIICTCCT CTCCGATGCC 
94 °C 30s 
57 °C 30s 
72 °C 90s 
MgZ' @ 1.5mM 
76 
All PCR reactions were "hot- started" to reduce the potential amplification of 
background templates. Samples were pre- heated to 94 °C for 1 minute prior to 1St 
cycle and 111l respective Taq DNA polymerase (Life technologies or ClonTech) was 
added to each sample tube below the paraffin oil. 
Standard PCR 
The following reaction mix was prepared:10111 l0X PCR reaction buffer (Life 
technologies), 6111 50mM MgC12 (Life technologies), 8111 1.25mM dNTP stock mix 
(Pharmacia Biotech), 11.1,1 100pmo1 /111 each primer A and B (Genosys) and ddH2O to 
98111. 
Hi- Fidelity PCR 
The following reagent mix was prepared: 2111 50X polymerase buffer with 15mM 
MgC12 ( ClonTech), 2111 50X dNTP mix (ClonTech), l00 10X High Fidelity PCR, 
reaction buffer (ClonTech), 1µl 100pmol/pl each primer A and B (Genosys), and 
ddH2O to 981l. 
2.2.2 Restriction endonuclease digestion of DNA 
Examples of typical restriction digest reaction volumes are detailed in table 2.2. 
These include routine volumes for the analysis of plasmid DNA, for the cloning of 
plasmid DNA and for the analysis of genomic DNA. Although total reaction 
volumes and incubation times differed for each application of this technique, the 
relative volume of restriction enzyme(s) were consistent and never exceeded 10% of 
the total reaction volume. To ensure complete cleavage, restricted DNA was 
electrophoresed through an agarose gel containing 0.1mg /m1 ethidium bromide and 
visualised using ultra- violet light. Molecular weight markers were loaded to 
determine size of fragments. The concentration of agarose in the gels was varied 
between 0.7 and 3% depending on the size of the fragments to be separated. 
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Table 2.2 Restriction analysis of DNA 




NEB 10X buffer, µl 2 1 5 3 
DNA, µg 0.2 /PCR -1 -15 10 
RNAase A, µl 0 0.5 0 0 
dH2O to increase total 
reaction volume to, pl 
20 10 50 30 
Restriction enzyme, µl 2 1 5 3 
Incubate at appropriate 
temperature for, hrs 
3 3 3 12 
2.2.3 Extraction of DNA fragments from agarose gels 
DNA fragments were isolated from agarose gels using the Qiaex II gel extraction kit 
(Qiagen). Appropriate fragments were excised from the gel using a sterile scalpel 
blade and placed into a pre- weighed 1.5ml microfuge tube. The microfuge tube was 
re- weighed to determine the weight of the gel slice. 300µ1 of QX1 buffer was added 
per 100mg of gel slice to solubilise the agarose, dissociate DNA binding proteins 
from the DNA fragment and give a suitable pH to allow absorption of the DNA 
fragment to the Qiaexll silica particles. QiaexIl particles were vortexed, 10111 of the 
solubilised sample added and incubated at 50 °C for 15 minutes. Particles were 
washed with QX1 buffer and 80% ethanol. Pelleted particles were vacuumed dry and 
DNA eluted with 2O1A1 of sterile dH2O. 
2.2.4 Purification of DNA 
An equal volume of phenol:chloroform:isoamyl alcohol was added to the sample 
volume and mixed to form an emulsion. This was centrifuged at 12,000rpm for 5 
minutes at room temperature. The clear aqueous phase was pipetted to a new tube, 
exactly two volumes of ice -cold absolute ethanol added to the aqueous phase and 
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mixed to form a visible DNA precipitate. The DNA mix was placed at -20 °C for 15- 
30 minutes, then centrifuged at 12,000rpm for 10 minutes at 4 °C. Pellets were 
washed and dried in air or under vacuum. Dry pellets were dissolved in the desired 
volume of dH2O or TE and stored at -20 °C until required for use. 
2.2.5 Dephosphorylation of vectors 
Following restriction, the intended vector sequence was added to the digests and 
incubated with 11l appropriate 10x reaction buffer, 8111 dH2O and 11l Shrimp 
Alkaline Phosphate (SAP). Samples were vortexed and the reaction incubated at 
37 °C for 1 hour. SAP was heat inactivated by incubation at 65 °C for 10 minutes. 
This step, though optional, reduces the frequency of background cloning products 
considerably by preventing the recircularisation of vector sequences in the absence of 
insert. Enzymatic treatment with SAP removes the 5' terminal phosphate groups 
from linearised vector sequence and thus prevents the ligation of free vector ends in 
the absence of insert sequence. 
2.2.6 Rapid ligation of DNA fragments 
This section details protocols used to clone fragments of DNA into plasmid vector 
backbones. This technique is applicable when the restriction enzyme(s) used in the 
preparation of DNA vector and insert are either identical and thus generate identical 
5' or 3' overhangs, or are different but generate compatible 5' or 3' overhangs. 
Both insert and dephosphorylated vector were cut with the appropriate restriction 
enzyme(s), as described (section 2.2.2). DNA was run in a 0.7% agarose gel (or 
appropriate) to separate desired DNA fragments from all non -required or undigested 
sequences present in the sample. The appropriate digested vector and insert bands 
were excised from the gel with a scalpel blade and purified using QlAquick Gel 
extraction kit (Qiagen): see section 2.2.3. 10% of the gel- purified vector and insert 
fragments were run on a 0.8% agarose gel beside known DNA standards. This step 
enabled evaluation of the integrity of the purified DNA fragments. DNA bands that 
appeared slightly diffuse or "smeary" were not used to attempt cloning, since this 
indicates poor integrity and /or degradation of the desired DNA fragment. The 
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concentrations of both vector and insert were determined using ethidium bromide 
plates. Plates contained 1% agarose in 1 x TBE buffer with 0.1 mg /ml of ethidium 
bromide. Both 1µl of samples and 111l standard DNA of known concentration 
ranging from 3ng /µ1 to 125ng /ul were pipetted onto the plate. Plates were left at 
room temperature for 25 minutes and viewed under ultraviolet light to estimate the 
concentration of unknown samples against the standards. Ligations using 5Ong of 
vector and a vector to insert molar ratio of 1:3 were prepared. This was calculated by 
the conversion of molar ratio to mass ratio using the following equation: 
10Ong of vector x Kb size of insert x molar ratio of insert = ng of insert 
Kb size of vector vector 
The following preparatory ligation reaction was set up: l0111 2x T4 DNA ligation 
buffer and l01.11 DNA (vector to insert in 1:3 ratio) in lx DNA dilution buffer. This 
was thoroughly mixed, and 1µ1 T4 DNA ligase (Boehringer Mannheim) added, 
mixed again thoroughly prior to incubattion at room temperature for 10 minutes. 
Competent bacteria were subsequently transformed with ligation reaction as 
described (section 2.2.7). 
2.2.7 Heat -shock transformation of competent E co /iwith plasmid DNA 
100µ1 aliquots of competent XL -1 blue E. coli (Stratagene) were removed from - 
70°C and thawed in a pre -chilled Falcon tubes on ice. ß- mercaptoethanol was added 
to give a final concentration of 25mM. Either 5Ong of supercoiled plasmid DNA, or 
10% volume of a plasmid DNA ligation mixture was added to the thawed cells. 
Samples were gently mixed by stirring with a p200 pipette tip, maintained on ice for 
a further 30 minutes then heat -shocked at 42 °C for 45 seconds, before being replaced 
on ice for 2 minutes. 9541 of preheated (37 °C) LB broth was added to each sample 
tube and incubated at 37 °C shaking at 225 rpm for 1 hour. Routine transformation of 
supercoiled plasmid DNA was achieved by plating 204t1 of each transformation 
onto LB -agar plates containing the antibiotic ampicillin. Plates were inverted and 
incubated at 37 °C overnight. The L -broth supports the growth of E. coli cells and the 
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ampicillin selects for bacterial colonies that have successfully been transformed with 
the plasmid, as the plasmid contains the ampicillin resistance gene. 
2.2.8 E co / /cultures and plasmid isolation 
Miniprep (small scale preparations) 
The preparation of plasmid DNA by this method produced between 20 -50µg DNA. 
This method was routinely used to provide sample DNA for the analysis of cloning 
steps involved during the construction of all vectors detailed within this thesis. For 
all buffer compositions, refer to Appendix II. 
5m1 of LB media (supplemented with appropriate antibiotic) in a white- capped 
universal tube (Griener) was inoculated with a single bacterial colony previously 
grown on a LB -agar plate. Samples were incubated at 37 °C overnight with vigorous 
shaking (225rpm). To promote efficient growth of bacterial culture, lids of universal 
sample tubes were left slightly loose to enable good oxygenation of sample. 
The Following Day 
1.5ml of each turbid sample was removed, spun at 4,000rpm for 5 minutes on a 
desktop microfuge (Sanyo) and all LB supernatant carefully removed and discarded. 
l00µ1 of ice cold resuspension buffer was added to remaining pellet and vortexed 
vigorously to ensure complete resuspension of pellet. 250µ1 of lysis buffer was added 
and the tubes gently inverted 4 -6 times to mix the sample. Bacterial suspensions 
should have become viscous and slightly clear. 3501.11 of neutralisation buffer was 
added, the tubes again gently inverted 4 -6 times to mix the sample which forms a 
cloudy white precipitate. To prevent shearing of bacterial genomic DNA and 
subsequent contamination of final plasmid DNA preparation, sample tubes were not 
vortexed at these two latter stages. Samples were incubated on ice for 5 minutes 
before centrifugation at full speed (13,000 rpm) on a desktop microfuge for 10 
minutes. 
Plasmid DNA was purified using the Qiaprep Spin System (Qiagen). The supernatant 
was carefully transfered to a QlAprep spin column in a 2m1 collection tube, spun for 
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1 minute and the flow -through discarded. Spin columns were washed by adding 
0.5ml of 95% ethanol and centrifugation for 1 minute. Flow- throughs were discarded 
and to completely remove residual ethanol, which may inhibit subsequent enzymatic 
reactions, spin columns were centrifuged for an additional 1 minute and residual wash 
buffer removed. 
Maxiprep (large scale preparations) 
The preparation of plasmid DNA by this method produced between 200 -50014 
DNA. The method employed used QIAGEN columns to produce very high quality 
plasmid DNA in large quantities, suitable for the purposes of mammalian cell 
transfection and DNA sequencing. 
Sterile 500m1 conical flasks containing 100m1 of LB media (supplemented with 
appropriate antibiotic) were inoculated with with a single bacterial colony previously 
grown on a LB -agar plate. The top of the conical flask was loosely covered the with 
tinfoil and samples incubated at 37 °C overnight with vigorous shaking (225rpm). 
The Following Day 
Plasmid isolation from bacterial cultures of 100m1 or more were carried out using the 
QIAGEN plasmid maxi prep kit. This is a scaled up version of the miniprep 
technique with the following alternative steps. Following addition of neutralisation 
buffer, mixtures were on ice for 20 minutes prior to centrifugation at 20,000 g for 30 
minutes at 4 °C. Supernatents were removed promptly and the supernatent applied to 
the QIAGEN -tip to allow it to enter the resin by gravity flow. QIAGEN -tips were 
washed with 2x 30m1 95% ethanol and the DNA eluted with 15ml elution buffer. 
DNA was precipitated by the addition of 10.5m1 (0.7 volumes) isopropanol to the 
eluted DNA, mixing and immediate centrifugation at 15,000 g for 30 minutes at 4 °C. 
Supernatent was carefully decanted, the DNA pellet washed with 5ml 70% ethanol 
and centrifuged at 15,000 g for 10 minutes. Supernatent was carefully decanted to 
prevent disturbing the pellets, which were air -dried for 10 minutes and the DNA re- 
dissolved in 50m1 TE, pH 8.0. 
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2.2.9 Dideoxy- sequencing of plasmid DNA 
To optimise sequencing results, plasmid DNA of the highest quality was used and 
prepared with a QIAGEN Maxiprep column. dH2O was added to 10µg of plasmid 
DNA to make a final volume of 45111 and DNA denatured by the addition of 5µ1 of 
2M NaOH, 2mM EDTA. Samples were thoroughly mixed by inversion and kept at 
room temperature for 5 minutes, and this strong alkali neutralised by addition of 5µ1 
of 2M ammonium acetate, pH 4.6 and vortexing. To precipitate DNA, 185µ1 of ice - 
cold absolute ethanol was added, the tube vortexed and placed at -70 °C for 30 
minutes. Sample tubes were spun at 13,000 rpm for 10 minutes at 4 °C and the 
supernatant decanted. Pellets were washed Xl with 2O0111 ice -cold ethanol, dried 
under vacuum for approximately 15 minutes before resuspension in 6µl of dH2O. 
Sequencing primers were annealled by addition of 2µl 5X Annealing Buffer (USB) 
and a 21.11 volume (0.5pmol) of primer to resuspended DNA. Samples were heated to 
65 °C for 2 minutes, the temperature then allowed to drop slowly (approx. 30 
minutes) to room temperature before chilling on ice. 2.5µl of each dideoxy 
termination mix (USB) was added to 4 eppendorfs and pre -warmed to 37 °C. To the 
annealed reaction tube 1µl of 0.1M DTT, 2µ1 Labelling Nucleotide Mix (USB), 0.5111 
or 5 tCi radio -labelled dATP (a -S35) and 2µl of a 1:8 diluted stock of Sequenase 
Enzyme (USB) was added. Where sequencing of DNA close to primer was required, 
1µl 0.1M MnC12, 0.15M sodium isocitrate further added. The total volume (approx. 
l5µ1) was mixed and incubated at room temperature for between 2 to 5 minutes, 
depending on requirement to read sequence either close or increasingly distant from 
the primer. 3.5111 of labelling reaction was transfered to each of the four pre -warmed 
dideoxy termination mixes, the termination reactions incubated at 37 °C for between 
2 -5 minutes before addition of 4µl of Stop Solution (USB). The sample was mixed 
and either kept on ice prior to running on a sequencing gel (see below), or stored at - 
20°C. 
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Preparation of a Polyacrylamide Sequencing Gel 
Two large sequencing plates were washed once with water and detergent, then 
washed once with acetone. The inner side of one plate was coated with "Gel- slick" 
(FMC BioProducts, USA) to facilitate the separation of both plates following 
electrophoresis of samples. The following were mixed in a 500m1 beaker: 80m1 
6 %Acrylamide, 6M Urea, 1X TBE, 8Oµ1 25% Ammonium Persulphate and 8Oµ1 
TEMED. Immediately following the addition of TEMED, the gel -mix was poured 
between the plates, an inverted sharks -tooth combs placed at the top of gel (to form a 
single large well) and left to polymerise at room temperature for between 45 to 60 
minutes. Following removal of comb, the gel was immediately transfered to an 
electrophoresis rig and positioned in the apparatus. Buffer tanks were filled with 1X 
TBE, and the single well rinsed out with buffer using a 50m1 syringe to ensure that 
all non -polymerised gel was washed out. Sharks tooth combs were replaced in the 
opposite orientation and pressure applied until the tips of the teeth penetrate about 2- 
3mm into the gel, forming individual wells in which to load samples. 
Denaturing PAGE of Sequencing Reactions 
Immediately prior to the loading of the sequencing reactions, the sequencing gel was 
pre -run at 40W, or 1.7kV for 20 minutes or until the temperature of the outer glass 
plate reaches approximately 50 °C. Samples were heated to 80 °C for 10 minutes and 
immediately placed on ice. 2111 of each reaction was loaded into wells, ensuring that 
the loading order of reactions is consistent (e.g. G, A, T, C from left to right) to 
enable subsequent interpretation of sequencing results. Samples were run at 40W or 
1.7kV until the bromophenol blue dye front from the samples reached the foot of the 
gel. If free wells were available, the current was stopped, samples reloaded in spare 
wells and the electrical current re- applied. Gels were run until either the 
bromophenol blue dye front of the newly loaded samples, or the cyanol blue of the 
original samples reached the foot of the gel. The electrophoresis rig was dismantled, 
taking great care since the bottom TBE buffer reservoir then contains S35 nucleotide. 
The glass plates were separated and one removed to expose the gel. The base plate 
was rested in a completely horizontal position, Gel Fix Solution poured over the 
entire surface area of the gel and left in contact with the gel for 10 minutes. The gel 
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was drained by carefully tipping the base plate, then removed by placing a piece of 
Whatmann 3MM paper on the gel surface, and peeling it away from the glass plate in 
one rapid and constant movement. The gel surface was covered in cling film and 
dried in a vacuum dryer at 80 °C for 2 hours, or until completely dry. The dried gel 
was placed in an autoradiography cassette, overlaid with a piece of Bio -Max MR -1 
film (Amersham) and sealed. Film was exposed to the gel at room temperature 
overnight and developed the following day. 
2.2.10 Southern transfer of plasmid and genomic DNA 
Genomic or plasmid DNA was digested overnight as described (section 2.2.2). 
Digests were run out on a 0.8% agarose gel until the 500óp DNA marker reached the 
foot of the gel, where upon the gel was photographed beside a ruler to enable 
accurate sizing of bands which subsequently hybridised to P32 radiolabelled probe. In 
instances where the fragment of interest was greater than 10Kó, depurination of 
DNA in situ was carried out prior to denaturation to increase the efficiency of DNA 
migration from the gel. The gel was transfered to a tray containing several volumes 
of depurination solution and soaked, with gentle agitation, for 10 minutes. After 
briefly rinsing with dH2O, the gel was placed in a tray containing several volumes of 
denaturation solution and gently agitated for 45 minutes. Subsequently the gel was 
rinsed with dH2O, transferred into a tray containing several volumes of neutralisation 
solution and left to soak, with gentle agitation, for 30 minutes before rinsing briefly 
with dH2O. 
Capillary transfer of DNA from gel to nylon filter 
A tray was filled with 10x SSC and a piece of plastic rested between the sides to 
form a platform over the 10 x SSC bath. the platform was wrapped with a piece of 
Whatmann 3MM filter paper soaked in 2 x SSC, ensuring that all trapped air bubbles 
that arise between paper and platform were removed and that the edges of the 3MM 
paper rest within the 10 x SSC solution. The neutralised gel was placed on top of the 
2 x SSC soaked 3MM paper. Strips of para -film were cut to cover all wet areas of the 
2 x SSC soaked 3MM paper not already covered by the gel, and a piece of Hybond- 
N+ (Amersham) nylon filter cut to size, was submersed in dH2O and placed on top of 
85 
was drained by carefully tipping the base plate, then removed by placing a piece of 
Whatmann 3MM paper on the gel surface, and peeling it away from the glass plate in 
one rapid and constant movement. The gel surface was covered in cling film and 
dried in a vacuum dryer at 80 °C for 2 hours, or until completely dry. The dried gel 
was placed in an autoradiography cassette, overlaid with a piece of Bio -Max MR -1 
film (Amersham) and sealed. Film was exposed to the gel at room temperature 
overnight and developed the following day. 
2.2.10Southern transfer of plasmid and genomic DNA 
Genomic or plasmid DNA was digested overnight as described (section 2.2.2). 
Digests were run out on a 0.8% agarose gel until the 500óp DNA marker reached the 
foot of the gel, where upon the gel was photographed beside a ruler to enable 
accurate sizing of bands which subsequently hybridised to P32 radiolabelled probe. In 
instances where the fragment of interest was greater than 10Kb, depurination of 
DNA in situ was carried out prior to denaturation to increase the efficiency of DNA 
migration from the gel. The gel was transfered to a tray containing several volumes 
of depurination solution and soaked, with gentle agitation, for 10 minutes. After 
briefly rinsing with dH2O, the gel was placed in a tray containing several volumes of 
denaturation solution and gently agitated for 45 minutes. Subsequently the gel was 
rinsed with dH2O, transferred into a tray containing several volumes of neutralisation 
solution and left to soak, with gentle agitation, for 30 minutes before rinsing briefly 
with dH2O. 
Capillary transfer of DNA from gel to nylon filter 
A tray was filled with 10x SSC and a piece of plastic rested between the sides to 
form a platform over the 10 x SSC bath. the platform was wrapped with a piece of 
Whatmann 3MM filter paper soaked in 2 x SSC, ensuring that all trapped air bubbles 
that arise between paper and platform were removed and that the edges of the 3MM 
paper rest within the 10 x SSC solution. The neutralised gel was placed on top of the 
2 x SSC soaked 3MM paper. Strips of para -film were cut to cover all wet areas of the 
2 x SSC soaked 3MM paper not already covered by the gel, and a piece of Hybond- 
N+ (Amersham) nylon filter cut to size, was submersed in dH2O and placed on top of 
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the gel. One side of the nylon filter was trimmed with a scalpel to facilitate 
subsequent orientation of the autoradiogram to the filter. Two pieces of Whatmann 
3MM paper were cut to the size of the gel, wet in 2x SSC and placed on top of 
Hybond -N+ filter. A stack of dry paper towels were placed on top of the wet 3MM 
paper, a glass plate was positioned over the top of the paper towel stack and weighed 
down with a heavy object. The edges of the tray were covered with cling -film to 
minimise the evaporation of 10 x SSC and left to transfer overnight. This procedure 
sets up a flow of liquid from the reservoir into the tray, through the gel and into the 
paper towels, transferring the digested DNA fragments from within the gel onto the 
nylon membrane. 
The following day, the stack was dismantled and Hybond -N+ filter completely dried 
between two sheets of 3MM Whatmann filter paper to ensure fixation of the DNA to 
the nylon membrane. 
2.2.11 Radiolabelling DNA probes with P32 by random priming 
All probes were labelled with the "High Prime" labelling kit (Boehringer 
Mannheim). 25ng of probe DNA and dH20 were combined in a single reaction tube 
to a volume of 114 The sample tube was boiled for 10 minutes, before briefly 
centrifuging to collect condensation and chilling on ice. 4111 of High Prime and 5p1 of 
1332 labelled dCTP (ICN) was added, mixed thoroughly and the reaction tube placed 
at 37 °C for a minimum of 10 minutes. At end of labelling reaction 2111 of 0.2M 
EDTA pH8.0 was added. 
Determination of radio -nucleotide incorporation 
The contents of a Sephadex G50 column (Amersham) was emptied and resin washed 
by allowing a minimum of 1 ml TE buffer to pass through the column. 2111 0.2M 
EDTA and 20111 10mg /ml Salmon sperm DNA were added to the sample, mixed 
thoroughly to stop the probe labelling reaction, and the total volume transferred 
directly onto Sephadex resin. 400111 TE was added directly onto the resin, and 
through flow collected. A second 400111 of TE was added to the resin, the probe - 
containing discharge secured in a screw -top eppendorf. Residual counts in the 
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Sephadex column were compared with those present in the fraction of TE containing 
labelled probe. 50% label incorporation was assumed if counts from both sources 
are approximately equal, which was the minimum radio -nucleotide incorporation 
efficiency that was used for subsequent experimentation. 
2.2.12Hybridisation of probe to DNA immobilised on nylon membrane 
The dry DNA -bound nylon membrane was rinsed in 2 x SSC solution. This was 
placed on top of a piece of dH2O -wetted nylon gauze, to ensure even distribution of 
probe over the entire surface of the DNA bound nylon membrane. The two pieces 
were rolled together to form a tube and placed inside of a Hybaid hybridisation tube. 
25ml of pre- hybridisation solution (with S00µ1 boiled l0mg /ml Salmon sperm DNA, 
Sigma) was added to the hybridisation tube and incubated with the membrane at 
65 °C in a rolling incubator for 3 hours. The P32 radiolabelled probe was boiled in a 
screw -top eppendorf (see section 2.2.10) for 10 minutes and pipetted into a blue - 
capped Falcon tube. The pre- hybridisation solution was immediately decanted into a 
Falcon tube containing the probe, inverted to mix, then quickly poured back into the 
Hybaid tube containing the membrane. The probe was incubated with the membrane 
at 65 °C, in a rolling incubator, overnight. The following morning, the 
probe /hybridisation solution was decanted from the Hybaid tube and rinsed twice 
with 2 x SSC. 100m1 Wash Solution I (pre- warmed to 65 °C) was added to the hybaid 
tube and incubated at 65 °C in the rolling incubator for 20 minutes before decanting. 
This step was repeated a further four times by sequentially adding 100m1 pre - 
warmed Wash Solution II through to V. This step removes non -hybridised and non- 
specifically hybridised probe from the nylon filter membrane. Following the last 
wash, the filter membrane was removed from the Hybaid tube, gently blot dried with 
a piece of Whatmann 3MM paper, sealed into a polythene bag and taped securely 
into an auto -rad cassette (with enhancer screens). A piece of KODAK Biomax MS 
film (Amersham) was laid onto the hybridised filter membrane and placed at -70 °C 
for between 1- 4 days prior to developing. 
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2.2.13 Plating k -PS genomic library 
The 2 -PS library was obtained from Molecular Biologische Technologie GmbH, 
Wagenstieg 5, D -37077 Gottingen, Germany. All recombinant DNA libraries 
contain a large number of bacteriophage plaques, each containing a relatively large 
amount of insert DNA. The technique of in situ plaque hybridization, originally 
described by Benton and Davis 1997 (Benton and Davis, 1977), identifies the 
location of specific DNA sequences of interest. The first step in the nucleic acid 
hybridization screening procedure is to grow large numbers of plaques on normal 
agarose plates. Replica copies of these colonies are transferred to nylon filters, 
where they can be screened. In this section the techniques for producing large 
numbers of plaques are outlined. 
To prepare plating bacteria (C600), a single colony of the bacterial strain C600 was 
grown in 50 ml of LB ++ (see appendix II) in a 250 ml flask, with vigorous agitation 
(250 cycles /minute in a rotatory shaker at 37 °C overnight). 50 ml was transferred into 
a sterile plastic tube, centrifuged at 2500g for 10 minutes, the supernatant decanted 
and the bacterial pellet resuspend in 25ml 20mM MgSO4. Plating bacteria were used 
up to five days hence if stored at 4 °C. To determine the titer a serial dilution of the 
library in SM was prepared as follows. 300111 of the C600 plating bacteria were 
infected with 1µl of a 10 -2, 10-3, 10-5, 10-6 dilution and incubated for 30 minutes at 
37 °C. In the meantime LB /MgSO4 8 cm diameter plates were warmed to 37 °C and 
the LB /top agar cooled to 55 °C, after melting in a boiling water bath. 4.5ml of the 
LB /top agarose was added to infected bacteria and poured onto the prewarmed 
plates, which were left at room temperature until solid before incubated in an 
inverted position at 37 °C overnight. The following day, the plaques were counted 
and the exact titer of plaque forming units ( pfu's) of the library stock calculated. 
To plate the library to guarantee complete representation of the genome, 2x106 pfu's 
were used for one library plating. 3 ml of C600 infected plating bacteria and 9m1 
LB /top agarose (kept at 55 °C) were poured onto prewarmed LB /MgSO4 plates (12cm 
x 12cm). To plaque blot, circular Hybond -N+ nylon filters (Amersham), pre- wetted 
in 2X SSC, were carefully laid on the agar surface. The membrane and agar were 
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marked using a sterile needle to ensure correct orientation of plaques. Using forceps, 
the filter was removed after 1 minute and placed, plaque side up, on sterile filter 
paper. The replica blots were treated as described (section 2.2.10). 
2.2.14 Isolation of genomic DNA by screening 2. -PS filters 
XPS is a replacement vector of lambda phage origin, containing DNA sourced from 
the mouse 129 Sv D3 strain. The linear vector contains two loxP sites in direct 
orientation flanking a high copy plasmid backbone (pBluescript) and approximately 
13kb of insert (Nehls et al., 1994). Recombination between these two sites is 
mediated by Cre recombinase, leading to the excision of the insert and multi -copy 
plasmid from the phage genome (see figure 3.11). Hence, this is termed automatic 
subcloning. It can be achieved simply by transferring the phage into the 
constitutively Cre- expressing E. coli strain BNN132. The process used to isolate 
genomic yGCSh sequences is outlined below. 
First, filter hybridization - as carried out as described previously (section 2.2.12). 
Any positive plaques were purified by 3 additional rounds of plating and 
hybridization. Plaques were picked using a glass pipette and transferred into a 
reaction tube containing 500µ1 SM/ 20µ1 Chloroform. The tube was vortexed and 
centrifuged briefly, then keep at 4 °C for further processing. Second, plating bacteria 
(BNN 132) were prepared. From BNN 132 cells grown on kanamycin plates 
(25pg/m1), a single colony was transfered into LB ++ medium and plating bacteria 
prepared as described for C600. Third, infection with purified phage. 200 of the 
purified phage stored in SM/Chloroform were added to 100µ1 of the BNN 132 plating 
bacteria. Phage- bacteria mixes were then incubated at 37 °C for 30 min, plated onto 
ampicillin plates (50µg/ml) and incubated overnight at 37 °C. Single colonies were 
picked and separately grown to saturation by vigorous agitation (250 cycles/ minute) 
in rotary shakers at 37 °C. Forth, plasmid DNA was isolated using standard protocols 
(section 2.2.8). 
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2.3 ES cell culture techniques 
2.3.1 Routine culture of ES cells 
ES cells were maintained in GMEM BHK -21 supplemented with non -essential 
amino acids, sodium pyruvate, L- glutamine, 10% foetal calf serum (Life 
Technologies) ß- mercaptoethanol (Sigma) and leukaemia inhibitory factor. 0.3x106 
cells /well were seeded in gelatinised 6 well plates (Greiner Laboratories) and 
propagated at 37 °C in 5% CO2, in a humidified atmosphere of 5% 02, 95% air. 
Medium was changed every day or every other day. 
Gelatinisation of tissue culture plates 
Swine skin gelatin (Sigma) was made up to 1% in dH2O, double autoclaved and 
stored at 4 °C (equivalent to a 10x stock solution). A sufficient volume to cover the 
entire base of tissue culture plate /wells was added and left for a minimum of 10 
minutes at room temperature to gelatinise the tissue plates, which were then ready for 
plating with ES cells. 
Passaging ES cells 
ES cells were routinely passaged 1 in 5 upon reaching approximately 70 -80% 
confluency. Culture media was refreshed approximately 3 hours prior to passaging 
cells by aspiration of medium and washing with an equal amount of warm PBS (Life 
Technologies). PBS was subsequently aspirated, pre -warmed 1% trypsin/EDTA 
(Gibco -BRL) added to cover the entire base of the tissue culture plate, and plates 
incubated for 2 -3 minutes at 37 °, with occasional agitation. The side of the 
flasks /plates were tapped to confirm, under magnification, that cells have detached 
from the gelatin to form a cell suspension. The trypsin was neutralised by promptly 
adding a minimum of 2 volumes of media, the cells diluted with medium as 
appropriate and transferred to a freshly gelatinized flask. Media was refreshed 3 
hours after passaging to remove any debris from the trypsinisation process. 
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Freezing ES cells 
Following trypsinisation, ES cells were centrifuged at 1,100 rpm for 3 minutes. 
Media was aspirated and the pellet resuspend in an appropriate volume of Freezing 
Media (FM). lml of FM -ES cell suspension was aliquoted into an appropriate 
number of Cryovials, as detailed in table 2.3, that were subsequently placed at -80 °C 






To Fill No. of 
Cryovials 
Area to Re -thaw 
Into 
24 -well 8O0111 1 24 -well 
6 -well 8O0µ1 1 6 -well 
25cm2 1.6111 2 6-well 
75cm2 6.5µ1 8 6-well 
175cm2 13 µ1 16 6-well 
Thawing frozen stocks of ES cells 
Cryovials containing cells were removed from liquid nitrogen or -80 °C storage and 
thawed rapidly (with agitation) in a 37 °C waterbath. The cryovial contents were 
diluted in 1 Ox volume of culture medium and spun immediately at 1,100 rpm for 3 
minutes. The medium was aspirated and the pellet gently resuspended in 1 -2ml 
medium, using a pastette. Resuspended cells were diluted in a volume of culture 
medium appropriate to the area of tissue culture plate to be used (1m1 =24 -well plate; 
3m1 =6 -well plate; 5m1 =25cm2 flask), and the media refreshed 3 hours post plating. 
Estimating ES cell concentration 
To ensure equal numbers of wild -type and p53 -/- ES cells was plated prior to 
experimental treatments, the approximate concentration of cells were estimated using 
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a rinsed, dried hemocytometer with an added cover slip. ES cells were trypsinised, 
neutralised with 10m1 medium and transferred to a Universal tube. 10µ1 trypsinised 
cell suspension was removed and added to a cryotube containing 80 pl PBS, 100 
tryphan blue (Sigma). The suspension was mixed by pipetting, and 10µ1 of the 
tryphan blue -cell suspension mixture transferred to the underside of the coverslip. 
Under magnification, the total number of cells in each of the central and four corner 
squares was recorded - the mean of these five values was taken to represent the 
number of cells x105 / ml. 
2.3.2 Vector preparation and electroporation of ES Cells 
Targeting vectors were linearised and confirmed by gel electrophoresis. The DNA 
was precipitated (section 2.2.4) and the pellet dried under sterile conditions. 0.6ml 
sterile PBS was added and the pellet resuspended by tapping the tube and incubating 
at 55 °C. Following trypsinisation, ES cells were centrifuged in a volume equivalent 
to 108 cells at 1,100 rpm for 3 minutes. The medium was aspirated, making sure the 
pellet was not disturbed, which was then carefully resuspended in 0.6ml of the vector 
in PBS, and transferred to an electroporation cuvette (Bio -Rad). The cuvette was 
capped and pulsed with a charge of 0.8kV, 3µF capacitance, which resulted in a time 
constant of 0.1 seconds (Bio -Rad Gene -Pulser). Electroporated cells were added to 
100m1 of non -selective culture medium, mixed and 10m1 cells plated on ten 10cm 
gelatinised plates (resulting in a density of 1x106 cells per plate which is appropriate 
to permit selection the following day with G418 and gancyclovir). 
2.3.3 Selection and picking of ES cell clones 
24 hours after electroporation, the non -selective CM was replaced with selective CM 
containing 1 x gancyclovir and 200µg /ml G418 (Gibco -BRL). Selective media was 
refreshed every 3 or 4 days until colonies of G418 and gancyclovir- resistant clones 
became visible to the eye (usually within 12 -13 days post -electroporation). A 96 well 
plate containing 100µ1 of trypsin -EDTA in each well was prepared. Selective media 
was aspirated from the 10cm plates, cells washed with lx in PBS and partially 
aspirated to leave a residual volume of PBS sufficient to cover the base of the tissue 
culture plate. This measure prevented dehydration of clones during picking. A p200 
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tip was placed over a single G418 and gancyclovir resistant ES cell clone, and gentle 
suction applied to take the clone up into the pipette. Clones were pipetted into a 
trypsin -EDTA containing well of a 96 -well plate and left for 2 -5 minutes at room 
temperature. Full resuspension of clones was confirmed under phase contrast 
microscopy, prior to transfer into a single gelatinised well of a 24 -well plate 
containing lml of non -selective CM. Clones were subsequently refreshed with non- 
selective CM on a daily basis. 
2.3.4 Preparation of ES cell DNA for analysis 
This protocol is essentially identical to that published (Laird et al., 1991). Following 
trypsinisation, ES cells were centifuged at 1,100 rpm for 3 minutes, washed x 1 in 
PBS and re- centrifuged at 1,100 rpm for a further 3 minutes. PBS was partially 
aspirated leaving sufficient residual PBS to cover the pellet. The side of the tube was 
flicked until the pellet was resuspended in this volume. 500111 Lysis Buffer was 
added, incubated at 55 °C for 3 hours prior to addition of 50011l isopropanol. DNA 
was precipitated by agitation on an orbital shaker for 30 minutes and carefully 
removed using a fine glass hook made from a Pasteur pipette. DNA was washed once 
in 70% ethanol, transferred to an eppendorf tube containing 1001,i1 TE buffer and 
incubated at 60 °C for 30 minutes to achieve evaporation of any trace residual 
ethanol. DNA was resuspended by adding 3011l dHZO and incubating at 50 °C 
overnight, before storage at 4 °C. 
Derivation of p53 -null embryonic stem cells by high G418 selection 
The p53 -/- ES cell line HG287 was derived from the hemizygous line R72 by high 
G418 selection (Mortensen et al., 1992) R72 cells were previously derived from E 14 
(Hooper et al., 1987a) by targeting the p53 locus with a neomycin resistance cassette 
(Clarke et al., 1993). 
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2.4 Experimental treatment of ES cell cultures 
The different treatments used in this study to modulate intracellular GSH levels and 
cause oxidative stress are prepared and administered as described (sections 2.4.1 and 
2.4.2). 
2.4.1 Pre- treatments of ES cell cultures 
2.4.1.1 BSO 
50mM stock solutions of BSO (DL- Buthionine -[S,R]- sulfoximine, Sigma) were 
prepared by dissolving 11mg BSO in 1ml dH2O under sterile conditions. Unless 
otherwise stated, BSO was diluted in complete medium to a final concentration of 
1001.1M. BSO was added 3 hours after passaging ES cells and incubated for 16 hours. 
At the end of the pre- treatment, the BSO- containing medium was discarded and the 
cells rinsed once with warm PBS. The cells were then exposed to the experimental 
treatment. 
2.4.1.2 DEM 
Using sterile technique, a 56mM DEM (Diethyl maleate, Sigma) stock was prepared 
by adding 1ml undiluted commercial DEM to 99ml dH2O. Unless otherwise stated, 
DEM was diluted in complete medium to a final concentration of 20µM, incubated 
and administered identical to BSO. 
2.4.1.3 GSH-MEE 
Using sterile technique, GSH -MEE (Glutathione -monoethyl ester, Sigma) was 
dissolved in PBS to make a 100mM stock. Stocks were made fresh on the day of use 
and used immediately, or frozen. The administration and incubation of GSH -MEE 
was identical to BSO. 
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2.4.1.4 NAC 
Using sterile technique, NAC (N- acetyl cysteine, Sigma) was dissolved in PBS to 
make a 100mM stock, and equilibrated to pH7.2 with NaOH. Stocks were stored at 
4 °C and used within 1 week of preparation. Unless specifically stated in the text, 
administration and incubation of NAC was identical to BSO. 
2.4.2 Induction of oxidative stress 
To identify a suitable oxidative stress -inducing agent that could be used to 
investigate the role of GSH and p53 in ES cell viability and death, five different 
oxidative stress -inducing agents were tested in ES cells. These were hydrogen 
peroxide, UVC- radiation, menadione and tBHQ. 
At approximately 60% confluency, the medium was replaced with normal medium, 
or medium containing 100µM BSO (Sigma) and incubated for 16 hours. At the end 
of this pre- treatment the medium was discarded and the cells rinsed once with warm 
PBS. Aside from UV -C (section 2.4.2.4), all oxidative stress -inducing stimuli were 
applied as a solution in serum free (SF) culture media. All other medium components 
remained unaltered. Medium containing stress agents were prepared on the day of 
use and maintained at 37 °C prior to application. Preceeding application, plates were 
rinsed twice with PBS to remove any traces of antioxidant -containing serum. Unless 
otherwise stated, all oxidative stress -inducing solutions were incubated with the cell 
culture for 1 hour. Following treatment, cells were rinsed twice with warm PBS and 
incubated with complete media until analysis. 
2.4.2.1 Hydrogen peroxide 
The concentration of undiluted hydrogen peroxide (H2O2) commercial solution 
(Sigma) was calculated from the molecular weight to be 8.8M. Each time this reagent 
was required, a 750mM stock was made by adding 0.6ml 8.8M H202 to 4.4ml dH2O. 
This was diluted, as a single bolus injection, to the required final concentration in SF 
medium. 
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2.4.2.2 Menadione (MQ) 
A 100mM stock solution was prepared by adding 17mg MQ (2- Methyl -1,4- naptho- 
quinione, Sigma) to 1ml DMSO in an eppendorf, before incubation at 37 °C with 
occasional vortexing. MQ stocks were prepared fresh at time of experimental use. 
Unless otherwise stated, the MQ stock was then diluted in SF media to a final 
concentration of 35µM. In high enough concentrations DMSO is itself toxic. 
Therefore, controls containing the same percentage of DMSO as that in the drug 
dilutions were included in each experiment. 
2.4.2.3 tBHQ 
A 100mM stock solution was prepared by adding 16mg tBHQ (tent -butyl 
hydroquinone, Sigma) to 1ml DMSO in an eppendorf, before incubation at 37 °C 
with occasional vortexing. Stock tBHQ was diluted in SF media to working 
concentrations as required. 
2.4.2.4 UV- irradiation 
UVC- irradiation was performed at 254 nm using a Spectrolinker XL -1500 
(Spectronics Corp.). The UVC -irradiation cabinet was previously tested for accuracy 
and recalibrated (S. Corbet, personal communication). At this time, the irradience 
was noted to be non -uniform across the floor of the delivery chamber. The highest 
irradience was in the centre of the chamber (5.58 m Wm -2), and this fell to almost 
half (2.92 m Wcm -2) at the edges. By using only the central region (a square 20cm x 
20cm) of the chamber this variation was shown to be restricted to less than 15 %. 
Since the doses used were small, it was necessary to use an attenuator to achieve the 
appropriate irradience. Suitable attenuators were made from multiple layers of thin, 
semi -opaque plastic and were used in all subsequent experiments. These were 
suspended 4cm above the cell cultures and extended to the walls of the cabinet so as 
to prevent light leakage. The transmission, at 254nm, of an attenuator consisting of 
two layers of plastic was found to be 5.6x10 
"3 
( +/- 5 %) and a three layered attenuator 
4.6x10-4 ( +/- 5 %). 
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To ensure that the irradience was consistent from one dose to the next, the machine 
was pre -warmed for two minutes prior to irradiation. Immediately prior to irradiation 
the medium was aspirated, and the cells washed twice with PBS. Plates were then 
positioned in the center of the Spectrolinker, and the base plate exposed by removal 
of the cover plate before irradiation for the required time. Upon completion, the 
media and cover plate were replaced and whole plates replaced in the incubator. 
2.4.3 Analysis of the effects of oxidative stress 
2.4.3.1 Quantitation of sample protein concentration 
This assay involves the formation of a colourimetric complex between bicinchonic 
acid and proteins whose absorbance can be read at 570nm (Bradford, 1976). This 
assay comes in the form of the "Bio-Rad Protein Assay" kit (Biorad). Note: samples 
used to measure GSH concentration were also used to determine protein 
concentration. 
A sufficient volume of 5X assay reagent was diluted to 1X with dH2O to provide 1 ml 
reagent per protein standard/protein sample. Bovine serum albumin (NEB) was 
diluted to 5µg, 10µg, 15µg, 20µg, 25µg and 50µg in the same buffer as the sample, 
and used to generate a standard curve each time experimental samples were 
measured. 200p1 1X assay reagent was added to 10p1 sample in a 96 well plate and 
left for 15 minutes at room temperature. The absorbence was recorded at 595nm on a 
multiwell plate reader. The protein concentration of each sample was calculated by 
comparing the absorbance with the recorded absorbencies of the known protein 
standards. 
2.4.3.2 Intracellular total reduced glutathione (GSH) levels. 
The main methods to measure the GSH concentrations of cells rely on HPLC (high 
pressure liquid chromatography), flow cytometry or an enzymatic 
spectrophotometric shift. Here they are briefly discussed with reference to their 
benefits and limitations. Other techniques to measure GSH, such as a colourimetric 
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system (reviewed in (Floreani et al., 1997)), were not considered due to inconsistent 
results obtained. 
One, HPLC. This technique relies upon passage and elution of cell extracts through a 
HPLC column. Detection is mediated by a GSH- specific dye such as 
monochlorobimane (MCB), which fluoresces upon reaction with GSH. GSH is 
bound to a molecular tag, which ultimately permits either UV or electrochemical 
detection. The process is widely used and generally considered accurate. However, 
others have obtained non -physiological levels of glutathione (Sian et al., 1997) or 
found GSH depletion underestimated with MBC/HPLC (Ublacker et al., 1991). 
Furthermore, it is also slow (approximately 30 minutes /sample) and relatively 
expensive. Therefore HPLC was not selected for use in this investigation. 
Two, flow cytometry. This process passes individual live cells through a laser beam, 
which detects fluoroescent GSH -MCB complexes. After extensive callibration, this 
technique is relatively rapid. Using this approach, it is possible to determine the GSH 
levels in multiple subpopulations of cells (Shrieve and Bump, 2001; Lee et al., 1989). 
For example, with suspensions of enzymatically digested solid tumours it can reveal 
the GSH content not only of transformed cells, but also stromal and immune cells 
that may be present. However, it can be difficult to obtain rigorous quantitative data 
with this approach (Cook et al., 1991). Since undifferentiated ES cells are the single 
cell type in this study and tissue culture (unlike the situation in vivo) ensures all cells 
receive homogenous treatment, there is no advantage in employing flow cytometry in 
this study. 
Three, spectrophotometric enzyme assay. This assay was originally described by 
Tietze (Tietze, 1969). The assay involves the recycling of GSH by glutathione 
reductase (GR, Sigma) and ß- nicotinamide adenine dinucleotide phosphate 
(NADPH, Sigma) as occurs in vivo, i.e. the glutathione redox cycle (see section 
1.3.1.1). The procedure measures total intracellular glutathione (reduced and 
oxidised). In the presence of 5,5'dithio- bis- 2- Nitrobenzoic acid (DTNB, Sigma), a 
compound which binds to thiol groups and forms a complex with an absorbance at 
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412nm, the amount of GSH which is produced during this cycle can be calculated by 
computer -driven analysis of 96 well plates. The Tietze mechanism is outlined below, 
where oxidised and reduced are indicated by Ox -DTNB and DTNB, respectively. 
Glutathione mixed disulphides are represented by DS -GSH. 
GSH + Ox-DTNB 
GSH + DS-GSH 
GR 
GSSG + NADPH + H+ 
DS-GSH + DTNB 
GS SG + DTNB 
2GSH + NADP+ 
DTNB is present in higher concentration than for the GSH assay so that the 
background is rapidly reached and any further absorbance is due only to GSH. The 
rate of formation of the DS -GSH complex is directly dependent on the concentration 
of GSH present in the sample. One limitation of the Tietze method is that it cannot be 
used to measure GSH in a heterogenous cell -type sample. However, this is not an 
issue with the homogeneity provided by the culture of ES cells. Despite the radically 
different approaches used to determine intracellular GSH levels, reports comparing 
GSH levels obtained by Tietze, flow cytometry and HPLC generally agree closely. 
For example, rates of GSH depletion in Chinese hamster ovary cells exposed to 
DEM were essentially the same using these three techniques (Rice et al., 1986). The 
Tietze approach is economical, rapid and sensitive. Moreover, since it is the most 
established of the techniques currently available - being used with numerous cell 
culture systems, the Tietze protocol was chosen to monitor GSH levels in ES cells. 
Total glutathione was measured since this value represents both the oxidised and the 
reduced form of glutathione. The total figure gives an estimate of the available pool 
at any one time, which includes newly synthesised GSH, and potential GSH recovery 
via the GR- catalysed recycling of GSSG. Whilst this approach does not give GSSG 
detail, it provides an overall estimation of the effect MQ has on intracellular 
glutathione levels. 
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Cell culture treatment 
Media was removed, cells rinsed thoroughly with PBS, trypsinised and neutralised. 
Resuspended cells were transferred to a 1.5ml eppendorf tube and spun at 3,000rpm 
for 5 minutes. Pellets were resuspended in PBS, spun at 3,000rpm for 5 minutes and 
all but approximately 1000 of the supernantent discarded, before storage of pellets 
at -20 °C. Pellets were thawed slowly on ice before addition of 0.5ml of ice -cold 
0.6% SSA/0.01% triton x -100 and cell lysed with freeze -thawing and repeated 
vortexing. Lysed samples were spun at 600 g for 5mins at 4 °C, and stored at -20 °C 
for up to 4 weeks. 
GSH analysis 
Samples were thawed on ice and keep on ice at all times to minimise auto -oxidation 
of GSH in air. To analyse 8 different samples, the following quantities of the two 
mixes were prepared: 
GR/KPE mix NADPH mix 
GR/KPE 2m1 NADPH/KPE 2m1 
DTNB /KPE 2m1 KPE 4m1 
KPE 8m1 
Total 12ml Total 6m1 
200 each GSH standard (made up in 0.6% SSA and 0.01% triton) in the region of 
0.167 -2.5 nmoles were added on one side of a 96 well plate. Subsequently, 20µl of 
each sample was added in triplicate to separate wells. Lastly, 120111 DTNB /GR mix 
(8 units /ml GR: 0.4mg/m1 DTNB) was added to all wells using a multi -pipettte and 
mixed. Plates were left at 25 °C for 30 seconds so that any other low molecular 
weight thiol compounds could bind with the DTNB. 60m1 NADPH mix (0.4mg/m1) 
was added to all wells and the change in absorbance at 412nm recorded using a 
Dynex -TC Multiplate reader. A standard curve was plotted for each plate using the 
GSH standards and linear regression used to estimate the GSH concentration of the 
samples. All results were expressed per mg of total protein present in the supematant. 
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2.4.3.3 Quantitation of apoptosis by acridine orange staining 
A variety of techniques have developed to assess the level of apoptosis occurring in 
tissue cultured in the laboratory or removed from an organism. They fall into two 
broad categories: those that observe the defining attributes of apoptosis and those 
that measure associated, biochemical events. The positive and negative aspects of 
these approaches are briefly outlined. 
The basis of detection via TUNEL (TdT- mediated X -dUTP nick end labelling) or 
ISEL (in situ end labelling) relies on identifying the 3' hydroxyl -termini of DNA 
strand breaks, characteristic of endonuclear cleavage (Drachenberg et al., 1997). 
TUNEL and ISEL have been used predominantly in histological samples, though 
reports of false positives or negative findings with these approaches are not 
uncommon. TUNEL in particular is sensitive to many parameters that require 
painstaking calibration, a process which does not always limit high degrees of 
variation (Saraste, 1999; Saraste and Pulkki, 2000). Despite recent advances, these 
techniques are yet to overcome these limitations. 
An alternative protocol using strand breaks to identify apoptosis is DNA Laddering 
(Itoh et al., 1995). This approach works by running DNA extracted from cells on 
agarose gels -a characteristic laddering of the bands signifies nuclear degradation, a 
hallmark of apoptosis. Whilst this technique is usually a reliable indicator of 
apoptosis occurring, it is not sufficiently sensitive to produce quantitative data. 
Furthermore apoptosis can sometimes generate only high molecular weight DNA 
fragments (Susin et al., 1999) or, on occasion, not produce any obvious DNA 
laddering (Clarke, personal communication). For this reason DNA laddering was not 
used to detect ES cell rates in response to oxidative stress. 
Other biochemical features associated with apoptosis include caspase activity, 
mitochondrial dysfunction, Cat+ ions flux and phospholipid membrane alterations. 
For example, opening of the plasma membrane exposes phosphatidylserine (PI), 
which is localised in the inner leaflet of the membrane of many non -apoptotic cells 
(Fadok et al., 1992). Annexin V is a phospholipid binding protein with a high affinity 
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for PI. To measure the appearance of PI, vindelov flow analysis has been utilised in 
conjunction with labelled annexin V. This immunological approach offers detection 
of early apoptosis, prior to the external cellular features becoming apparent. 
Furthermore, vindelov flow analysis can enable the investigation of a large number 
of cultured cell types in a short time. However some cell types, including embryo 
myoblasts and embryonic megakaryoblasts, express PI on their cell surface when not 
undergoing apoptosis (Van den Eijinde et al., 1997) (Poelmann et al., 1998; Wang et 
al., 1999). 
It is also possible to use EM (electron microscopy) to detect apoptosis by directly 
observing cellular morphology. This offers the advantage of accurately noting the 
subcellular features of apoptosis. Despite this attractive specificity, EM is 
cumbersome for large numbers of cells and is therefore very inefficient at producing 
quantitative information (Gorman et al., 1996). 
A technique that can provide both morphological confirmation of apoptosis and 
quantitative data regarding apoptotic rates is the examination of fixed cells with light 
microscopy. Acridine orange is a metachromatic fluorochrome that differentially 
stains double stranded versus denatured DNA. The dye is an intercalating agent that, 
on excitation with UV light, emits green light when bound to double -stranded DNA 
and red light when bound to denatured DNA. The nucleus of a stained cell thus 
appears green under UV light whilst the cytoplasm stains red. Such staining permits 
for the detection of cells undergoing apoptosis by direct examination of nuclear 
morphology, outlined below. Endogenous phagocytosis reduces this techniques' 
sensitivity with tissue samples, however for use with cultured cells it remains a gold 
standard (Walsh et al., 1998; Saraste, 1999; van et al., 2000). For these reasons, 
morphological criteria were chosen as the method of choice in evaluating the 
response of ES cells to redox imbalance. 
At six hours post treatment media was removed by pipette, and cells washed in warm 
PBS which was also removed by pipette. Both media and PBS washes were retained 
in a 15ml conical tube. Cells were trypsinised and centrifuged at 220g for 10 minutes 
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at 4 °C, together with the retained medium and PBS from the pre -trypsinisation wash. 
The supematant was discarded, the pellet resuspended by flicking the tube gently and 
spun again. This wash was repeated once more before resuspension of the pellet in 
0.5ml PBS, 1ml ice cold fix (90% ethanol, 10% formaline). Cell suspensions were 
stored in this form at 4 °C for a maximum of 8 weeks. Prior to counting, cells were 
washed twice and resuspended in lml PBS. 10 [11 of the cell suspension was dropped 
onto a clean glass slide. An equal volume of acridine orange solution (10µg /ml, 
Sigma) was dropped onto a coverslip and carefully lowered onto the slide. Cell 
morphology was observed under fluorescence microscopy (Leitz). 
Identification of apoptosis 
Cells displaying the classical appearances of apoptosis, including condensed 
chromatin, fragmented nuclei and smaller size were counted (Corbet et al., 1999). 
Clusters of very small apoptotic bodies were considered to have undergone 
fragmentation and were assumed to have derived from one cell. Spherical retractile 
bodies that occurred in pairs were suspected to be mitotic and, unless they were 
perfectly spherical and failed to exhibit anchoring pseudopodia, were ignored. A total 
of 200 cells were counted in each field. The prevalence of apoptosis in the fields was 
expressed as the number of apoptotic (non- mitotic, retractile) bodies as a percentage 
of the number of live cells per field ( "percentage apoptosis "). 
Due to the clear and consistent data provided by this approach (see section 5.8), a 
secondary confirmation of apoptotic cell death was not deemed a prerequisite. 
Additionally, it should be borne in mind that identification of apoptosis by a single 
biochemical attribute associated with it has inherent limitations. In contrast, the 
visual examination of cells made it possible to discriminate genuine apoptosis (as 
histologically defined) from such molecular alterations. 
2.43.4 Estimation of immediate cell viability with the MTT assay 
ES cell viability was determined by the modified tetrazolium salt 3-(4-5 - 
dimethylthiazoyl-2-yl) 2- 5- diphenyl -tetrazolium bromide (MTT, Sigma) assay as 
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described (Hansen et al., 1989). The following protocol was used for 6 well tissue 
culture plates (Greiner). Media was removed, cells rinsed with warm PBS and 450111 
media/150111 MTT (5 mg /ml in PBS) added to each well. Samples were incubated for 
3 hours at 37 °C, washed once with PBS and left to dry in a fume cupboard. When 
completely dried, 1.5ml dimethyl formamide (DMSO) was added and the plates 
gently swirled to dissolve the crystals. From each well 2Oµ1- 8011l DMSO and 10411 
neat sample was transferred to a 96 -well plate and the plated agitated to mix. the 
optical densities at 590 nm were measured using a multiscanner autoreader 
(Dynatech MR 5000), with DMSO as a blank. Only mean values that fell in the 
optical density range of 0.1 -0.8, where reading is accurate, were recorded. 
2.43.5 Estimation of long -term viability with the clonogenic survival 
assay 
Following incubation in SF -media or incubation with oxidative stress -inducing 
agents cells were trypsinised, and the trypsin neutralised with two volumes of cell 
culture medium. An aliquot of cell suspension was removed and loaded onto a 
haemocytometer to (a) determine the cell density, and (b) confirm the suspension 
only contains single cells and not clumps. Cells were plated out in triplicate at 
densities of 3.5x103, 3.5x104 and 3.5x105 cells per 10cm plate. Plates were 
maintained for 10 days and cells fed as appropriate. After 10 days, the medium was 
removed and the cells fixed in 70% ethanol. Plates were stained with 5% Giemsa 
(Sigma), and colonies counted. 
2.5 Statistical methods 
All results were analysed using the statistical software package SigmaStat (SPSS), 
version 2.03. When comparing two groups Normality and Equal Variance are 
automatically tested. Where these criteria are met parametric (unpaired t) tests were 
applied, where these criteria were not met non -parametric (Mann Whitney rank sum) 
tests were applied. In instances where more than two simple comparisons were 
tested, a one way ANOVA analysis of variance was additionally employed with the 
Tukey Test, a conservative pairwise multiple comparison procedure. 
104 
Chapter 3 
Cloning and characterisation of yGCSh 
3.1 Introduction 
A principal project aim was to characterise the role of yGCSh in vitro and in vivo. To 
this end, a targeted disruption of yGCSh was planned, an approach that relies upon 
the insertion of foreign sequences at specific loci to inactivate the gene of interest. To 
achieve efficient homologous recombination between exogenous DNA and 
endogenous loci, the sequences must be as similar and long as possible (see section 
4.2.2). During the course of this project, mouse yGCSh genomic sequence was not in 
the public domain. Therefore the first requirement was to isolate a substantial section 
of the mouse yGCSh gene. This is routinely achieved via screening of genomic 
libraries with related DNA as a probe. 
3.1.1 Recombinant DNA libraries 
Recombinant libraries consist of a large number of DNA clones, each of which 
contains a different segment of foreign DNA. Since only a few of the thousands of 
clones in a library encode the desired nucleic acid sequence, the investigator must 
devise a procedure for identifying the desired clones. The optimal procedure involves 
a positive selection for a particular nucleic acid sequence. If the desired clone confers 
a phenotype that can be selected in bacteria, then it can be isolated under selective 
conditions. However, most eukaryotic genes do not encode proteins with a selectable 
function. Clones encoding nonselectable sequences are identified by screening 
libraries: the desired clone is identified either because it hybridises to a nucleic acid 
probe or because it expresses a segment of protein that can be recognised by an 
antibody (Schroder and Thorpe, 1987). 
Screening libraries requires an assay to identify and purify clones containing the 
desired sequence (figure 3.1). This procedure is normally carried out on bacterial 
colonies containing plasmids, cosmids, bacteriophage plaques or by PCR on artificial 
105 
chromosomes. To test a large number of clones at one time, the library is spread out 
on agarose plates, then clones are transferred to nitrocellulose filters (see section 
2.2.13). The clones can be simultaneously hybridised to a particular probe (see 
section 2.2.14) or bound to antibody. 
3.1.2 Attempted isolation of the murine yGCSh gene using human cDNA 
To screen a genomic DNA library, the selection procedure must first be chosen. 
Although mouse yGCSh cDNA was unavailable, full length human yGCSh cDNA 
had been previously cloned (Gipp et al., 1992). This was kindly provided (Dr C 
Smith) and used to probe the mouse genomic bacteriophage lambda (X) 2000 library. 
Three attempts were made. Although initial screening of primary filters was 
successful (data not shown), each time, at the point of developing the secondary 
screen, no signal was recorded. The cause of this was not established. 
3.2 Isolation of murine yGCSh cDNA 
In consideration of the inability to progress beyond the primary screen of X2000 
using human yGCSh cDNA, this system was discarded and alternative systems 
investigated. Current gene isolation is predominantly accomplished in either 
recombinant bacteriophage libraries, such as X2000, or BAC (bacterial artificial 
chromosome) libraries. Typically, a BAC clone will contain up to 100kb whereas X 
clones carry 15kb. To minimise the extent of characterisation required prior to 
construction of a suitable targeting vector, an alternative mouse bacteriophage library 
was screened. To identify clones, mouse yGCSh cDNA sequence was isolated for use 
as probe. 
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Figure 3.1 Flow chart for screening DNA libraries 
Bacteriophage, cosmid or plasmid libraries 
Plate library 
(considering library base and insert size) 
Screen library by: 
Hybridization to DNA 
Immunoreactivity 





There are two main approaches to clone a particular cDNA of interest. One is to 
screen a cDNA library with a sequence related to the target sequence. The second 
approach relies on reverse transcriptase (RT) -PCR to amplify mRNA from the target 
species, using primers designed on related sequences. Due to the problems 
encountered using human yGCSh cDNA as a probe with the x 2000- library, the RT- 
PCR strategy was selected. This approach first requires selection of the tissue from 
which to extract RNA. 
Though all mammalian tissues contain GSH, the liver contains high levels of 
intracellular GSH and is considered the primary source of GSH for export (Deneke 
and Fanburg, 1989). Consequently, cells of hepatic origin are hypothesised to have a 
high rate of GSH synthesis and strong expression of yGCSh. Liver was therefore the 
site chosen to extract RNA for yGCSh RT -PCR. 
3.2.2 Results 
3.2.2.1 Attempted generation of 5' 7GCSh cDNA by RT -PCR 
One approach to inactivate a gene using gene targeting is to delete the transcription 
(ATG) start site. To isolate a yGCSh genomic clone containing this motif, a cDNA 
probe spanning the corresponding region should be used. In consideration of this, an 
attempt to amplify mouse cDNA containing the 5' end was undertaken. Multiple 
sequence alignments between the published sequences of Homo sapiens [GI: 
3747102], Ratus ratus [GI: 204281] and Saccharomyces cerevisiae [GI: 218428] 
yGCSh cDNA revealed regions of sequence conservation (figure 3.2). To amplify the 
5' region, this information was used to design primers annealing to the start site and 














































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Total RNA was extracted from C57 /BL6 mouse liver, reverse transcribed (section 
2.1.3) and PCR performed as described in section 2.2.1. No specific product was 
generated (data not shown). To maximise the probability of this PCR reaction 
working, a High Fidelity PCR kit (Boehringer) was used (section 2.2.1). This 
combines the simultaneous use of a primary and a 3' -5' proofreading polymerase in 
one reaction, resulting in an error rate significantly lower than that of conventional 
PCR with Taq alone (Barnes, 1994). Of particular note, the use of a two -polymerase 
system also elevates the efficiency and yield of PCR assays (Frey and Suppmann, 
1995). However, despite varying magnesium ion and cycle optimisation parameters 
(see section 2.2.1), the use of standard or High Fidelity PCR yielded no cDNA 
product (data not shown). 
3.2.2.2 Generation of the central region of yGCSh cDNA by RT -PCR 
To amplify an alternative segment of yGCSh cDNA, a degenerate RT -PCR strategy 
was devised. PCR primers were designed along the length of the cDNA in areas of 
inter -species sequence homology. By attempting to amplify separate sections of the 
molecule, this tactic served to maximise the prospect of generating yGCSh cDNA 
sequence. Figure 3.3 illustrates the positions and predicted sizes of primer 
combinations. Mouse liver RNA was then used as a template for the degenerate RT- 
PCR reactions, outlined in 2.2.1. The PCR products generated by this approach 
correspond to the predicted sizes and are shown in figure 3.4. 
3.2.2.3 Cloning PCR products 
All four amplified PCR products were subsequently cloned directly into the pTAg 
vector (figure 3.5). This pre -linearised vector contains single deoxythymidine (T)- 
overhangs at the 3' ends of the DNA, to receive single 3' deoxyadenosine (A)- 
overhangs generated by ß- polymerases (Clark, 1988). The resultant cDNA- 
containing plasmids are detailed in Figures 3.6a and 3.7a. Liberation of the fragments 
by restriction digestion with Xho I and Xba I, described in section 2.2.2, confirmed 
subcloning of PCR products (figure 3.6b and 3.7 b). 
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Figure 3.4 Degenerate RT -PCR products 
Agarose gel electrophoresis of mouse RT -PCR from primers designed on conserved 
yGCSh cDNA sequence. Numbers next to actual product indicate predicted cDNA 
sizes. A, Short PCR products. Lane 1, failed ATG (5') end reaction; lane 2, primers 
2 +2; lane 3, primers 3 +3; lane 4, primers 4 +4 and lane 5, negative control showing 
primer -dimers. B, Long PCR products. Lanes 1 -3, Primers 2 +4; lane 4, positive 
control amplifying the house -keeping gene I3-actin and lane 5, negative control. 
A 
B 
M 1 2 3 4 5 M 
1.3kb cDNA 
I39bp 98bp 108bp 



















480bp (3-actin - 0.5kb 
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Figure 3.5 The pTAg plasmid 
A, The linear, PCR -ready form with indicated A- overhangs and B, re- circularised. 
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Figure 3.6 Cloning of 1.3kb RT -PCR product. 
A, structure of cloned 1.3kb cDNA RT -PCR. B, Agarose gel electrophoresis of 
cloned RT -PCR products digested with Eco RI only. Lanes 1 -3, 5 and 8 show 1.3kb 
cDNA liberated from pTAg; lanes 3, 6, and 7, no 1.3kb cDNA; lane 9, marker. 
kanR 
BamH I (85) 
T7 promoter 
1.3kb cDNA PCR 





Hind 111 (1500) 
1 2 3 4 5 6 7 8 9 
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Figure 3.7 Cloning of small RT -PCR products. 
A, structures of cloned small RT -PCR products. B, Agarose gel electrophoresis of 
cloned RT -PCR products. Lanes 1,3, 4 and 8 show the liberated cDNA fragments 
108bp, 98bp and 139bp, respectively. 
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3.3 Characterisation of yGCSh cDNA 
Section 3.4.1 -3.4.3 describes the amplification and cloning of cDNA products of the 
size predicted by comparison with the yGCSh sequence of other species. Prior to 
screening a genomic library using this sequence as a probe, it was necessary to 
conclusively demonstrate that the DNA encoded yGCSh sequence. 
3.3.1 Results 
3.3.1.1 Confirmation of yGCSh sequence 
(1) By restriction analysis. Human, rat and yeast yGCSh cDNA sequences all contain 
a single Bgl II and two Pvu II restriction endonuclease sites (not shown). These sites 
are in useful positions for examining the identity of the cloned mouse 1.3kb PCR 
product. Subsequently, published full -length mouse cDNA shows the exact sites and 
predicted sizes after restriction digestion (figure 3.8a). pBS -1.3kb was incubated with 
Xho and Not Ito liberated the PCR product, which was excised from the gel, purified 
and checked. Incubation of the pure 1.3kb PCR product with Bgl II generated two 
fragments, approximately 640bp and 690bp, while incubation with Pvu II produced 
fragments of approximately 750, 390 and 200bp (figure 3.8b). These correspond 
closely to the sizes predicted from the mouse cDNA restriction map. 
(2) By PCR. The cloned 1.3kb PCR product was used as a template for yGCSh PCR. 
Figure 3.8a outlines the position of primers and predicted size of the product. 
Conditions for amplification were identical to the original degenerative strategy and 
yielded products of the length predicted (figure 3.8c). 
(3) By sequencing. (Described in section 2.2.9). Figure 3.9 shows the DNA encoded 
sequence that closely matched the sequence of rat yGCSh cDNA. 
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Figure 3.8 Characterisation of 1.3kb RT -PCR product 
Confirmation of yGCSh sequence in cloned 1.3kb cDNA PCR product prior to use as 
a probe. A, Schematic representation of full length and cDNA fragments to illustrate 
diagnostic restriction digestion and PCR products. Predicted Bgl II fragments (light 
green), Pvu II fragments (dark green) and PCR product (blue) are indicated. B, Gel of 
purified 1.3kb DNA after digestion with Bgl II (lane 1) or Pvu II (lane 2). Numbers 
refer to sizes of DNA bands in bp. C, Gel of PCR on 1.3kb cDNA using primers 
Up2 +RevB with 1.3kb cDNA as a template (lane 1), or no template (lane 2). 
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Figure 3.9 Sequence analysis of 1.3kb RT -PCR product 
Confirmation of yGCSh sequence in cloned 1.3kb cDNA RT -PCR product prior to 
use as a probe II. A, Comparison of cloned 1.3kb mouse yGCSh cDNA with full - 
length cDNA, showing relative position of 1.3kb cDNA. B, Gel electrophoresis of 
sequence from mouse 1.3kb RT -PCR compared with published yGCSh eDNA 
sequences. * indicates non -identical sequence matches. 
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3.3.3 Summary and discussion 
These sections have introduced the different approaches to clone complimentary and 
genomic DNA sequences, and covered an attempt to clone yGCSh genomic sequence 
from X2000 using human cDNA as a probe. After an unsuccessful endeavour to 
generate the 5' region of mouse cDNA for use as a substitute probe, amplification of 
the central area of mouse cDNA was successful by RT -PCR. The cloning and 
comparative analysis of these novel sequences confirmed approximately 70% of the 
mouse yGCSh cDNA sequence had been isolated: sufficient to probe X- libraries. 
Later, in September 1997, the sequence of full -length mouse cDNA was made 
available (Reid et al., 1997). This information [GI:1815761] was entered in the 
primer design program "Primer3 ", located at http: / /www- genome.wi.mit.edu/. 
However, no primer could be placed in the first 103bp of mouse yGCSh sequence. 
This probably reflects the presence of strong secondary structure in this region and 
may account for the failure of 5' PCR reactions reported here. 
3.4 Isolation of genomic yGCSh sequence 
The techniques routinely used to isolate clones containing a significant length of the 
gene of interest are discussed elsewhere (section 3.2). However, due to the successful 
generation of a mouse cDNA probe with RT -PCR using "conserved 
oligonucleotides ", this approach was employed to explore a potential shortcut to 
generating fragments of genomic DNA. At the same time, the mouse yGCSh cDNA 
was used as a probe to screen a newly acquired X library. 
119 
3.4.1 Results 
3.4.1.1 PCR was not a viable technique to generate large sections of 
yGCSh gene sequence 
After successful amplification of regions of yGCS cDNA, the same primers were 
used in an attempt to amplify corresponding yGCSh gene sequences. As no gene 
structure was available, the genomic distances between cDNA primers were 
unknown. Therefore lengthened Taq extension times were attempted (detailed in 
table 2.1). Using the primer combination up2 and rev2 (figure 3.3), a genomic PCR 
product of approximately 230bp was generated (figure 3.10a), as opposed to the 
139bp cDNA product. This was subcloned into pTAg and sequenced (figure 3.10b). 
This revealed the presence of 139bp coding sequence and an 87bp intron, the latter of 
which accounted for the size difference compared to the cDNA. Unfortunately, other 
primer combinations generated no larger fragments (data not shown). It is likely the 
primers were too far apart, or the fragile nature of long- distance genomic PCR may 
have prevented consistent rounds of amplification. Due to these considerations, the 
PCR approach to cloning large fragments of genomic yGCSh was abandoned. 
3.4.1.2 Isolation of independent clones by screening X -PS library 
A second bacteriophage genomic library, 2 -PS, was obtained (Molecular 
Biologische Technologie). The k -PS system is a novel library that has a facility to 
enhance subcloning, described in the following section. X -PS is a replacement 
vector of X. phage origin, which accommodates mouse 129 /Sv male embryonic stem 
cell DNA inserts of approximately 14kb (Nehls et al., 1994). The library was plated 
and replica filters made as described in section 2.2.13. Purified 1.3kb yGCSh cDNA 
was randomly labelled with dCTP -P32 (see section 2.2.11) and used to probe for 
genomic homologs. Three rounds of screening were carried out, as outlined in 
section 2.2.14. 10 clones were picked at primary screen, but only 3 remained 
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Figure 3.10 Direct yGCSh genomic PCR 
A, Agarose gel analysis of yGCSh genomic DNA PCR. Numbered arrows refer to sizes 
of DNA bands in bp. Lanes 1 -6, PCR with primers 2 +2; lanes 7 -12, PCR with primers 
3 +3 (for primer information, see figure 3.3) and blank lanes, negative controls. 
Increasing product between lanes 1 -6 and 7 -12 is reflective of increased template 
concentration only. B, Extract of 230bp PCR product sequence detail, showing novel 
intron -exon boundary. 



















Figure 3.11 Screening the X- 
PS library 
Representative autoradiographs 
showing screening rounds of the X- 
PS library using mouse 1.3kb 
),GCSh cDNA as a probe. Increased 
purification of yGCSh- containing 
phage is shown from initial picking 
of a positive clone (indicated by the 
arrow) in the primary screen (A), 
through the secondary (B) and 
tertiary screen (C). 
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Figure 3.12 Subcloning the insert 2 -PS clones 1 -3 
A, Strategy to subclone phage insert from X -PS into pBluescript (pBS). Top, 
Simplified X -PS structure. Black boxes represent phage arms (Cos R and L). Also 
shown are polylinkers, position of loxP sites (yellow arrows), foreign genomic 
insert (purple line) and pBS (grey line). Middle, Cre- catalysed recombination at 
loxP sites excises the insert and pBS from the a, genome. Phage recombination 
products not shown. B, Agarose gel showing resultant bands representing whole ?a, 
2 and 3 clones linearised with Sac II. 























positive at the second screen, designated a, -phage 1, 2 and 3 (figure 3.11a-b). One additional 
screening step was made to purify the positive phage (figure 3.11c). 
3.4.1.3 Subcloning the phage insert 
The structure of the 2 -PS vector is shown in figure 3.12a. The genomic insert is ultimately 
flanked by two phage arms that permit viral replication. To construct a restriction map of the 
insert, this phage arm DNA must be removed. The a. -phage contain two loxP sites in direct 
orientation flanking pBluescript (pBS). Recombination between these two sites is mediated 
by Cre recombinase, leading to excision of the insert-pBS fragment from the phage genome 
(see section 4.3.2). This was achieved by transforming E. coli strain BNN132, which 
constitutively expresses Cre, with 2 -phage 1 -3 (figure 3.12b). The subcloned inserts of X,- 
phage 1 -3 are subsequently referred to as Xl, 2 and 3. 
3.4.2 Discussion 
With the system utilised, PCR could not generate genomic fragments of sufficient size to use 
as regions of homology in a targeting vector. However, at the end of this section, three 
independent X. clones that potentially contain yGCSh gene sequence had been purified, 
expanded and the inserts subcloned. 
3.5 Characterisation of partial yGCSh locus 
For any of the three clones to be of use in targeting vector construction, it was necessary to 
first identify the DNA that they carried. On confirmation that the insert contained yGCSh 
DNA the generation of a restriction map of the phage insert would be carried out. 
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3.5.1 Results 
3.5.1.1 Restriction analysis of 1 -3 to seclude a single clone for further 
investigation 
A preliminary examination was undertaken to (1) confirm the size of the insert, and (2) 
identify suitable restriction patterns that would facilitate subsequent analysis. In particular, 
the fragments must be easily separable and be of amenable size to clone, restriction map and 
sequence. Therefore, the following relatively rare cutting enzymes were chosen to restrict a,1- 
3: Sac I, Cla I, Nco I, Bgl II, Pvu II and Sty I. 
Figure 3.13 shows Pvu II restricted all clones in excess (cutting >x12), whilst Cla I and Nco I 
cut all clones insufficiently (x2 -3). Sac I, Bgl II and Sty I digest particular clones into an array 
of fragments of useful sizes. 
The Bgl II enzyme has extra analytical potential, however, as there is a unique Bgl II site in 
the centre of the 1.3kb cDNA probe used to isolate a.1 -3. Knowledge of this site could assist 
in the downstream analysis of the genomic DNA (outlined in section 3.7.1.2). Digestion of 
?A with Bgl II generates 5 fragments of approximately 6, 5.5, 2.3, 1.8 and 1 kb: all useable 
sizes. It was therefore decided to dedicate all further analysis upon the Bgl II- restriction 
products of on 2 l. 
3.5.1.2 Southern analysis of 21 restricted with Bg /II 
Identification of DNA fragments containing coding sequence can be achieved by southern 
analysis using related cDNA sequence as a probe. Identical southern blots of X1 digested 
with Bgl II were made in parallel. Linearised 1.3kb yGCSh cDNA and pBluescript were 
purified (figure 3.14), labelled and used to probe discrete filters. Bands annealing to cDNA 
and bands annealing to pBluescript will harbour respective sequences. This approach 
identified the 1, 2.3 and 6kb Bgl II fragments as containing exonic sequence (figure 3.15b). 
Comparison of the two blots shows the 5.5kb band contains the pBS backbone (figure 3.15c). 
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Figure 3.13 Restriction analysis of 2,1 -3 
A, Agarose gel showing restriction digestion of 1 -3 with multiple single enzymes. 
Horizontal numbers identify the clone analysed, vertical numbers indicate size of 
DNA fragments in kb. Bgl II restricts X1 into sizes amenable to further 
characterisation (6, 5.5, 2.3, 1.8 and lkb) and the Xlinsert size is correct (- 17kb). 
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Figure 3.14 Purified yGCSh cDNA and pBluescript probes 
Agarose gel showing gel excised and purified 1.3kb yGCSh cDNA (lane 1) and 2.9kb 
linearised pBS (lane 2), prior to random P32- labelling. 
M 1 2 M 
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Figure 3.15 Southern analysis of 2,.1 with yGCSh cDNA and pBuescript 
Determination of Xi. Bgl II bands that hybridise yGCSh coding sequence and plasmid 
sequence. A, Gel electrophoresis of Bgl II- digested 2.1. B and C, Autoradiographs of 
identical southern blots of A probed with 1.3kb yGCSh cDNA and pBluescript, 
respectively. Numbers indicate sizes of DNA bands in kb. 
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3.5.1.3 Subcloning 2,.1 fragments. 
If, as the southern analysis data suggest, k1 contained yGCSh gene sequence then the 
unique cDNA Bgl II site would permit confirmation of it. The genomic Bgl II site 
corresponding to the unique cDNA site, carried in the 1.3kb probe, will have 
neighbouring exonic sequence. Thus, two of the five Bgl II fragments were expected 
to contain coding sequence at one termini. 
Therefore, all five Bgl II fragments were cloned separately, into Bgl II- 
complimentary Barn HI- linearised pBS. Liberation of each fragment by restriction 
digestion with Xho I and Not I confirmed all fragments were subcloned (figures 
3.16a and 3.18a). 
3.5.1.4 Confirmation of yGCSh coding sequence in 21 fragments. 
Subsequently, all cloned fragments were partially sequenced to detect for the 
presence of yGCSh coding sequence (figure 3.19- 3.22). Sequencing was carried out 
within our laboratory manually and externally using automated sequencers 
(Veterinary School, Summerhall, Edinburgh). This approach identified the 1.8kb 5' 
terminus and 1 kb 3' terminus as harbouring a Bgl II site and adjacent coding 
sequence. The sequence data correlated with the southern analysis data in showing 
the 6, 2.3 and 1 kb fragments to contain exonic sequence. In total, five complete 
exons were identified: two in the 6kb fragment, two in the 2.3kb fragment and one in 
the 1kb fragment. The exons were consecutive and permitted alignment of all Bgl II 
fragments relative to one another. Figures 3.19 -3.22 also show partial restriction site 
maps of the sequence represented in ? l, generated from the sequence information. 
3.5.1.5 Generation of restriction maps 
Since the complete sequencing of fragments greater than 1 kb was not undertaken, a 
partial restriction map was made. Only the 6kb fragment, owing to the large quantity 
of unknown sequence contained within it, was subject to a concerted mapping 
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Figure 3.16 Cloning genomic Bg /II fragments 
A, 1% agarose gels showing subcloned Bgl II fragments in pBS (2.9kb). All 
plasmids digested with Xho I and Not I to liberate cloned fragments: Lane 1, 6kb; 
lane 2, 1.8kb; lane 3, lkb and lane 4, pBS only. B, Structure of the 6kb -pBS 
plasmid, showing insert orientation. 
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Figure 3.17 Structure of cloned 1 and 1.8kb X1 Bg /II gene fragments 
Schematic diagrams showing orientation of cloned fragments in pBS. A, lkb 
genomic fragment and B, 1.8kb genomic fragment. 
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Figure 3.18 Cloning genomic Bg /II 2.3kb fragment. 
A, Agarose gel showing liberation of subcloned 2.3kb fragment from pBS by digestion 
with Xho I and Not I (lanes 5 and 6). B, Structure of the 2.3kb-pBS plasmid. 
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Figure 3.19 Confirmation of gene sequence in X1 6kb Bg /II band 
A, linear representation showing partial restriction site and functional map. B, 3' 
sequence data (completed externally). Green letters, pBluescript; black letters, intronic 
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Figure 3.20 Confirmation of gene sequence in 2.1 2.3kb BgI II band 
A, Linear representation showing partial restriction map, including a unique Mun I 
restriction site used in section 4.6.3 for screening recombinant ES cell clones. The 
positions of exons 6 and 7 are indicated. B, Extract of corresponding sequence data 
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Figure 3.21 Confirmation of genomic sequence in 1kb Bg /II band. 
A, partial RE map of the whole lkb molecule showing position of exon 8, the remaining 
sequence of which is located in the 1.8kb fragment. B, complete sequence data, and C, 
representative sequence autoradiograph corresponding to the 3' end, compared to 
published rat sequence (green font). 
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Figure 3.22 Confirmation of genomic sequence in U 1.8kb Bg /II band 
A, linear representation showing partial restriction site and functional map. B, 5' 
sequence data (completed externally). Green letters, pBluescript; black letters, intronic 
sequence; red letters, coding sequence (as compared to human and rat cDNA, data not 
shown). 
Sac I (349), 
Xba I (248) 
Pst 1(72) 
Pst I (1668) 
550bp sequenced 
Coding sequence (5bp) 
5' 
550bp sequenced 

















exercise. Figure 3.23 details the frequency of restriction enzymes cutting the 6kb 
fragment. Those enzymes cutting once were subsequently incubated in double 
digests to position the restriction sites relative to one another (data not shown). This 
approach produced a limited overall map of the 6kb fragment that is incorporated 
with the sequence- derived restriction site data (figure 3.19a). In addition, limited 
restriction analysis was carried out in other k 1 Bgl II fragments to both confirm the 
presence of sites predicted by sequence analysis, and to identify the presence of 
restriction sites in areas not sequenced. This data is summarised in figure 3.24. 
3.5.1.6 Determining and cloning the terminal ends of 2.1 
The 5' and 3' termini represent the final area of a,1 that remained uncharacterised. 
Extra sequence at the 5' terminus was desired to act as a potential external probe in 
screening recombinant ES cell clones. The 5.5kb Bgl II band contains, because it was 
the only band to hybridise pBS, the whole vector backbone and the extreme ends of 
the X1 insert. As 2.9kb of the 5.5kb fragment are accounted for by pBS, 2.7kb of 
remaining insert sequence is represented by 2,GCSh DNA. This 2.7kb of sequence is 
divided between the 3' and 5' ends of the insert, though the quantity comprising each 
end was unknown. The size of the 5' sequence was established by a restriction 
mapping strategy of the whole Xl outlined in figure 3.25. This showed that of the 
2.7kb, 1.4kb was located at the 5' and 1.3kb located at the 3' end, respectively. 
Thus the extreme 5' end, at 1.4kb, was of sufficient size to potentially use as a probe 
in downstream targeting experiments. Due to the similar size of the 5' and 3' termini, 
both fragments were subcloned to prevent accidental isolation of the incorrect (3') 
DNA. The 5.5kb band was cloned by gel excision, purification and simply re- 
circularising in an otherwise unmodified ligation reaction, confirmed by linearisation 
with Not I (data not shown). The 5' and 3' ends were subsequently cloned as 
described in figure 3.26. This represents the final characterisation of Xl. 
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Figure 3.23 Frequency of restriction endonucleases cleaving the 2.1 6kb 
Bg /II fragment. 
A, The presence or absence of restriction endonuclease sites (RES) in the purified 
6kb Bgl II fragment was determined by systematic single digestion tests with the 
listed enzymes. B, Representative agarose gel. Lane 1 -9, Kpn I, Hind III, Barn HI, 
Eco RI, Nco I, Sac I, Sty I, Not I and uncut 6kb, respectively. Numbers on left-hand 
margin indicate sizes of bands in kb, numbers in blue panel show amount of bands 
produced by each enzyme and the number of corresponding sites present. 
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Figure 3.24 Presence of RES in all Bg /II fragments. 
Presence of restriction enonuclease sites (RES) in different kl Bgl II fragments. N= 
not present, Y= present and - = unknown. All information was determined by single 
restriction digests of respective plamsids and, in areas of doubt, purified fragments 
(data not shown). 
RES presence in: 
RES 6 kb 2.3 kb 1 kb 1.8 kb 
ApaI N N 
Apo I Y Y N Y 
Barn HI Y N 
Bgl I N Y 
Bgl II N N N N 
Bss HII Y 
Bst XI Y Y N N 
CIa I N 
Dra III N N 
Eco RI Y Y 
Eco RV N N N N 
Fsp I Y N - 
Hind III Y Y 
Kpn I Y Y - 
MIu I Y N - 
Mun I Y Y N N 
Nde I N N N Y 
Not I N N N N 
Nco I Y Y Y Y 
Nhe I Y - 
Nsi I Y Y Y - 
Pm! I N - - 
Pst I N Y Y 
Pvu II Y Y Y - 
Sac I Y Y N Y 
Sac II Y N N N 
SmaI N - - - 
Sph I Y - 
Stu I N N N N 
Sty! Y Y Y Y 
Xba I N N Y N 
Xho I N N N N 
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Figure 3.25 Determination of the 5' and 3' ends of a.i. 
The termini of X1 were examined by restriction analysis. The 5' (Kpn I) and 3' (Not 
I) restriction sites are common to all subcloned X -PS- derived clones (Mo Bi Tec, 
1996). The Kpn I sites in the 6 and 1.8kb Bgl II fragments were mapped manually 
(data not shown). Knowledge of these four RE sites allows identification of the 5' 
and 3' ends by comparative mapping. Numbers on gels refer to sizes of fragments in 
kb. 
A, Agarose gel (1%) of initial determination using whole X1. Lane 1, X1 digested 
with Kpn I; lane 2, X1 digested with Kpn I and Not I. 
B, Final determination on 2% agarose gel. Lane 1, 5.5kb Bgl II fragment cut with 
Kpn I and Not I; lane 2, 2kb 3' fragment from X1 restricted with Bgl II only. 
C, Resulting structure of whole X1. Green numbers show position and sizes of all Bgl 
II restriction fragments, brown and pink numbers correspond to DNA fragments in A 
and B, respectively. 
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Figure 3.25 Determination of the 5' and 3' ends of 2.1 
A B 
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Figure 3.26 Subcloning the 5' and 3' termini of the 2.1 insert 
Recircularisation 
The linear 5.5.kb Bgl II fragment was separated from the 6kb by agarose gel 
electrophoresis, gel excised and purified. Incubation of this DNA in a ligase reaction 
re- circularises the the molecule at the exposed Bgl II termini. The reaction was used 
to transform E.coli and generate large quantites of the circular plasmid. Pure 5.5kb 
DNA preparations were treated separately as follows. 
Restriction digestion 
The circular 5.5kb was digested with either Bgl II and Not I to liberate the 5' 
terminus, or with Bgl II and Kpn I to liberate the 3' terminus. Each fragment was gel 
excised and purified. and Restriction with of the resulting plasmid with Kpn I and 
Not I excises the 5' 1.4kb terminus (lower panel, lane 2). 
Subcloning 
The 5' fragment was subcloned into pBluescript linearised with Barn HI and Kpn, the 
3' fragment ligated to pBluescript linearised with Barn HI and Not I. 3' and 5' 






































































































































































































































































































































































3.5.1.7 Concluding map of the X1 insert 
The combined data of chapter 3 are assembled and simplified in figure 3.27 to 
generate a functional map of the area covered in X1. Full -length cDNA, subsequently 
published (Reid et al., 1997), is included to show the coding area spanned in Xl. The 
full gene, subsequently cloned and sequenced by Shi et al., 2000, has allowed 
numbering of the exons identified. Except for Bgl II, restriction endonuclease sites 
are excluded for the purposes of clarity. 
3.6 Summary and concluding remarks 
This chapter outlines the different approaches taken to isolate different forms of a 
unique genetic sequence. The data presented in this chapter charts the isolation of 
novel mouse cDNA and gene sequences. Approximately 1.3kb of complementary 
and 14kb of 2,GCSh gene sequences were successfully cloned into high -copy number 
plasmids. The combined analysis of this DNA, mainly by restriction mapping, 
southern analysis and sequencing has generated an overall map for a substantial 
fragment the central region of the 2GCSh locus. This data was of sufficient size and 




































































































































































































































































































































































































Gene Targeting of 7GCSh 
4.1 Introduction 
A multitude of human pathologies have origins that reside in the genetic sequence. 
The bulk of early research investigating the role of hereditary factors in disease were 
carried out on organisms such as yeast, the nematode, Caenorhabditis elegans and 
the fruit fly, Drosphila melanogaster. These species have short replicative cycles and 
relatively small genomes that permit rapid analysis of mutations. While information 
gleaned from this work laid the foundations for understanding mechanisms 
mediating gene expression and development, they were of limited value in 
understanding the genetic disorders of vertebrates. The size of the human genome, at 
approximately 3x109 bp, and the complex interaction of genes within it cannot be 
accurately reproduced in relatively simple organisms. Subsequently, higher 
mammals physiologically similar to humans have become utilised as research tools 
to model disease. The advantages of mouse models for the study of human 
physiology, disease and developmental abnormalities have been extensively 
reviewed (Jaenisch, 1988; Bedell et al., 1997a; Bedell et al., 1997b; Rubin and 
Smith, 1997). 
Processes that can artificially introduce candidate disease genes represent a powerful 
aid to elucidate gene function. Development of pronuclear injection techniques 
allowed foreign DNA to be inserted into the germline of mice (Hogan et al., 1994). 
Subsequently, the creation of transgenic mammals carrying genes associated with 
human dysfunction has facilitated elucidation of their involvement in disease. There 
are constraints, however, in the use of transgenic animals to develop disease models. 
Transgenes integrate at random genomic sites, where local regulatory sequences 
often exert their control. This leads to unpredictable elevations (al -Shawi et al., 1991) 
or depressions (Jaenisch, 1988) in transgene expression, which can be further 
compounded by integration of variable copy numbers. In addition, analysis of the 
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phenotype may be complicated by indiscriminate recombination with endogenous 
genes. Indeed, significant phenotypic differences in lines of transgenic mice 
expressing the same transgene have been reported (Bedell et al., 1997a). While some 
of the above shortcomings have been resolved by the use of YACs (yeast artificial 
chromosomes), the limiting factor of transgenic models remains that genetic material 
can only be inserted, not deducted, from the genome. 
A deficiency in a single gene yields a more intimate insight into gene function. Gene 
targeting is a technique that permits introduction of site -specific mutations into 
endogenous genes in vitro and in vivo. The original protocol relies upon generating a 
vector containing two sequences of DNA homologous with the cellular locus, 
separated by a selectable marker. The endogenous process of homologous 
recombination is harnessed to insert the marker at loci isogenic to the vector DNA 
sequences, inactivating the target gene. 
4.2 Homologous recombination (HR) 
The first reports of homologous recombination were from yeast (On-Weaver et al., 
1981), though the phenomenon was soon proven to occur in somatic mammalian 
cells (Folger et al., 1982). The process involves the exchange of genetic material 
between associated DNA sequences and can occur during DNA replication and 
repair. During the repair of strand breaks in both models, a dynamic search for a 
homologous partner takes place by a mechanism that encompasses a large 
chromosomal domain (Inbar and Kupiec, 1999). Upon identification, genetic 
information is transferred between the interacting DNA sequences (gene conversion). 
Despite an explosion of new applications dependent on homologous recombination, 
the underlying mechanism remains obscure. However, two main models have been 
proposed to account for it (reviewed in (Hooper et al., 1987b). 
4.2.1 Models of HR 
In the first model, developed by Meselson and Radding (1975), recombination is 
initiated by a single chromosomal strand break (figure 4.1). An alternative theory 
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Figure 4.1 Single- strand break model of homologous recombination 
The exposed 3' end of a single strand nick acts as a primer for DNA synthesis (a). 
With extension, the new strand displaces its proximal homologue which invades the 
exogenous homologue, displacing a D -loop (b). Degradation of the D -loop precedes 
ligation of the invading strand, forming an intermediate asymmetric heteroduplex. 
Concurrent synthesis of the donor strand and degradation of the recipient chromatid 
expands the region of heteroduplex (c). Ligation of the 5' and 3' single strand ends 
produces a Holliday junction (d), which can migrate along the molecules as a 
symmetric duplex. Resolution of the Holliday junction can be achieved by one of 
two methods, branch migration (e) or isomerisation (f). Restriction of the crossed 
strands yields a parental strand and a strand that has undergone gene conversion 
without crossover (e). Alternatively, by isomersiation, the original crossed strands 
uncross and vice versa. Subsequent restriction of the crossed strands yields a region 





non -crossover crossover 
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Figure 4.2 Double- strand break model of homologous recombination 
Recombination is initiated by a break in both strands. 3' exonuclease activity generates 
a gap flanked by 3' single strands (a). One 3' end invades a homologous duplex, 
displacing a D -loop (b). Extension of the invading strand expands the D -loop until the 
other 3' end can anneal a complimentary single stranded sequence (c). Synthesis from 
the second 3' end concludes the gap repair (d). Ligation of remaining ends produces 
two Holliday junctions. Junction isomerisation determines the final configuration, 
occurring at either the left -hand (G), the right -hand (H), neither (E), or both junctions 




E non -crossover left crossover G 
F double crossover right crossover H 
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invokes a double strand break to inaugurate the process of strand exchange (figure 
4.2) (On-Weaver et al., 1981; Stahl, 1996; Szostak et al., 1983). 
4.2.2 Factors affecting the frequency of HR 
While the mechanism of homologous recombination has yet to be fully resolved, 
progress has been made in determining the factors that control the frequency of its 
occurrence. Early work using two species of crippled selectable marker genes 
showed homologous recombination occurred between non -integrated plasmids in 
mammalian cells. Each plasmid carried a distinct, deactivating mutation in a drug 
resistance gene that conferred tolerance to an antibiotic. Survival of clones in 
medium supplemented with antibiotic was dependent upon extrachromosomal 
homologous recombination to reconstruct a functional resistance gene (Kucherlapati 
et al., 1984; Folger et al., 1985a; Folger et al., 1985b). Importantly, related work 
revealed that the efficiency of this recombination was dependent on several factors: 
increasing the length of homology between two sequences proportionally increased 
the frequency of homologous recombination (Ayares et al., 1986; Thomas et al., 
1992; Deng and Capecchi, 1992; Hasty et al., 1991a). While administration of high 
concentrations of exogenous DNA does not enhance homologous recombination, the 
addition of DNA at early to mid S -phase of the cell cycle does (Wong and Capecchi, 
1987). In addition to cell cycle sensitivity, recombination with linear DNA is more 
efficient than supercoiled (Folger et al., 1982; Bollag et al., 1989). Subsequently 
extrachromosomal, crippled selectable marker genes were targeted to chromosomal 
homologs. This occurred at high frequency and demonstrated, perhaps surprisingly, 
that locating a duplicate sequence in 3x199 bp was not a limiting factor (Thomas et 
al., 1986). 
With a large tract of exogenous sequence locating a highly similar large tract of 
cellular sequence, minor sequence variations were thought not to impact upon the 
frequency of homologous recombination. Indeed, Torres and Kuhn reported that use 
of DNA nonisogenic to the target sequence did not significantly affect the incidence 
of homologous recombination (Torres and Kuhn, 1995). However, the notion that 
sequence heterology between DNA molecules influences recombination is not 
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generally contested. Targeting of murine strain BALB /c DNA to 129 /Sv ES cells was 
found to be 20% less efficient than targeting 129 /Sv to 129 /Sv (te Riele et al., 2000; 
Deng and Capecchi, 1992). Thus, interstrain sequence polymorphisms, such as small 
deletions, insertions and base pair substitutions may influence the fidelity of targeted 
recombination. 
While the above factors relate mainly to exogenous and recipient DNA, protein 
factors are known to influence the frequency of recombination. RecA is an E. coli 
protein with homologous DNA pairing and strand exchange activities. 
Overexpression of nuclear- tagged RecA increased the frequency of homologous 
recombination 10 -fold in mouse teratocarcinoma cells (Shcherbakova et al., 2000). 
Structural homologs of RecA are widely distributed in higher eucaryotes, including 
mouse and man. An excess of the human RecA homolog, hRAD51, led to a similar 
increase in gene targeting frequencies in human cells (Yanez and Porter, 1999). 
These studies suggest cell type differences in chaperones dedicated to mediating 
reciprocal DNA exchange will lead to cell -type differences in DNA recombination 
rates and may, with further characterisation, be open to enhancement. 
Combined knowledge of these factors can be used to attenuate the frequency of non - 
homologous integrations. Nevertheless, homologous recombination between 
exogenous DNA and chromosomal loci usually occurs at much lower efficiency than 
random recombination (Thomas et al., 1986). In the absence of a selectable 
phenotype, isolation of cells harbouring infrequent homologous recombination 
events would be difficult to detect. Use of intact marker genes, within and out with 
the targeting vector region of homology, enables enrichment of clones bearing a 
targeted gene. 
4.3 Approaches to disrupt endogenous loci 
Selectable marker cassettes have become the predominant enrichment vehicle for 
homologous recombination events. A typical cassette comprises a complimentary 
DNA sequence of a marker gene flanked by a robust promoter and poly adenosine 
signal: a construction formula that maximises expression of the marker protein 
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regardless of the integration site. The gene for hprt (hypoxanthine phosphoribosyl 
transferase) was originally utilised to select for recombinants, since it was possible to 
select for its presence in HAT medium or absence in 6- thioguanine. With time 
alternative genes have been utilised to enhance selection. The bacterial neo gene 
(neomycin phosphotransferase) confers resistance to the antibiotic G418, while the 
gene for tk ( thymidine kinase), derived from the herpes simplex virus, imparts 
susceptibility to the nucleoside analogue gancyclovir. Genes encoding potent toxins, 
such as DT -A (Diptheria toxin A) and Ricin A have also been used to deplete cell 
populations (Arase et al., 1999). Positioning of cassettes internal (positive selection) 
and external (negative selection) to the recombination region provides a mechanism 
to select for targeted recombination. For example, as a consequence of embedding a 
neo cassette within the targeting vector region of homology and a tk cassette adjacent 
to the region of homology, proliferation in G418- containing medium intimates 
plasmid integration, and resistance to gancyclovir implies loss of tk by recombination 
(figure 4.3). Such negative, or counterselection, enriches for recombination 
specifically between neo and tk, where there is sequence similarity between vector 
and the genome. This dual "positive- negative" selection procedure is a powerful tool 
for isolating rare recombination events. 
Implanting a vector -borne selectable marker into an endogenous coding sequence 
identifies that event, but also acts as a mutagen. When the goal is to constitutively 
deactivate a gene, there are a variety of approaches to ablate gene function using this 
key premise. 
43.1 Null alleles 
One method involves implanting a selectable marker, along with the complete 
targeting construct, in the genomic locus. This type of "insertion" targeting vector 
relies on the large quantity of foreign DNA in the coding sequence of a gene to 
deactivate it through gross sequence disruption (figure 4.4a). However, insertion 
vectors can cause the formation of tandem duplications. Such duplications are 
unstable and may undergo intrachromososmal recombination, resulting in 
elimination of the vector sequence and reversion of the locus to its wild -type state 
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Figure 4.3 Positive -negative selection. 
A, Homologous recombination between replacement vector and endogenous 
locus leads to targeted replacement of a gene segment with neo, and loss of tk. 
Clonal cells are G418 and gancyclovir resistant. B, non -homologous 
recombination between vector and genome leads to insertion of neo and tk. 
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Figure 4.4 Gene inactivation by replacement or insertion 
A, Insertion of vector sequence disrupts endogenous loci. Vector is linearised 
within the region of homology. Exchange between the exposed ends of the 
vector with homologous endogenous sequences is followed by recombination at 
the double strand break. Vector insertion generates a partial locus duplication. 
B, Replacement of endogenous sequence with exogenous neo sequence. Vector 
is linearised in plasmid backbone and homologous recombination with locus 
deletes gene segment. Open boxes represent coding sequence; grey lines, 


























(Thomas et al., 1992). A different technique is to replace a designated segment of 
coding sequence of an endogenous gene with the selectable marker, thereby causing 
a deletion of that segment (figure 4.4b). This "replacement" type of targeting vector 
leaves the modified genomic locus free of other sequences present in the vector. 
According to different sources, the replacement approach yields a higher (Thomas et 
al., 1992), lower (Hasty et al., 1991b), or no (Thomas and Capecchi, 1987; Thomas 
et al., 1986) discernable difference in the targeting fidelity. 
Insertion and replacement approaches utilise a strong promoter imported with the 
plasmid to drive expression of the selectable markers. If a gene is not expressed in 
ES cells, these approaches have the advantage of permitting selection of clones with 
a targeting vector integrated at otherwise transcriptionally silent genomic regions. 
However if a gene is active in ES cells, an alternative design may be taken to enrich 
selection of a targeted clone. This strategy utilises a vector with similar configuration 
to replacement and insertion plasmids, but differs in that the neo gene has no 
imported promoter and is inserted in -frame with the targeting vector genomic 
homology. Only integration into a transcriptionally active area, and distal to a 
functional endogenous promoter will permit expression of the marker -fusion protein. 
Homologous recombination is the process most likely to mediate this event and 
"promoterless" constructs correspondingly show elevated targeting frequencies (te 
Riele et al., 1990). 
4.3.2 Subtle modifications 
Since the advent of gene targeting, protocols have diversified to suit the particular 
hypothesis under study. The above approaches are useful to examine the effect of 
gene loss, as an initial analysis when the gene function is not clearly defined. 
However, many human diseases correlate with the inheritance or acquisition defined 
mutations, and these methods cannot reproduce small aberrations. However, the "hit 
and run" method permits removal of selection cassettes and introduction of a single 
base pair modification in a known gene (reviewed in Hasty et el., 1993). This relies 
on two rounds of targeting, one to insert selection markers and a second, 
intrachromosomal event to conclude the process (figure 4.5). In "double 
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Figure 4.5 "Hit and run" gene targeting 
The vector carries the mutation of choice and has neo and tk cassettes out with the 
area of homology. "Hit ": linearisation within the area of homolgy precedes insertion 
via homologous recombination (HR) between the exposed vector ends and the locus. 
This renders cells resistant to G418 and sensitive to gancyclovir. Clones with the 
desired intermediate structure are isolated by screening and expanded. "Run ": 
resolution of the duplication is by intrachromosomal homologous recombination (IR), 
a process occurring spontaneously at low frequency in targeted ES cells. Resistance to 
G418 and gancyclovir selects for this event. Bold blue numbers indicate exons 
derived from the targeting vector; *, a specific mutation and solid arrows, the 
direction of selection cassette orientation. 
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replacement ", a variation of hit and run, the latter step is substituted with a second 
targeting vector (Stacey et al., 1994; Wu et al., 1994). 
More recently, gene targeting technologies not reliant on homologous recombination 
have emerged and been harnessed. In "site- specific recombination" exchange occurs 
at specific positions that are the targets of specific recombinases, rather than between 
DNA molecules sharing regions of extensive sequence homology. The "Cre /loxP" 
recombination system relies upon exchange between 34bp "loxP" sites, mediated by 
the bacteriophage P 1- derived protein Cre (catalysed recombinase). The unmodified 
system is functional in mammalian cells and opens new avenues in the mode of 
mutation delivery. When loxP sites (locus of crossover (x) in Pl) are placed in the 
same orientation on a linear DNA molecule, Cre catalyses a loxP -loxP 
intramolecular exchange that concludes with excision of intervening "foxed" 
sequence (figure 4.6a). 
LoxP sites can be incorporated into the genome of ES cells via conventional 
targeting techniques. Administration of Cre can be by transgene in cultured ES cells, 
the germline of mice derived from these ES cells or in a manner based on the 
specificity of the Cre -transgene promoter. This latter approach can permit tissue- 
specific gene inactivation (figure 4.6b). For many genes, large and inactivating germ - 
line mutations cause embryonic lethality, preventing study of the mutation in adults. 
The potential control offered by Cre /lox system circumvents this limitation by 
permitting inactivation in a conditional manner. For example, mice null for the 
signalling molecule Stat3 die early in utero. By crossing Stat3flox /- mice with a strain 
expressing Cre under the promoter of the milk protein gene ß- lactoglobulin (BLG), 
the remaining Stat3 allele was specifically deleted in the mammary gland. This 
revealed a function for Stat3 in gland involution (Chapman et al., 1999). Such 
conditional targeting can be further refined to accomplish spatio -temporal control of 
gene expression. The versatility of Cre /loxP system has triggered an explosion of 
genetic modifications possible and permits the replacement of promoters or genes, 
and deletions or integrations of over 100kb in size. 
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Figure 4.6 Cre /IoxP system and conditional gene inactivation 
A, Excision products of Cre- catalysed recombination between two directly repeated 
loxP sites (green triangles) on linear DNA. One loxP site persists on each product. B, 
Strategy for conditional gene targeting in vivo. Upper left, a mouse strain carrying a 
functional loxP flanked allele, generated in ES cells. Upper right, a transgenic mouse 
strain expressing Cre constitutively or in an conditional fashion (purple area). Lower 
centre, result of crossing the two strains. In the cells expressing Cre, catalysed 
recombination between loxP sites excises the intervening sequence. The animals must 







4.3.3 Recent advances 
Strategies to modify gene structure continue to flourish. One -step sequence deletions 
have been achieved at high frequency using PCR in the fungus Ashbya gossypii. 
PCR -generated 45bp target homologies at the termini of a selectable marker gene are 
sufficient to mediate homologous recombination with the endogenous gene. PCR - 
targeting does not demand prior cloning and characterisation of target genes, or the 
construction of standard insertion cassettes. Conventional PCR screening strategies 
can confirm locus modification ( Wendland et al., 2000). This relatively simple 
technology has been successfully applied in E. coli (Murphy et al., 2000). Both of 
these species have high levels homologous recombination, and whether it will 
operate in mammalian cells remains to be reported. 
A further simplification to the gene targeting procedure involves the use of E. coli 
RecE and RecT to mediate strand exchange (ET recombination). Strains ectopically 
expressing these proteins have enhanced homologous recombination via a double 
strand break repair mechanism (Zhang et al., 1998; Muyrers et al., 1999). Others 
have applied ET recombination to generate targeting constructs from a subcloned 
fragment of genomic DNA in a single step, regardless of restriction sites (Angrand et 
al., 1999). 
4.4 Embryonic stem cells 
Whilst many new gene targeting principles are pioneered in ultra -recombingenic 
prokaryotic cells, the majority of targeted mutagenesis completed to date has been 
performed in mouse embryonic stem (ES) cells. This cell type was isolated from the 
ICM (inner cell mass) of preimplantation blastocysts (Evans and Kaufman, 1981). 
During normal embryogenesis the ICM differentiates to form the ectoderm, 
endoderm and mesoderm which, over the course of development proliferates to form 
the entire foetus. Similarly, isolated ICM- derived ES cells grown in culture 
contribute to the ICM when re- introduced to blastocysts. Thus undifferentiated ES 
cells are, by their ability to contribute to all somatic cell types and functional 
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gametes, both pluripotent and totipotent. This trait permits transmission of targeted 
mutations generated in vitro to the germline and analysis in vivo. 
Without specific blockers of differentiation however, explanted ES cells can 
differentiate into multiple cell phenotypes (Matsui et al., 1992). To prevent in vitro 
differentiation, ES cells were initially cultured on feeder layers of mitotically 
inactivated mouse fibroblasts (Evans and Martin, 1975). Experimentation with media 
supplements preceded the purification of efficient anti -differentiation factors, in 
particular a molecule eventually shown to be identical to LIF (leukaemia inhibitory 
factor). Use of LIF, now cloned and routinely extracted, has made the requirement 
for feeder layers redundant (Williams et al., 1988; Smith et al., 1988; Moreau et al., 
1988). Careful maintenance of ES inhibits differentiation, in turn permitting 
continuous proliferation and ensures retention, even with protracted passage, of 
pluripotency. 
The property of continuous proliferation facilitates genetic manipulation of ES cells. 
The introduction of site -specific modifications to the ES cell genome, using gene 
targeting techniques, does not greatly alter their culture potential. Moreover, the 
extensive culture process to generate ES cells bearing specific deactivated genes does 
not reduce, once microinjected into a blastocyst, their ability to repopulate in the 
ICM. Implantation of recombinant ES cell- containing blastocysts in a pseudo 
pregnant mouse can initiate normal development, generating chimearic progeny that 
harbour recombinant ES cell- derived somatic and germline tissues. (Stewart et al., 
1994; Matsui et al., 1992). 
Most of the ES cell lines currently in use are derived from a congenic 129 /SvJ strain 
of mice carrying wild -type alleles at the albino (c) and pink eyed dilution (p) coat 
colour loci. The mice derived from these cells are thus agouti in coat colour. Most 
host blastocysts used for ES cell microinjection are derived from C57BL /6J mice that 
are non -agouti. Thus mice that are produced by injection of blastocysts with ES cells 
are chimaeric for the desired mutation and pigmentation, and must be further bred to 
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test for germ -line transmission of the mutant allele and to generate mice hetrozygous 
and homozygous for the modification (Livy and Wahlsten, 1991; Gerlai, 1996). 
The unique properties of ES cells permits the creation, by homologous 
recombination, of cells that can ultimately transmit defined mutations at defined loci 
to cell lineages comprising the mature organism. 
4.5 Aims and experimental strategy 
The normal physiological function of ),GCSh in somatic tissue and during 
embryogenesis were unknown when work for this thesis was in progress. Generation 
of a ),GCSh -/- phenotype should therefore provide valuable information regarding 
these roles. Consequently, advanced targeting strategies to introduce specific 
mutations were rejected and a "replacement" type approach, described in section 
4.3.1, chosen to disrupt the ),GCSh gene. 
Using the genomic sequence characterised in chapter 3, a replacement targeting 
vector was designed and constructed. The plasmid, pGCSh -TV2, shown in figure 
4.7, incorporates a neomycin resistance cassette (neo) as a positive selectable marker 
and replacement agent, and a herpes simplex virus thymidine kinase (tic) cassette as a 
counter -selectable marker. Homologous recombination between pGCSh -TV2 and 
,GCSh locus would replace a 2.3kb genomic fragment with neo (figure 4.7). This 
event would also introduce an alteration in the downstream open reading frame 
(ORF) (figure 4.8). The extent of sequence disruption introduced by targeted 
recombination is over 60 %, and is detailed in table 4.1. At the time of writing, the 
relative positions of active sites, inter disulphide bridge(s) and other regions crucial 
to performing catalysis remain unidentified. In consideration of this, it is not possible 
to assert that a partial polypeptide sequence may retain residual enzymatic activity. 
However, a mutation altering >60% of the protein would be very likely, by radical 









































































































































































































































































































Figure 4.8 Introduction of frameshift mutation 
Schematic representation of the predicted missense mutation in the yGCSh locus by 
gene targeting. A, local splicing in a wild -type yGCSh locus and, B, predicted 
splicing after homologous recombination between the targeting vector and 
endogenous gene causes a shift on ORF. Thick grey lines signify unknown or 
intronic sequence, blue lines neomycin phosphotransferase sequence, red lines 
sequence with a change in ORF and yellow boxes, coding sequence. 
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Table 4.1 Predicted yGCSh sequence disruption 
Comparison of the total normal sequence in a wild -type yGCSh allele with a potential 
pGCS -TV2- targeted allele. 1164/1914 bp or 388/638 amino acids (60.8 %) would be 
constitutively altered. 
Status of yGCSh Proportion of mutant Proportion of normal 
allele coding sequence coding sequence 
% bp aa % bp aa 
Wild -type 0 0 0 100 1914 638 
Targeted 60.8 1164 388 39.2 750 250 
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4.6 Results 
4.6.1 Construction of yGCSh Targeting Vector 
At the time of experimentation, detail of the yGCSh gene structure available was 
confined to that elucidated in this thesis. The area, spanned by the insert carried in 
X.1, covered the central domain of the gene (figure 4.7). The sequence information 
derived from k1 characterisation was used to design a targeting vector with a total 
homology of approximately 7kb. This required a two -step cloning strategy utilising 
the base vector pPNT (kindly provided by Dr S Seibert), outlined in figure 4.9. 
The first step in the targeting vector construction was the non -directional insertion of 
a a.1 917bp yGCSh Bgl II fragment into pPNT. This represents the 3' arm of 
homology. Whole k i was digested with Bgl II, and the 917bp fragment purified from 
other fragments prior to subcloning into Bgl II- compatible Barn HI- lineraised pPNT. 
This cloning step generates two products, one plasmid containing the 917bp 3' arm 
of homology in the 5' -3' (correct) orientation: pGCSh-TV1, and one in the 3' -5' 
(incorrect) orientation: pGCSh-TV1*. Analysis of plasmids by restriction digestion 
with Nsi I and Eco RI permits resolution of these products (Figure 4.10). 
The final step of the targeting vector construction was the directional insertion of a 
k1 6kb yGCSh fragment into pGCSh-TV1. The pBS -6kb and pGCSh-TV1 plasmids 
were digested with Not I and Xho I. This liberates the original 6kb yGCSh Bgl II 
fragment with an additional 77óp of polylinker sequence and linearises pGCSh-TV1 
at the 5' polylinker. Ligation of these sequences subclones the 6kb yGCSh fragment, 
in the correct orientation, into pGCSh-TV1. The resulting plasmid, pGCSh -TV2, is 
the completed vector. Liberation of the 6kb fragment from pGCSh -TV2 by digestion 
with Not I and Xho I confirmed the final construction step (Figure 4.11). 
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Figure 4.9 pPNT 
Base plasmid for construction of j.GCSh targeting vector. Schematic representation 
of pPNT functional features and restriction endonuclease map of enzymes used in 
targeting vector construction. 
pUC18 badcbaie 
5 pdylrker 
Not I (56) 












Figure 4.10 Targeting vector construction: cloning step 1 of 2, 
and orientation of 3' yGCSh homology 
Top: Gels of the diagnostic restriction analysis of the two species of intermediate 
plasmid, pGCSh-TV1 and pGCSh -TV 1 *, with Nsi I and Eco RI. Plasmids carrying 
the 3' homology in the 3' -5' orientation, pGCSh -TV1 *, generate a 694 and 7571bp 
fragment (A, lane 1). Plasmids bearing the homology in the 5' -3' orientation release 
a 264óp and 8001 bp fragment (A, lane 2; and confirmed in high resolution (4% 
agarose) electrophoresis B, lanes 1 -3,). Identification of the 264 and 694bp DNA 
fragments by size were used to resolve the 3' homology status of parental vectors. 
Vertical numbers represent size of DNA in bp. Bottom: Schematic organisation of 
intermediate plasmids, showing insertion of the 917bp 3' homology in the 5' -3' and 
the 3' -5' direction (C and D, respectively). 
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Figure 4.10 pGCS -N1 construction 
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Figure 4.11 Targeting vector construction, cloning step 2 of 2 
Directional insertion of 5' yGCSh homology into Not I and Xho I- linearised pGCSh- 
TV1 produces the final plasmid, pGCSh -TV2. A, gel of diagnostic restriction 
analysis: lane 1, pGCSh -TV2 digested with Not I and Xho I. This liberates the 5' arm 
(6kb), leaving linearised pGCSh-TV1 (8.2kb). Vertical numbers represent size of 
DNA in kb. B, schematic representation of final plasmid structure. 
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4.6.2 Obtaining antibiotic -resistant clones 
Prior to electroporation into ES cells, pGCSh -TV2 was linearised by digestion with 
Not I and prepared as described in section 2.3.2. Not I has a unique recognition site 
6bp upstream from the terminus of the 5' homology (figure 4.12). After introduction 
of the linear DNA in to 129Sv HM -1 ES cells by electroporation, clones were 
selected for 10 -12 days with either 200µg /ml G418 alone (positive selection) or in 
combination with 50µg /ml gancyclovir (positive- negative selection). Table 4.2 
details the number of resistant colonies obtained, showing a 18 -fold enrichment with 
positive- negative selection. At this point, clones were picked and grown in isolated 
wells. Clones were subsequently split into two duplicate wells (outlined in section 
2.3.3), one used to isolate genomic DNA, the other stored at -80 °C for future use. 
Table 4.2 Positive - negative enrichment of ES cell clones 
Details the mean number of HM -1 ES cell colonies obtained per plate with single, 
positive selection (G418) or double selection (G418 and gancyclovir). 
Selection Fold enrichment 
( +) ( + / -) 
pGCS-TV2* -900 N50 18 
4.6.3 Clone Analysis 
Positive -negative selection enriches for corrctly targeted clones, which must be 
definitively identified by southern analysis using a probe external vector. Optimally, 
both ends of the intended insertion site should be screened. However, the DNA 
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Figure 4.12 Linearised pGCS -TV2 
Analysis of pGCSh-TV1 prior to electroporation into ES cells. 
Lane 1: 5µg Not I- linearised pGCSh -TV2; Lane 2, 15µg Not I -li 
TV2. B, Schematic represenation of pGCSh -TV2 linearised 
cutter, Not I. 
A 
B 
M 2 M 
Neomycin phosphotransferase cassette 
5' homology (6kb) 
A, Gel showing: 
nearised pGCSh- 
with the unique 
3' homology (1kb) 
13kb 
Thymidine kinase cassette 
Xho 1(6125) 
Not 1(56) pUC18 
pGCSh-TV2 
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intended to act as a 5' probe incorporated radiolabelled nucleotides at low levels and 
hybridised non -specific sequences on southern blots (data not shown). An alternative 
5' probe was not isolated, due to the small size (1.4kb) and incomplete restriction site 
information of the extreme 5' region of 2 1. 
However, an external 3' probe, "P" (figure 4.13), originating from the k 1 1.8kb Bgl 
II fragment labelled normally. The southern strategy adopted in this experiment to 
differentiate between clones containing a wild -type and a modified locus is outlined 
in figure 4.14. P can only show a band shift pattern if the endogenous gene is altered 
as it cannot anneal to a vector integrated randomly. A test 3' screen performed on 
wild -type ES cell DNA showed a band of the size predicted (figure 4.15a). Results 
were obtained from a total of 556 clones from two independent targeting 
experiments. However, all the results were consistent with an unmodified locus 
(figure 4.15b). 
4.6.4 pGCSh -TV2 modification and re- targeting 
Due to negative results obtained in section 4.6.3, the pGCS -TV2 vector was re- 
analysed. It was found that the 3' arm of homology was inserted in the 3' -5' 
orientation during construction, an error not detected by the initial mapping analysis 
and only found on subsequent examination (figure 4.10 A lane 2 -3, and C). In light of 
this unexpected result, the vector was entirely rebuilt using the previous cloning 
strategy. Upon completion, it was ensured that the 3' arm was inserted in the 
orientation originally intended (figure 4.10 B lane 1 -3, and D). However, when 
electroporated into ES cells, the correct pGCS -TV2 yielded a similar degree of 
enrichment as before (table 4.3). Moreover, no positive clones were identified in the 
285 screened (data not shown). 
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Figure 4.13 Preparation of 3' probe for southern analysis 
A, schematic representation showing the origin of probe "P" relative to the cloned 2 1 
1.8kb Bgl II fragment. Purple arrow indicates position and orientation of the 1.8kb 
fragment. B, gel showing purified 570bp genomic probe P (lane 1) liberated from 
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Figure 4.15 Wild -type and clone DNA analysis 
Autoradiographs of the Southern screen, probed with 570óp 2GCSh DNA external to 
the 3' region of homology in pGCSh -TV2. A, wild -type ES cell DNA digested with: 
lane 1; Sph 1, lane 2; Sac II, lane 3; Xba I, lane 4; BamHI, lane 5; Mun I (highlighted 
with * to show the 8kb band), lane 6; Bst XI and lane 7; Cla I. B, representative 
autoradiograph of Mun I- digested clone DNA, from a total of 285 clones screened. 
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Table 4.3 Positive -negative enrichment of ES cell clones 
Details the mean number of HM -1 ES cell colonies obtained per plate with single, 
positive selection (G418) or double selection (G418 and gancyclovir). 
Selection Fold enrichment 
( +) ( + / -) 
Incorrect targeting vector, pGCS -TV2* 900 50 18 
Correct targeting vector, pGCS -TV2 375 25 15 
4.7 Discussion 
This chapter has focused on the approaches to disrupt specific genes and gene 
targeting of the mouse yGCSh gene in ES cells. In common with most gene 
inactivation experiments, a "replacement" strategy was employed to inactivate 
yGCSh gene function. The approach relied upon substitution of 2.3kb of endogenous 
gene with neo, and subsequent introduction of a frameshift mutation. To this end, a 
vector was designed and constructed with the aim to constitutively deactivate a 
yGCSh allele. However, despite correction of a cloning error in the original vector, 
all clones screened had an intact yGCSh locus. Failure to isolate a clone carrying a 
targeted yGCSh allele may be attributed to several factors. 
First, if the enforced expression neomycin applies, directly or indirectly, an ROS 
burden to ES cells, it is conceivable that the proliferative capacity of yGCSh- targeted 
ES cells would be reduced. As such, slow clone growth would reduce the apparent 
targeting frequency. However, insufficient data is available to support this argument, 
and as such it remains unsubstantiated. 
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Similarly, it was also thought conceivable, though unlikely, that yGCSh 
heterozygosity could impact upon ES viability. A situation could be envisaged where 
a yGCSh- targeted ES cell, with a compromised reducing capacity, could be selected 
against non -targeted cells with a complete reducing capacity. However, experiments 
performed later in this thesis show that transient reduction of the intracellular GSH 
level of ES cells with a specific inhibitor of ?GCS, BSO, had no detectable effect on 
long- or short-term indicators of cellular viability. These experiments were 
conducted in a culture environment similar to that imposed by the process of gene 
targeting. Further work indicated that only when a degree of additional oxidative 
stress is applied, does the GSH level of ES cells become critical to maintain viability. 
Moreover, the proposition is likely to be incorrect since the generation of yGCSh -/- 
mice using HPRT as a positive selection marker (Shi et al., 2000). Shi et al showed 
that while complete GSH deficiency led to embryonic lethality at day 8.5, the 
proliferation of yGCSh -/- ES cells in media supplemented with NAC was comparable 
to wild -type ES cells (Shi et al., 2000). These cells had undetectable levels of GSH 
and confirms that yGCSh hetrozygosity would not affect the ability of ES cells to 
survive the process of gene targeting. 
In consideration of the above points, other factors must have prevented a high 
frequency of homologous recombination. These factors may relate to the structure of 
the plasmid. First, the length and division of homology flanking the selectable 
marker are thought to directly affect the identification, strand pairing, branch 
migration and resolution of recombination junctions. Although the overall homology 
of pGCS -TV2 to the target locus is sufficient at approximately 7kb, the 3' homology, 
at 917bp, is relatively short. However, whilst this region is usually longer it remains 
within the periphery of the size recommended by others (Torres and Kuhn, 1995). 
Indeed, homologous recombinants have occurred successfully with constructs with a 
short arm of less than 0.5kb, as long as the "long" arm is generally greater than 4 - 
5kb (Hasty et al., 1991a; Torres and Kuhn, 1995), though aberrant recombination 
products are found at higher frequency using shorter arms. This trend could be 
reversed when the homology was distributed equally (Thomas et al., 1992). This 
adds weight to a prediction of Thomas et al., (1987), that the use of a short arm may 
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preferentially depress the frequency of homologous recombination when using 
replacement targeting vectors. While it was acknowledged at the time of construction 
that the sequence balance of pGCS -TV2 was unequal, the position and frequency of 
restriction endonuclease sites in the k1 insert were not fully known. A complete 
genomic map would have permitted optimal use of the sequence, perhaps allowing a 
configuration of the targeting vector with approximately equal lengths of homology. 
In addition, the requirement of probes external to the region of homology was a 
further consideration. In this respect, the total length of the X,1 insert presented an 
additional construction constraint, and it should be noted the targeting vector was 
designed with these delimiters in place. 
Second, an important variable determining the frequency of homologous 
recombination is the extent of sequence similarity. Until recently, the significance of 
this factor was thought restricted to that of between strains, for example, 129 DNA is 
twenty times more efficient at targeting the retinoblastoma locus in 129- derived ES 
cells than in BALB /c- derived ES (te Riele et al., 2000). The ES cell line used in this 
thesis for electroporation was 129Sv HM -1, while the genomic k -clone obtained in 
section 3 and used to construct the targeting vector was derived from a 129Sv strain 
"most commonly used in gene targeting" (Mo Bi Tec, 1996). Later, analysis showed 
some 129 /Sv substrains had diverged enough to cause graft rejections. Historical 
tracing of substrains revealed X,1 DNA: 129 /Sv D3 (substrain "steel ") was discrete 
from the ES cell DNA: 129 /Sv HM -1 (substrain "parental "). Although analysis of 25 
protein markers from 129 /Sv HM -1 and 129 /Sv D3 strains showed little variation, 
some allelic differences were detected using simple sequence length polymorphisms 
(SSLP) (Simpson EM et al., 1997). Therefore k -PS 129 /Sv D3 library DNA is subtly 
distinct from the 129 /Sv HM -1 ES cells used for electroporation. While the exact 
impact of this factor is difficult to predict, substrain genetic disparity may have 
aversely affected the frequency of homologous recombination between pGCSh -TV2 
and the ),GCSh locus. 
Third, although 295 individual colonies were successfully examined by southern blot 
analysis this may have actually been insufficient. It is conceivable that if many more 
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clones were studied a positive targeting event may have been detected. Last, it should 
be noted that different targeting experiments, undertaken in similar conditions often 
produce substantially different targeting frequencies (Torres and Kuhn, 1995; Deng 
and Capecchi, 1992). Clearly, the process of homologous recombination between 
exogenous and cellular sequences remains to be fully elucidated in mammalian cells. 
Subsequently there are likely to be parameters left unoptimised in the system used in 
this investigation. In conclusion, aside from the sometimes unpredictable nature of 
gene targeting, the low frequency of predicted recombination here is most likely 
attributable to the combined effects of a relatively unequal distribution of homology, 
marginal sequence variation and, due to time constraints, the restricted quantity of 
ES cell clones screened. 
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Chapter 5 
Responses of ES cells to oxidative stress 
5.1 Introduction 
ROS produced during normal metabolism or following exposure to exogenous pro - 
oxidants may adversely affect embryogenesis by causing DNA lesions, lipid peroxidation 
and protein degradation (section 1.1.2). Cellular mechanisms to maintain redox 
homeostasis and curb oxidative injury includes a complex array of chemical and 
enzymatic reducing agents, damage sensors and response effectors (outlined in section 
1.2.1). 
A key determinant in the maintenance of the redox equilibrium is the tripeptide GSH. 
GSH is the most abundant intracellular thiol, which affords protection against oxidative 
stress directly, or indirectly as a co- factor in repair reactions catalysed by GSTs and GPx 
(section 1.3.1.3). Cells under oxidative stress can respond by expanding the GSH pool. 
The mechanism mediating this GSH- response, though complex and poorly understood, 
frequently incorporates transactivation of yGCSh (section 1.3.2.2). 
Another central factor involved in the maintaining cellular integrity is the stress - 
surveillance transcription protein, p53 (Lotem et al., 1996; Renzing et al., 1996). In 
response to a variety of stress signals, p53 co- ordinates the cellular processes of cell cycle 
arrest, DNA repair and apoptosis (section 1.5.4) (Lane, 1992; Clarke et al., 1993; Smith 
et al., 1995; Levine, 1997). In addition to its role as a tumour suppressor gene, section 
1.5.5 details strong evidence that p53 also plays a significant role during embryogenesis. 
For example, many p53 deficient animals fail to develop normally and show a variety of 
defects, particularly related to neural tube malformations (Armstrong et al., 1995; Sah et 
al., 1995). How p53 performs such a function is unknown, but I hypothesise that it 
mediates removal of cells bearing oxidative injury. 
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ROS can activate p53 (section 1.5.2.3) and induce p53- dependent apoptosis (Symonds et 
al., 1994; Lowe et al., 1994; Kroemer et al., 1997). Accordant with this, cells can be 
rescued from apoptosis in some instances by addition of GSH (Jiang et al., 2000) or 
yGCSh overexpression (Manna et al., 1999) (and section 1.4.5). ROS are also implicated 
as downstream effectors in the execution phase of p53- dependent cell death (O'Connor et 
al., 1990; Lennon et al., 1991; Johnson et al., 1996; Lee, 1998), via transactivation of 
redox -related genes (Polyak et al., 1997) (see also section 1.5.3). Moreover, the discovery 
that p53 transactivates the GPx gene (Tan et al., 1999) opens a potential link between the 
p53 pathway and GSH regulation: a hypothesis developed in section 5.7.1. The function 
of GSH was therefore investigated in wild -type and p53 -/- ES cells. 
Data regarding ES cell GSH status was unavailable at the time of writing. Therefore this 
chapter (section 5.2 to 5.5) covers the preliminary work, utilising inducers of oxidative 
stress and GSH -depletion agents, required to create an in vitro experimental model. The 
model is then used to explore the role of GSH and p53 in the response of ES cells to 
oxidative injury (sections 5.6 to 5.9). Specifically, this chapter tests whether p53 and 
GSH affect both the immediate and long -term tolerance of ES cells to oxidative stress, 
and if p53 mediates tolerance through regulation of GSH levels. Furthermore, possible 
mechanisms by which p53 and GSH act as `guardians' during early embryogenesis are 
addressed. 
5.2 Synthesis of yGCSh and GSH in ES cells 
5.2.1 Introduction 
Though GSH is thought to be present in all mammalian cells, the levels of GSH deviate 
considerably between cell types. Embryonic cells, proliferating in a low (5 %) oxygen 
environment, may be expected to metabolise oxygen at a lower rate than mature tissue at 
atmospheric oxygen tensions. Due to these considerations, we analysed whether yGCSh is 
expressed and GSH is present in ES cells. 
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5.2.2 Results 
5.2.2.1 ES cells express yGCSh 
Using primers designed for isolation of mouse liver yGCSh cDNA (section 3.2.2.2), RT- 
PCR was performed on total RNA extracted from subconfluent wild -type mouse ES cells. 
This generated two separate fragments that correspond to the sizes predicted from 
published human and rat sequences (figure 5.1). The larger of the two fragments 
contained the unique Bgl II site present in yGCSh cDNA (data not shown), and identifies 
the DNA as yGCSh sequence. 
5.2.2.2 ES cells contain GSH 
The total GSH levels, measured by the Tietze method (as described in section 2.4.3.2), 
showed the basal intracellular GSH level of wild -type ES cell extracts was 16.1 nmoles 
mg total protein -1 ±1.5. Untreated p53 -/- ES cell extracts contained 16.01 nmoles mg 
total protein -1 ±1.9. Table 5.1 compares the GSH content of ES cells with that of other 
cell types. 
5.2.3 Discussion 
The RT -PCR data confirms that ES cells constitutively express yGCSh. However, it 
should be noted that this procedure is non -quantitative and does not indicate the level of 
expression. The GSH assay data shows ES cells also contain GSH, in levels comparable 
to other embryonic tissue but substantially lower than the majority of cell lines analysed, 
which are predominantly transformed (table 5.1). It was expected ES cells would produce 
GSH. This is predicted from a wealth of data, summarised in section 1.3.5, which 
suggests GSH is required for modulating ROS throughout early developmental processes. 
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Figure 5.1 ES cells express yGCSh transcripts 
RT -PCR strategy to detect the presence of yGCSh mRNA in ES cells. (A) Dashed 
blue lines represent PCR products, solid black line cDNA template. yGCSh exonic 
primers up2 + rev2 generate a 139bp product, up2+ rev4 a 1321bp product. (B) 
Agarose gel electrophoresis of RT -PCR performed on total RNA isolated from 
subconfluent wild -type HM -1 ES cells. M: lkb ladder, lane 1: PCR with up2 + rev2, 
lane 2: up2 + rev4, lane 3: positive control amplifying the housekeeping gene 
encoding 3 -actin (480 bp product), lane 4: negative control. 
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Table 5.1 Levels of GSH in different cell types 
Illustrates the GSH level of ES cells in comparison to levels of intracellular GSH 
detected in other tissues. All GSH values are expressed as nmol/mg protein except 
values marked *, expressed as pmol /embryo. ND = no detectable level of GSH. 
Cell type Basal 
[GSH] 
References 
Human alveolar carcinoma, A549 
Human hepatocarcinoma, HepG2 
Bovine arterial endothelium 
Rat lung epithelial, L2 
Mouse embryonic epithelial: 
BDC -1 (wild type) 
GCS -1 (yGCSh -I -) 
Mouse embryonic stem (ES): 
HM -1 (wild -type) 
HG287 (p53 -/ -) 
Rat embryo 
Mouse 2 cell embryo 
Mouse blastocyst 
150 (Rahman et al., 1996) 
71 (Galloway et al., 1999) 
20 (Shi et al., 1994a) 
18 (Shi et al., 1994b) 
18 (Shi et al., 2000) 
ND (Shi et al., 2000) 
16 this thesis 
16 this thesis 
12 (Ishibashi et al., 1996) 
* 0.4 (Gardiner and Reed, 1995) 
* 0.2 (Gardiner and Reed, 1995) 
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5.3 Optimising depletion of ES cell GSH 
5.3.1 Introduction 
Considering the complexity of GSH synthesis, there are a number of approaches to 
depleting cellular GSH in vitro. BSO (buthionine sulphoximine, figure 5.2a), a specific 
and irreversible inhibitor of yGCS (Griffith and Meister, 1979), is the most widespread 
reagent utilised for this purpose and is used clinically to deplete tumour GSH levels 
(reviewed in (Bailey, 1998). BSO competes with glutamate for the yGCS glutamate - 
binding site, where it binds as a transition state analogue. Inhibition occurs via a stable 
interaction between the S -alkyl moiety of BSO and yGCS (Griffith and Mulcahy, 1999). 
Other workers have used the anti -inflammatory glucocorticoid steroid DEM (diethyl 
maleate, figure 5.3a) to deplete cellular GSH. Whereas BSO inhibits new synthesis, DEM 
acts on pre- existing GSH via a GST- catalysed reaction which produces a GSH -thioester 
conjugate (Gardiner and Reed, 1995b; Garcia -Ruiz et al., 1995; Watson et al., 1996). 
The degree of GSH depletion depends on the species and cell -specific kinetics of GSH 
turnover (Deneke and Fanburg, 1989). Thus, the conditions necessary for these inhibitors 
to exert their effect varies between cell types. To estimate the optimum concentration of 
BSO and DEM to use on ES cells, cellular GSH levels and viability were measured 
following administration of a series of dosages. Cell viability was determined using the 
MTT assay (section 2.4.3.4), which measures dehydrogenase activity, and plotted as a 
percentage of untreated controls. 
5.3.2 Results 
5.3.2.1 BSO depletes ES cell GSH 
Cells were pre- incubated for 16 hours in full GMEM medium supplemented with BSO 
(section 2.4.1.1). This treatment confirmed the ability of BSO to reduce GSH levels, 
although the reduction was similar for all BSO concentrations within the 25 -250 µM 
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range employed (figure 5.2b). 1001.1M BSO reduced wild -type ES cell GSH levels by 
69.8% ±2.10 (t -test P= 0.001), though no impact on the MTT index registered until used 
at 2501..IM (figure 5.2c). This concentration has not been frequently used in previous 
studies, and was included as an indicator of ES cell tolerance to BSO. P53 -/- ES cells 
showed a 70.4% ±2.81 (t -test P= 0.001) depletion in GSH levels when incubated with 
100µM BSO. To see any effect of a shorter incubation period, BSO at 100µM was also 
applied for 6 hours. This variation did not effect the level of GSH reduction observed 
(data not shown). 
5.3.2.2 DEM depletes ES cell GSH and is dose sensitive 
Figure 5.3b shows the degree of GSH depletion by DEM is dependent upon the dosage. 
At concentrations between 5 -5011M, DEM reduces cellular GSH levels by approximately 
70% and does not alter the MTT index (figure 5.3c). Higher DEM doses depletes GSH 
levels further, though treatment with DEM at 1001.1M and 300µM reduced MTT values 
by 41.22% ±3.87 and 45.42% ±2.51 (Maim-Whitney Rank Sum test P= 0.035, for both 
values), respectively. Though DEM acts upon on pre- existent GSH and may thus act 
rapidly, a shorter incubation was not included in this experiment in case a protracted 
incubation period provided maximal GSH depletion. 
5.3.2.3 BSO and DEM fully deplete ES cell GSH 
In an attempt to lower ES cell GSH levels below that afforded by incubation with BSO or 
DEM alone, whilst not affecting viability, wild -type ES cells were co- incubated with both 
100µM BSO and 201AM DEM. This treatment was found to reduce GSH levels 99.8% 
±1.07, t -test P= 0.001), approximately that of non -cellular controls. However, the 
combined treatment also reduced the MTT index by 41.1% ±3.27 (t -test P= 0.001). 
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Figure 5.2 Depletion of GSH with BSO 
Chemical structure of BSO (A). Total GSH content (B) and viability (C) of wild -type 
ES cells after incubation with a gradient of BSO concentrations, or without BSO. 
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Figure 5.3 Depletion of GSH with DEM 
Chemical structure of DEM (A). Total GSH content (B) and viability (C) of wild -type 
ES cells after incubation with a gradient of DEM concentrations, or without DEM. 
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Many studies performed on diverse cell types use BSO in the 50 -100µM range. At these 
concentrations BSO is non -toxic and effectively depletes ES cell GSH levels, suggesting 
de novo GSH synthesis occurs in this cell type. The extent of GSH depletion in ES cells 
is broadly consistent with that obtained for the culture of other mammalian tissues with 
BSO, which ranges from <75% (Lu et al., 1999) to >90% (Aliosman et al., 1996). 
Although dose -sensitivity was not recorded with this concentration range, treatment with 
BSO at less than 251.IM may have revealed dose -dependent reduction of GSH. 
20µM DEM significantly reduced ES cell GSH levels without loss of viability. The use 
of DEM as a GSH depletive agent is less prevalent and the concentration used more 
heterogeneous. For example, different groups have used DEM at 101.1.M (Gardiner and 
Reed, 1995b) and 2mM (Ghibelli et al., 1998). At high DEM levels it may be impossible 
to differentiate the effects of low GSH from other cellular changes induced, most notably 
alterations in the expression of glucocorticoid- responsive genes (reviewed in (Barnes and 
Adcock, 1993). Due to these non -specific actions of DEM, BSO was selected to reduce 
GSH levels in ES cells (summarised in table 5.2). 
Co- incubation with both DEM and BSO, using dosages individually non -toxic, depleted 
ES cell GSH levels altogether but lowered the MTT index, signifying a reduction in 
viability. However a 2,GCSh -/- embryonal cell line, subsequently generated by others, 
proliferates almost normally in culture supplemented with NAC (Shi et al., 2000) (see 
section 5.7.3 for detail). In reference to this, it should be noted that only with extended 
culture in media supplemented with 2 -5mM NAC did this embryonic cell line eventually 
acquire the ability to grow effectively without GSH. Therefore, one possible explanation 
is that ES cells did not have sufficient time for compensatory responses, such as 
increasing the levels of other antioxidants, to occur. Alternatively or additionally, it is 
possible alterations in gene expression induced by 
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Table 5.2 Effects of BSO on wild -type and p53 -/- ES cells 
ES cells were treated for 16 h with 10011M BSO in full media. Immediately after 
treatment, cytosolic extracts were prepared and stored as described (section 2.4.3.2), 
prior to determination of GSH levels via the Tietze method. Cell viability twenty - 
four hours post BSO exposure was evaluated using the MTT assay. Data are mean ± 
SEM values from at least 9 independent experiments performed in triplicate. GSH 
reduction: * and I, t -test P = 0.001 vs untreated value. 
GSH GSH reduction Cell viability 
Genotype Treatment n (nmoles/ ( %) ( %) 
mg protein) 
Wild -type Untreated 18 16.1 ±1.5 0 100 
BSO 1001iM 9 4.93 ±0.45 69.82 ±2.10 * 102.5 ±1.26 
p53 -/- Untreated 9 16.01 ±1.9 0 100 
BSO 100µM 9 4.54 ±0.7 70.4 ±2.81 98.8 ±2.35 
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DEM may be incompatible with blocked GSH resynthesis. Since the mechanism 
underlying the observed fall in viability was not clear, BSO and DEM were not used in 
conjunction in subsequent experiments. 
5.4 Pro -oxidant cytotoxicity in wild -type ES cells 
5.4.1 Introduction 
To assess the role of GSH and p53 in oxidative stress, a model oxidising agent was 
required. Oxidative stress can be induced by a plethora of naturally occurring and 
synthetic chemicals, ionising and ultraviolet radiation and biological signalling factors. 
Many of these compounds produce ROS in different ways (discussed in section 1.1.1) 
and as such require particular methods of detoxification. A series of compounds were 
chosen on the basis of their diverse mechanisms to generate oxidative stress, and tested 
on ES cells to define the range in which moderate cytotoxicity was induced. 
5.4.2 Results 
5.4.2.1 Hydrogen peroxide 
Hydrogen peroxide (H2O2, figure 5.4 Al) is membrane permeable and produced naturally 
within cells, at low levels, though it can be released in large quantities by activated 
leukocytes during inflammation. H2O2 is catabolised to water by GPx, using GSH as a 
co- factor, or by catalase. The toxicity of H2O2 is thought to mainly rest on its local 
conversion, in the presence of neighbouring metal ions such as Fee +, to the highly 
reactive OH. radical. Possibly owing to the presence of cell -specific metabolic pathways, 
different groups predominantly attribute the toxicity of H2O2 to DNA damage (Wu et al., 
1998), protein disulphide production (Rahman et al., 1995) or lipid peroxidation (Kyle et 
al., 1989). Figure 5.4 A2 shows, unexpectedly, that ES cells are resistant to relatively 
H2O2 high concentrations: at 5001AM H2O2 does not significantly impact on viability (t- 
test P= 0.411). However, 1mM H2O2 reduces the MTT index by 55.07% (t -test 
P= <0.001). 
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Figure 5.4 Kill curves for pro- oxidant compounds 
Chemical structure of H2O2 (Al) and MQ (B1) are shown. Viability of wild -type 
ES cells twenty -four hours post incubation with a dosage gradient of H,O2 (A2) 
and MQ (B2), in comparison to untreated controls. Error bars represent SEM 
values from 3 independent experiments. * and t show significant reductions 
compared to untreated controls: ANOVA P= <0.001 and P= 0.029, respectively. 
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5.4.2.2 2- Methyl -1,4- naphthoquinone 
2- Methyl -1,4- naphthoquinone or menadione (MQ, figure 5.4 B1), is a synthetic member 
of the quinone family that occurs widely in nature, and due to a relative absence of side 
effects is increasingly used as a chemotherapy agent (Wu et al., 1993; Nishikawa et al., 
1995; Taper et al., 1996; Yaguchi et al., 1997). Quinones can exist in various redox states 
and diffuse across the lipid bilayer of plasma membranes. 
Intracellular MQ, upon enzymatic semireduction to the MQ. radical can spontaneously 
react with molecular oxygen to form superoxide, regenerating MQ. This redox cycle 
(detailed in section 1.1.1 and figure 1.2) can produce ROS including 02. -, H2O2, 102 and, 
ultimately, OH.: all of which have detrimental reactivity towards endogenous 
macromolecules. 
Comparable to the reaction of GSSG with protein sulfhydryl groups to form GSSG- 
protein conjugates (PrSSG), MQ can also react directly with sulfhydryl- containing 
cellular components. This ability of MQ to arylate protein SH- groups to form MQ- 
protein conjugates, an event not dependent upon the presence of ferric iron (Kyle et al., 
1989), is well documented (Kyle et al., 1989; Di Monte et al., 1984). This event, like 
redox -cycling, also produces superoxide (Thor et al., 1982; Di Monte et al., 1984). Thus, 
metabolism of MQ can exert oxidative stress by two routes, arylation or oxidation. Figure 
5.4 B2 shows the tolerance of ES cells to MQ decreases in a linear fashion and is 
relatively low: 5001.1M MQ causes a 99.31% drop in the MTT index (t -test P= <0.001). 
5.4.2.3 tent- butylhydroquinone 
tert -butylhydroquinone (tBHQ, figure 5.5 Al) is also a sulfhydryl- oxidising chemical 
belonging to the quinone superfamily. tBHQ, though a primary metabolite of the 
antioxidant 2(3)- tert- butyl -4- hydroxyanisole (BHA), is implicated in tumourigenesis 
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Figure 5.5 Kill curves for pro- oxidant compounds (continued) 
Chemical structure of tBHQ (A 1). Viability of wild -type ES cells twenty -four 
hours post incubation with a dosage gradient of tBHQ (A2) or UV (B), calculated 
relative to untreated controls. Error bars represent SEM values from 3 independent 
experiments. * and t show significant reductions compared to untreated controls 




























0 2 5 10 20 
UV, Jm2sec1 
194 
(Prochaska and Talalay, 1988; Rushmore et al., 1991). Figure 5.5 A2 shows the 
resistance of ES cells to tBHQ at a variety of concentrations. At 5001.1M tBHQ the MTT 
index falls by 64.94% compared to untreated controls (t -test P= <0.001). 
5.4.2.4 Ultraviolet light 
UV was used as an alternative vehicle to induce oxidative stress from that initiated by 
incubation with chemical agents. At high doses, ultraviolet light (UV) produces 
mutagenic dimers in DNA thought capable of initiating (Hall et al., 1988) and promoting 
(Romerdahl et al., 1989) malignancy. Exposure of mammalian cells to UV light triggers a 
global stress response (Devary et al., 1992) that can conclude in growth arrest, repair of 
DNA by NER or apoptosis (discussed in section 1.5.4). UV light can also be absorbed 
directly by other cellular macromolecules, preventing the correct folding of proteins and 
generating photoproducts following energy absorption (Renzing et al., 1996). UV 
irradiation initiates oxidative stress via the formation of free radicals (Bose et al., 1990; 
Konishi et al., 1991; Jurkiewicz and Buettner, 1994). Figure 5.5 B shows the survival of 
ES cells after UV irradiation. At 20 Joules min-1 sec -1, UV precipitates a 36.32% fall in 
MTT index (t -test P= <0.001). 
5.4.3 Summary 
All the selected agents have genotoxic potential and demonstrate cytotoxicity to ES cells. 
The purpose of these experiments was define appropriate doses with which to challenge 
wild -type and p53 -/- ES cells. In this regard, the toxicity of these compounds towards 
wild -type ES cells varied considerably. Surprisingly, H2O2 was only toxic at high 
concentrations, whereas UV dramatically reduced viability at relatively low doses and the 
quinone moieties exerted an intermediate cytotoxicity. The incubation time of chemical 
agents were pre -set and maintained at a constant of one hour. This is for comparative 
purposes since, in previous studies, this is often the default period of exposure used to 
examine the effects of cytotoxic compounds on cultured cells. 
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5.5 Effect of BSO and GSH on pro -oxidant cytotoxicity 
5.5.1 Introduction 
The objective of this experiment was to identify compounds selectively detoxified by 
GSH, for use in subsequent experiments.. Therefore, concentrations of pro- oxidants 
tested in section 5.4 that caused a -50% loss of viability were tested for toxicity on wild - 
type ES cells with low GSH levels. Increasing the quantity of cellular antioxidants in 
cells prior to oxidative insult generally provides protection against the effects of ROS. 
Therefore, the selected agent was also tested with GSH homologues to discern the effect 
of excess thiols. 
5.5.2 Results 
5.5.2.1 BSO preferentially potentiates the cytotoxicity of MQ 
Figure 5.6 shows the toxicity of H2O2 remained largely unchanged when cellular GSH 
levels were pre -lowered: viability altered from 43.02% ±2.56 to 36.12 ±1.55 (t -test 
P= 0.06), an insignificant shift. BSO enhanced the toxicity of tBHQ and UV in ES cells 
by 33.51% (t -test P= 0.018) and 41.50% (t -test P= <0.001), respectively. In comparison, 
the viability of ES cells exposed to MQ after BSO pre- treatment fell from 46.04 ±6.15 to 
17.21 ±1.29, a reduction of 62.62% (t -test P= 0.003). Thus, BSO enhances the cytoxicity 
of MQ by the greatest margin. 
5.5.2.2 Excess GSH homologues are partially toxic to ES cells 
GSH, unable to enter the majority of cells intact, is broken down extracellularly and the 
components imported prior to intracellular resynthesis (see section 1.3.1.3). To analyse 
the cellular effect of GSH repletion in vitro, many investigators utilise the lipid soluble 
GSH -monoethyl- ester, GSH -MEE (figure 5.7). The effect of GSH -MEE on normal and 
ES cells undergoing MQ- induced oxidative stress is shown in figure 5.7. As expected in a 
non -stressed environment treatment with 2mM GSH -MEE, a standard working 
concentration, does not impact upon ES cell viability. Unexpectedly, incubation of ES 
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Figure 5.6 Effect on GSH depletion on pro -oxidant cytotoxicity 
Viability of wild -type ES cells 24 hrs post incubation with pro- oxidants +/- prior GSH 
depletion by BSO. Control cultures were incubated with serum free (SF) media, 
whilst experimental cultures were exposed to 1mM H202, 34iM MQ, 1501.1M tBHQ 
or 10J m -1 sec-1. Error bars represent SEM values from 4 independent experiments. 
Symbols indicate significantly reduced values in comparison to (adjacent) controls: * 
















Figure 5.7 Effect of GSH -MEE on MQ cytotoxicity 
Viability of wild -type ES cells 24 hrs post incubation +/- 351..im MQ +/- prior treatment 
with GSH -MEE (structure summarised, top). Cultures were incubated with either GSH - 
MEE only (black bars), or GSH -MEE prior to MQ exposure (blue bars). CM indicates 
complete media; PBS, phosphate buffered saline. Error bars represent SEM values from 
3 independent experiments. *, $ and § indicate lower values compared to MQ -only 
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Figure 5.8 Effect of NAC addition on MQ cytotoxicity 
Chemical structure of DEM (A). Viability of wild -type ES cells twenty -fours hours 
post incubation with or without NAC only (B), or MQ with or without prior 
incubation with NAC (C). Error bars represent SEM values from 4 independent 
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cells with 2mM GSH -MEE prior to 351.1.M MQ served to sensitise ES cells to oxidative 
challenge: viability fell by 43.52% (t -test P =0.03) from 43.08% ±4.36 to 24.33% ± 5.03. 
Figure 5.7 also demonstrates dilution of GSH negated this effect, whereas the medium of 
dilution had no effect. This impact of 2mM GSH -MEE was also observed with MQ at 
different concentrations, tBHQ and H2O2 (data not shown). GSH -MEE was incubated for 
16 hours, in line with the majority of previous studies demonstrating a protective function 
against a wide variety of oxidant -induced injuries. Therefore a time -course of incubation 
periods was not pursued. 
In light of this finding, GSH -MEE was instead replaced with the GSH derivative and 
antioxidant in its own right, NAC (figure 5.8a). Without stress, NAC at concentrations 
from 0.25mM to 2mM did not affect viability (figure 5.8b). However, incubation with 
2mM NAC reduced the viability of ES cells then exposed to MQ by 80.14% (t -test 
P= <0.001). Decreasing concentrations of NAC were less toxic after MQ treatment, in a 
dose -dependent fashion (figure 5.8c). Reducing the NAC incubation period from 16 to 4 
hours served only to lessen the negative impact on viability after MQ treatment (data not 
shown). 
5.5.3 Discussion 
The cytotoxicity of H2O2 was not greatly affected by low GSH levels. This suggests that 
in ES cells H2O2 interacts with alternative H2O2 defence factors, such as catalase. This is 
in contrast with conclusions drawn from a foetal mouse study by El -Hage et al, which 
showed a low catalase mRNA and enzyme activity in early embryogenesis, but which 
rose with development (el -Hage and Singh, 1990). This may be explained by the use of 
ES cells in this experiment, compared to the overall catalase levels obtained from total 
foetal tissue. Indeed, aminotriazole, a specific inhibtor of catalase (Michiels and 
Remacle, 1988) blocked the development of 2 -cell stage embryos, indicating this enzyme 
is functional in early embryogenesis (Nasr -Esfahani and Johnson, 1992). 
Consistent with numerous other reports however, the cytotoxicity of MQ was greatly 
enhanced by low GSH levels. Because BSO is a specific inhibitor of yGCS, non -toxic in 
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ES cells and other types examined (Martensson et al., 1991; Rahman et al., 1998; Sagara 
et al., 1998), this is indicative of a dependence on GSH. Although the cytotoxicity of UV 
and tBHQ were also increased by GSH depletion, the extent of this was less marked. It 
should be noted that UV has multiple and ill- understood effects at the cellular level 
(Devary et al., 1992). The objective of this study was to elucidate the ES cell GSH- and 
p53- dependent response mechanisms specifically to oxidative stress. Therefore, MQ was 
selected as a paradigm reagent to deliver oxidative stress in following experiments. 
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Prior addition of GSH -MEE or GSH precursors to culture systems can be associated with 
increased cell GSH levels and resistance to oxidative stress (Trocino et al., 1995; 
Ishibashi et al., 1996; Deneke, 2000). In other systems no protective benefit of GSH - 
MEE is reported (Gardiner and Reed, 1994; Mulier et al., 1998). The data presented here 
show that, in ES cells, high concentrations of GSH -MEE and NAC have a deleterious 
effect under oxidative stress. 
The GSH -MEE and NAC experiments were included to reveal any protective effect 
addition of these agents might confer upon ES cells to counter oxidative stress. If such an 
effect was found, then the intracellular concentration of GSH would have been 
ascertained. Since this was not found to be the case, the value in pursuing this line of 
investigation was naturally diminished. Therefore, GSH levels were not monitored in this 
particular instance. 
However, that ES cells were sensitised suggests that a critical GSH concentration is 
required for ES cells to deal with the effects of MQ. Mulier and co- workers also proposed 
that a specific thiol level was required to protect pulmonary epithelia against the effects 
of H2O2. ES cells usually grow in conditions of low oxygen and are uniquely sensitive to 
DNA damage: they undergo apoptosis more readily than growth arrest (Aladjem et al., 
1998; Choi and Donehower, 1999). It is possible that perturbation of their redox 
equilibrium, such as that imposed by a GSH or NAC surplus, is detrimental to their 
capacity to recover from MQ. 
Low GSH levels, via altering the redox state, are reported to upregulate compensatory 
antioxidants including catalase, SOD and quinone oxidoreductase (NQO1) in bacteria 
(Storz et al., 1990) and a variety of mammalian cell types (Loven, 1988). Excess GSH 
may equally downregulate ES cell antioxidants and sensitise the culture to subsequent 
oxidative challenge. Certainly, the antioxidant potency of NQO1 (for mechanism, see 
figure 1.2) has been verified by the increased toxicity of MQ in NQO1-1- mice 
(Radjendirane et al., 1998) and increased mutagenicity of MQ during NQO1 inhibition 
(Chesis et al., 1984). Thus it is tempting to speculate that dowregulation of NQO1 alone, 
or in combination with other factors, reduces the overall antioxidant capacity in this case. 
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An alternative explanation relates to thiol- mediated radical engendering. Under some 
conditions, GSH in surplus is known to be a source of thionyl radicals (see table 1.1) and 
lipid peroxidation (Tien et al., 1982; Ross et al., 1985). However, since both low GSH 
levels and excess GSH enhance the cytotoxicity of MQ, I argue that disturbance of a 
critical ES cell GSH level accounts for the effect of GSH -MEE and NAC. 
5.6 Dependency of MQ cytotoxicity on p53 and GSH levels 
5.6.1 Introduction 
After demonstrating physiological levels of GSH are required for full neutralisation of 
MQ in wild -type ES cells, the joint effect of p53 and GSH deficiency on the ability of ES 
cells to cope with oxidative stress was examined. To discern any function in the response 
to oxidative stress, time courses of the immediate viability (defined as zero to forty -eight 
hours post treatment) of wild -type and p53 -/- ES cells were compared, using the MTT 
assay. 
5.6.2 Results 
5.6.2.1 p53 deficiency confers immediate survival advantage post MQ 
Figure 5.9 shows that wild -type ES cells displayed a sustained decline in viability in the 
period post treatment, dropping to 17.03% ±1.02 of control values at forty -eight hours 
post stress. Pre -treatment of wild -type ES cells with BSO augmented MQ cytotoxicity at 
all time points, reducing viability to <5% of control levels at forty -eight hours. 
Following exposure to MQ, p53 -/- ES cells displayed a considerably higher viability than 
their wild -type counterparts throughout the experimental period. The magnitude of this 
difference expanded with time, from 20.82% (t -test P =0.01) at six hours to 31.69% (t -test 
P= 0.002) at twenty -four hours, and 51.51% (t -test P= <0.001) at forty -eight hours. Pre- 
treatment of p53 -/- ES cells with BSO also exacerbated MQ cytotoxicity at all time 
points. However, p53 -/- cells receiving this treatment displayed a higher viability than 
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Figure 5.9 Immediate tolerance of ES cells to MQ and BSO 
Short-term viability of wild -type (WT, black lines) and p53 -/- (red lines) ES cells 
twenty -four hours post incubation +/- MQ +/- previous treatment with BSO (see 
figure for key). Error bars represent SEM values from 3 independent experiments. * 
and $ indicate the difference in comparison to wild -type ES cells treated with MQ 
only (P= <0.001 t -test) and with MQ +BSO (P= <0.001 t- test), respectively. 
-A-WT: MQ 
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their wild -type counterparts at six (41.48 %, t -test P= <0.001), twenty -four (40.97 %, t -test 
P= <0.001) and forty -eight hours (42.30 %, t -test P= <0.001). 
5.6.3 Discussion 
Cells with non -functional p53 display a striking survival advantage post- oxidative stress. 
Similar results have been obtained using cell lineages ranging from normal fibroblasts 
(Yin et al., 1998) to breast carcinomas (Shatrov et al., 2000). That this effect became 
more pronounced over time in ES cells suggests it is mediated by loss of damage 
checkpoints that normally halt cell division, or trigger programmed cell death. This 
conjecture is investigated in section 5.8. 
A role for GSH in the response of ES cells to oxidative stress is supported by the increase 
in MQ cytotoxicity observed after pre -treatment with BSO. This effect, apparent in both 
wild -type and p53 -/- genotypes, is also noted in a variety of transformed and non - 
transformed cell types (Mehlen et al., 1996; Arsalane et al., 1997; Sagara et al., 1998). 
Furthermore, it suggests ES cells, despite their protective environment in vivo (Gardiner 
et al., 1998) are able to mount a GSH- dependent response to oxidative stress. This 
proposition was investigated in the following section. Together, the data indicate that 
GSH and p53 play a critical role in the immediate viability of ES cells exposed to 
oxidative stress. 
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5.7 Role of p53 in the GSH response to oxidative stress 
5.7.1 Introduction 
Oxidative stress is known to activate p53 (Renzing et al., 1996; Yin et al., 1999), causing 
nuclear translocation (Uberti et al., 1999) prior to up or downregulation of p53 target 
genes. Depending upon the nature and level of the damage, p53 can transactivate redox- 
regulation genes that concur with the onset of apoptosis, or inhibition of apoptosis 
(described in sections 1.5.3- 1.5.4). One member of the latter category is the GSH - 
dependent enzyme, GPx (Tan et al., 1999). 
The p53- dependent transactivation of GPx directly links the p53 response with the 
antioxidant response. Consequently, p53 may play a role in the GSH- response to 
oxidative injury. Such a link could manifest on multiple levels. For example, via a p53- 
dependent transactivation of GSH synthetic enzymes, such as yGCSh. Indeed, GPx can be 
co- upregulated with yGCSh (see table 1.5) via an unknown mechanism (Thanislass et al., 
1995; Kojima et al., 1998a; Kojima et al., 1998b). Furthermore, GSH levels are 
implicated in the activation of the stress JNK kinase pathway (Liu et al., 1996; Wilhelm 
et al., 1997; Kurata, 2000), which controls cellular responses to stress signals. JNK 
activation can lead to both p53:mdm2 dissociation (Fuchs et al., 1998b) and elevated 
GSH levels (Erdos et al., 1995; Guyton et al., 1996; Liu et al., 1996; Fuchs et al., 1998a). 
Therefore GSH levels may also be involved in p53 activation. 
Alternatively, p53 may downregulate basal yGCSh or yGCS/ expression. Constitutive 
upregulation of GSH is associated with acquired drug resistance in many tumour- derived 
cell lines. Transiently transfected p53 downregulates steady state SOD levels and activity 
in mouse fibroblaststs (Pani et al., 2000). If p53 performed a similar function on yGCS, 




5.7.2.1 p53- independent elevation of GSH in response to MQ 
In order to assess any alteration in the level of GSH subsequent to MQ exposure, 
intracellular levels were monitored at different time points post exposure to MQ. 
Following incubation with 35µM MQ, wild -type ES cells showed a rapid elevation of 
free GSH levels at six hours (ANOVA P= 0.005). GSH levels peaked at 34.39 ±2.56 
nmol mg protein-1 twenty -four hours post exposure, before subsiding to basal levels 
forty -eight hours (figure 5.10). The fluctuation of GSH levels seen in untreated controls 
is consistent with the degree of confluency, as reported with other cell types (Shi et al., 
1994b; Kojima et al., 1998a; Reiners et al., 2000). 
Next the response to BSO removal, which reduces ES cell cellular GSH levels by 
approximately 70% (for details, see table 5.2), was examined. When incubated with fresh 
media, ES cells depleted of GSH recovered basal levels by twenty -four hours. 
Importantly, ES cells pre- incubated with BSO failed to induce an elevation in GSH when 
treated with 351.1M MQ. Furthermore, GSH levels remained suppressed, with recovery to 
control levels only achieved at forty -eight hours. P53 -/- cells also showed a clear GSH 
response post MQ treatment. Indeed, the GSH levels did not significantly differ between 
wild -type and p53 -/- cells at six hours (ANOVA P =0.57) or twenty -four hours ( ANOVA 
P= 0.59). 
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Figure 5.10 GSH response of wild -type and p53 -/- ES cells to MQ 
Total free GSH levels in wild -type (top panel) and p53 -/- ES cells (bottom panel) 
+/- 35µM MQ and +/- 10011M BSO treatment: see figure legend for key. Time at 
Oh = end of the MQ treatment. Error bars represent SEM of 3 independent 
experiments. * indicates the difference in comparison to MQ- treated p53 -/- ES 
cells (P =0.57 ANOVA), and $ signifies the difference compared to untreated wild - 
type cells (P =0.59 ANOVA). 
Time, hrs 
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5.7.3 Discussion 
The aim of this work was threefold. First, to reveal the presence and characteristics of 
any ES cell GSH response to oxidative stress. Second, to investigate whether a 
correlation exists between cellular GSH levels and viability under oxidative stress. Third, 
to establish whether the GSH and p53 pathways are functionally associated. Though 
published evidence supports the concept of a functional interplay between the GSH- and 
p53- response, no work to date has proposed or tested this conjecture. 
Different groups report GSH is of critical (Trocino et al., 1995; Ishibashi et al., 1996) or 
marginal importance (Nasr- Esfahani and Johnson, 1992) in early development. A 
blastocyst -derived yGCSh -/- epithelial cell line (GCS -1), since created by others (Shi et 
al., 2000), has clarified this issue. yGCSh -/- cells die in culture unless supplemented with 
GSH, where upon they uptake a minimal amount (^-2% of wild -type cells) and grow 
normally. However after continued passage in the presence of NAC, yGCSh -/- cells can 
grow normally, albeit at a slightly reduced rate (Shi et al., 2000). Thus, while GSH is not 
required for growth per se, a reducing equivalent must be present. 
The data presented in this section shows that ES cells, the earliest embryonic lineage, are 
indeed capable of launching a modest GSH response. As for other cell types and stresses 
this response to MQ- induced oxidative injury is transitory, being complete forty -eight 
hours post stress. In conjunction with the work of Shi et al, this data indicates embryonic 
cells have a functional GSH- dependent detoxification system, which although 
dispensable for growth under normal conditions becomes necessary in the response 
against oxidative stress. 
BSO blocks the ES cell GSH response to MQ (figure 5.10). This suggests that the 
normal response is mediated via an amplified rate of de novo GSH synthesis. In doing 
so, BSO augments the cytotoxic effect of MQ (figure 5.9). Indeed, GSH deficiency also 
magnifies the cytotoxicity of pro -oxidants toward cells of respiratory (Shi et al., 1994b), 
hepatic (Morales et al., 1997b), nervous (Iwata- Ichikawa et al., 1999), endocrine (Urata 
et al., 1996), vascular (Moellering et al., 1998) cardiac and renal origin (Park et al., 
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1998). As such, many authors consider the elevation in GSH to perform an important 
protective function against oxidative injury. The results presented here support this 
premise. 
One apparent anomaly is the observed initial fall in GSH levels, evident in other cell 
types exposed to MQ, was not seen in ES cells. A pilot study testing the effects of 701.1M 
MQ at a range of incubation periods also showed no early GSH depletion (data not 
shown). 
Two principle mechanisms are thought to mediate the toxicity of MQ. Damage can 
occur via oxidation from redox cycling (Rossi et al., 1986) (van Ommen et al., 1988; 
Schnellmann et al., 1989)or covalent arylation of macromolecules (Powis et al., 1981; 
Thor et al., 1982; d'Arcy et al., 1987) (see also section 1.1.1 -1.1.2). Utilising quinones 
closely related to MQ, but which have either enhanced propensity to arylate or negligible 
arylation potential, the relative contribution of oxidative versus conjugative processes 
has been studied. In liver cells, the toxicity of MQ is predominantly mediated via 
arylation reactions (Gant et al., 1988; Stone et al., 1996; Qiu et al., 1998), whereas in 
variety of other tissue types it is attributed to redox cycling (Nicotera et al., 1990a; 
Brown et al., 1991). It is now apparent that the mode of cytotoxicity which predominates 
is heavily dependent on the exact model used. 
The Tietze method used in this study measures total glutathione levels: reduced and 
oxidised. However GSH- conjugates such as PrSSG, formed by arylation reactions, are 
not detected and their formation would register as a loss of glutathione. It is therefore 
probable that GSH scavenges MQ- generated ROS, and that arylation reactions are not 
predominant in ES cells. Thus oxidation of GSH to GSSG, coupled with rapid GSH 
synthesis, could account for the lack of a preliminary fall in total GSH levels. 
The two ES cell strains utilised contrasted solely by their capacity to produce functional 
p53. The results show the steady state GSH level in ES cells was unaffected by p53 
status. This makes a role for p53 in basal transcription of ),GCSh or related enzymes 
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unlikely, and is consistent with the notion that p53 transcribes target genes only when 
activated by cellular injury. Moreover, the GSH response profile of wild -type and p53 -/- 
ES cells under oxidative stress were virtually superimposable and statistically 
indistinguishable. This is strong evidence that oxidative stress induces GSH via a 
mechanism independent of p53. 
It is possible that the increase in GSH is instead mediated via transcriptional alteration by 
other redox- sensitive transcription factors, such as NF -kß and AP -1. These have been 
shown to elevate GSH in a variety of cell types, coincident with an upregulation of 
yGCSh (Sekhar et al., 1997b; Morales et al., 1998; Rahman et al., 1999; Kitteringham et 
al., 2000). However, at the time of writing no evidence regarding their activity in ES cells 
was available. 
5.8 Effect of p53 deficiency on MQ- induced cell death 
5.8.1 Introduction 
Exposure of wild -type ES cells to MQ leads to a rapid reduction in viability, a decline 
potentiated by GSH deficiency. With normal or depleted GSH levels, the decline 
observed in p53 -/- ES cell viability was markedly less. ES cells are highly sensitive to 
forms of genotoxic stress, and can react by arresting growth or initiating death in a 
controlled (apoptotic) or uncontrolled (necrotic) fashion. However, the MTT assay does 
not differentiate between these cellular fates. Given the prominent role of p53 in these 
processes, the mechanism underlying this reduction in ES cell viability was examined. 
This was accomplished directly, by analysing cellular morphology (as described in 
section 2.4.3.3). 
5.8.2 Results 
5.8.2.1 MQ induces apoptosis in wild -type and p53 -/- ES cells 
No difference in the rate of apoptosis between untreated and BSO- treated wild -type or 
p53 -/- ES cells was detected (figure 5.11). This correlates with unchanged MTT indicies 
211 
Figure 5.11 Effect of BSO or MQ on the induction of apoptosis 
Wild -type and p53 -/- ES cells were treated with 1041M BSO or 3511M MQ. Cell 
death was examined 6 hours post MQ removal and the percentage apoptosis 
occurring in each experiment was assessed directly, using morphological criteria. 
Blue bars represent percentage of intact cells, black bars percentage of apoptotic 
cells. Error bars represent SEM values from 3 independent experiments. ANOVA 
statistical indicators are shown as: §, (P= <0.001) vs. untreated wild -type ES cells; , 
(P= 0.019) vs. untreated p53 -/- ES cells, and *, (P= <0.001) vs. wild -type ES cells 
















for these samples (data not shown). Compared to untreated controls, wild -type ES cells 
initiate a strong apoptotic response (52.5% ±3.6, ANOVA P= <0.001) six hours following 
MQ exposure. This correlates with a fall in the MTT index at the same time point (figure 
5.9). In response to MQ treatment, p53 -/- ES cells also displayed a significant apoptotic 
response in comparason to control cultures (15.8% ±3.48, ANOVA P= 0.019). However, 
the incidence was considerably reduced in comparison to that observed for wild -type 
cells ( ANOVA P= <0.001), concordant with high MTT indices for p53 -/- cells at this time 
(figure 5.9). 
5.8.2.2 BSO appears to convert MQ- induced apoptosis to necrosis 
In comparison to samples treated with MQ, the proportion of ES cells remaining intact 
post BSO and MQ exposure was reduced. However, there was no evidence of apoptosis 
in these samples. Instead the cells appeared lysed: the cellular contents were liberated and 
locally diffused, adjacent to membraneous fragments (data not shown). This observation 
was consistent regardless of genotype. Whilst no further experiments were performed to 
definitively identify the cause of these cellular fragments, the morphology was indicative 
of necrotic cell death. 
5.8.3 Discussion 
This study aimed to characterise the cellular events associated with the exposure of 
normal and p53 deficient ES cells to MQ. ES cells, being the progenitors of all tissue 
types, rely on accurate cell division to pass on an intact genome to daughter cells. 
Sustained damage is thought to be eradicated by apoptosis rather than risking improper or 
incomplete repair. The results show the oxidative injury inflicted by MQ to wild -type ES 
cells is sufficient to cause a strong apoptotic response. Thus the results are consistent 
with the "primed to die" property thought to ensure proliferation of only gentically 
healthy cell populations. 
Oxidative damage activates p53 (Renzing et al., 1996; Ngo et al., 1998; Meplan et al., 
2000), and p53 is required to induce apoptosis in mouse embryo fibroblasts in response to 
it (Yin et al., 1998; Yin et al., 1999). However the data presented here indicate that, in the 
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absence of p53, oxidative stress can commence an alternative apoptotic programme in ES 
cells. These findings serve to underline the complex role played by p53 in the response of 
ES cells to damage. Aladjem et al observed only p53- independent apoptosis in response 
to ribonucleotide depletion and DNA damage, whilst Corbet et al showed both p53- 
dependent and p53- independent apoptosis in response to UV (Aladjem et al., 1998; 
Corbet et al., 1999). It is becoming apparent that ES cells, perhaps due to their pluripotent 
role, excite a very precise response to counter the nature of particular stress agents. 
While MQ initiates apoptosis in both p53 -/- and wild -type ES cell lines, the immediate 
apoptotic response was weaker in p53 -/- ES cells. It is likely that the higher viability of 
p53 -/- ES cells post MQ treatment is accounted for by an attenuated rate of early 
apoptosis, and the low viability of wild -type cells by the higher rate of early apoptosis. 
The lower incidence of apoptosis observed in p53 -/- ES cells at six hours does not 
necessarily imply an attenuated p53 -/- apoptotic response. Others have revealed, with 
extended time courses, the presence of a delayed wave of p53- independent apoptosis 
(Clarke et al., 1994; Merritt et al., 1997; Frenkel et al., 1999). Thus the lower apoptotic 
index observed at six hours post MQ treatment is interpreted as a kinetic shift, rather than 
a reduced response per se. This is also in agreement with the primed to die function 
where, even in the absence of p53, ES cells recognise injury and activate a death 
pathway. Because ROS act as downstream mediators in some apoptotic pathways, it is 
possible that MQ, via ROS generation, may directly activate apoptotic factors in the 
absence of the p53 protein (Qiu et al., 1998). 
It should be noted that, as well as DNA damage inflicted by MQ and the subsequent 
induction of apoptosis, the embryonic toxicity of MQ may manifest via a subtle re- 
programming of gene expression. Such alterations are difficult to monitor in vitro and 
could effect cellular changes not detected within this study. 
MQ is known to initiate apoptosis in a variety of cell systems (McConkey et al., 1988; 
Hockenbery et al., 1993; Schulze -Osthoff et al., 1994; Caricchio et al., 1999). However, 
MQ and other inducers of oxidative stress can also initiate necrosis. In these instances, 
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the type of cell death is determined by the concentration of pro- oxidant: with lower 
concentrations initiating apoptosis and higher dosages causing necrosis (Dypbukt et al., 
1994; Sata et al., 1997; Vayssier et al., 1998). Similarly BSO can convert oxidant - 
induced, but not etoposide- induced apoptosis into necrotic cell death (Fernandes and 
Cotter, 1994). This parallels the observed shift in ES cell morphology from apoptotic to 
necrotic death. 
The active site of caspases are known to contain redox- sensitive cysteines (Alnemri et al., 
1996; Nobel et al., 1997). This led Lemaire et al and others to propose the switch from 
apoptosis to necrosis is mediated via caspase inactivation (Lemaire et al., 1998; Samali et 
al., 1999). It is possible that such a mechanism accounts for the effect MQ has on BSO- 
treated ES cells, though this evidently requires additional experimentation to verify. 
5.9 Effect of p53 and GSH deficiency on long -term ES cell viability 
5.9.1 Introduction 
The ability of cells to maintain genomic integrity is vital for survival and proliferation. 
Previously, approaches to analysing the impact of oxidative stress concentrated on 
monitoring the viability of primary or transformed cell lines. However, there are clear 
limitations when extrapolating viability data from immortalised cell lines to the normal 
situation in vivo. One restriction irrecoverably associated with an alternative system, 
primary culture, is the duration of the period under scrutiny. Many studies estimate the 
cytotoxicity of a particular oxidative agent by analysing viability several hours post 
exposure. However, oxidative stress can cause DNA damage, an injury that may not 
impact on the immediate health of the cell. Indeed, DNA lesions inflicted by MQ have 
been dissociated from short-term cell death in hepatocytes (Coleman et al., 1989) and 
fibroblasts (Renzing et al., 1996). 
Genotoxic injury may have long -term effects on the cell and, when propagated by 
mitosis, may become detrimental to the development of the organism. The ability of ES 
cells to proliferate in culture allows assessment of the long -term effects of oxidative 
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stress on a physiologically normal cell population. In comparison to wild -type ES cells, 
p53 -/- ES cells are refractory to apoptosis at six hours post MQ exposure (section 5.8) 
and display an immediate survival advantage over wild -type cells, manifested up to 48 
hours post exposure (section 5.6). To ascertain whether loss of p53 conferred a continued 
growth advantage over an extended period, we compared the clonogenic survival of wild - 
type and p53 -/- ES cells after exposure to MQ. This assay tests the ability of cells to 
tolerate a given stress: cells that survive and that sufficiently recover from injury to 
proliferate form, in time period of approximately 10 -12 days, a clonal population. 
5.9.2 Results 
5.9.2.1 p53 attenuates MQ- reduced clonogenicity 
A small difference in plating efficiency was detected between genotypes, with wild -type 
cells showing a plating efficiency of 85.4% compared to p53 -/- cells. To control for this 
difference, all data was calculated relative to untreated controls of the respective 
genotype. Unexpectedly, following treatment with 351.1M MQ, the long -term ability of 
p53 -/- ES cells to form clones was lower than wild -type ES cells (figure 5.12). This 
clonogenic survival difference between wild -type and p53 -/- ES cells was significant 
(17.34 %, ANOVA P= 0.004). Reduction of GSH with BSO prior to MQ exposure served 
to exacerbate the disparity between genotypes (21.8 %, ANOVA P= 0.002). 
5.9.3 Discussion 
This result implies that, following exposure to MQ, the strong and early apoptotic 
response of wild -type ES cells leads to a greater long -term survival than p53 -/- ES cells. 
Considering the widely acknowledged role for p53 as an anti -proliferation factor, this 
may at first seem paradoxical. However, in addition to causing death p53 also has an 
increasingly recognised function in facilitating repair (Abramova et al., 1997), especially 
via BER (Offer et al., 1999; Nakano et al., 2000; Zhou, 2001). This pathway acts to 
ensure surviving cells are genetically normal. Thus, in the presence of p53 -dependent 
repair, surviving ES cells are likely to carry a lower level of DNA damage - which could 
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Figure 5.12 Clonogenic survival of ES cells following exposure to MQ 
The long -term ( >10 day) viability of ES cells after exposure to 35µM MQ with or 
without prior 100µM BSO treatment. Wild -type ES cells are represented as solid bars 
and p53 -/- cells as shaded bars. Error bars represent SEM values of 3 independent 
experiments. * indicates the statistical significance in comparison to wild -type ES 
cells treated with MQ only (P =0.004 ANOVA), and + represents the significance in 






permit effective replication. Equally, in a p53 -free environment accumulation of DNA 
damage may reduce repair, lower clonogenicity and ultimately disrupt development. 
Alternatively, in the absence of p53 genotoxic stress could trigger delayed p53- 
independent pathways that halt cell proliferation. Such a reserve pathway may terminate 
either in permanent GI arrest or in apoptotic cell deletion. Delayed p53- independent 
apoptosis has been previously reported in ES cells subjected to ribonucleotide depletion 
(Aladjem et al., 1998) and UV irradiation (Carbet et al., 1999). It is clear this could 
provide an explanation for the lower long term survival of p53 -/- ES cells exposed to 
MQ, with or without prior depletion of GSH. This is in agreement with the conclusions 
reached by Frenkel et al., 1999 who showed p53 -/- embryos, upon irradiation, display not 
only altered patterns of apoptosis but accentuated levels of delayed death compared to 
their wild type counterparts (Frenkel et al., 1999). This is also consistent with the broader 
view that in development loss of cells is less detrimental to the organism than retention of 
damaged cells. Thus the data presented here, with that of section 5.8, point toward a 
strong, delayed p53- independent response. It should be remembered that these results 
reflect early organogenesis ( <10 days post fertilization) and may not be the case for later 
development, where p53 levels decrease with differentiation. 
GSH deficiency potentiated the long -term effects of MQ in both genotypes. To date, most 
studies investigating the effects of GSH depletion on drug cytotoxicity extend into the 
short term only. These studies have shown that lowered GSH levels in diseased tissue and 
cell cultures exposed to oxidant challenge are associated with increased lipid 
peroxidation (Thanislass et al., 1995), DNA damage (Park et al., 1998), protein oxidation 
(Tapper et al., 2000), and stunted foetal growth (Ishibashi et al., 1996). Here it is 
demonstrated that inhibition of the GSH response, which appears complete at forty -eight 
hours post stress, nevertheless effects the ability to survive up to 8 days later. This further 
underscores the protective function of the GSH response. This result is also supporting 




Concluding summary and discussion 
Disruptions in GSH homeostasis and the p53 gene are implicated in many human 
disorders, including malignancy and developmental dysfunctions such as 
teratogenesis. A number of other groups have used gene targeting technology to 
investigate the function of p53 and various antioxidants in mice. Aside from the 
previously discussed yGCSh knockout of Shi et al (section 1.3.5 and 5.7.3), and 
Dalton et al (section 1.3.5), the most relevant to this study are the knockout strains 
of GST -P, the selenoenzyme GPx1 and the transmembrane GSH salvage protein, 
yGT. To date, GR, GS and alternative GPx/GST isoenzymes have not been 
specifically inactivated in vivo. 
GPx1 was originally deleted via homologous recombination in 1997 (see table 6.1 
for targeting vector detail of this and other genes discussed herein). Despite an 
important role predicted for this widely expressed isoform, homozygous GPx]-/ - 
progeny grew to term at a normal rate. Furthermore, they were fertile and other than 
an 18% rise in the activity of liver GR, were initially indistinguishable from their 
wild -type littermates (Ho et al., 1997). This was attributed to redundancy between 
GPx family members or other cellular antioxidants, and strongly points toward a 
limited role of GPxi under physiological conditions. More surprising was a lack of a 
statistical difference between GPx] -/- and wild type mice in either viability or lipid 
and protein oxidation levels post exposure to >99% oxygen (Ho et al., 1997). 
An alternative GPx1 knockout similarly confimued that GPx1-1- offspring were 
healthy (Cheng et al., 1997). Furthermore, this study also found that under conditions 
of vitamin E or selenium deficiency, GPx] loss did not affect growth rates or GPx 
isoenzyme mRNA levels. However, de Haan and colleagues have revealed a notable 
effect of GPx] deletion. Intraperitoneal treatment with the pro -oxidant paraquat at a 












































































































































































































































































































































































































































































































































































































































































































































whilst wild -type mice remained alive at ten days (de Haan et al., 1998). Wild -type 
mice were found to upregulate GPx activity 2 -fold in the lung, whereas GPx1 -/- mice 
displayed no GPx activity. Furthermore neuronal viability, as assayed by the MTT 
technique in culture, showed that normal cells was unaffected by 651AM H202: a 
concentration that caused a 30% decline in viability of cells derived from GPx1-/- 
mice (de Haan et al., 1998). 
This study therefore showed an effect of GPx1 absence in vivo and in culture, not 
under developmental or physiological conditions, but under particular forms of 
oxidative stress. Subsequent work showed exposure to paraquat increased lipid and 
protein oxidation, whilst lowering NADPH/NADP and NADH/NAD ratios in GPx1- 
/- mice liver (Cheng et al., 1999). This latter observation is purported to signify an 
altered redox status, an assertion yet to be confirmed or confounded. 
Whilst a function for GPx1 became evident only after extensive experimentation, 
targeted deletion of yGT generated a clear phenotype under non -stressed conditions. 
Mice carrying a yGT -/- genotype grow slower than wild -type mice, with 6 week old 
males and females weighing approximately 45% and 57% of their littermates, 
respectively (Lieberman et al., 1996). This was found to be largely reversible by 
dietary addition of NAC. Furthermore, 100% of yGT -/- mice developed cataracts, 
displayed reproductive abnormalities and by week 25 over 80% had died (Lieberman 
et al., 1996). Such mice had a dramatically higher plasma and urine GSH content, 
while GSH levels were lowered in most tissue (except the kidney and small intestine, 
cell types thought able to uptake intact GSH (Deneke and Fanburg, 1989)). 
In a separate analysis, Kumar and co- workers revealed detailed morphological, 
histological and functional abnormalities in the reproductive tract of yGT -/- mice. For 
example, males had lower testosterone levels, smaller testes, a fraction of the normal 
sperm count (which were immotile) and a severely hypoplastic epididymis (Kumar et 
al., 2000). Liver cultured from yGT -/- mice was found to have, in comparison to 
wild -type liver, over 50% mitochondrial GSH depletion and impaired respiration. 
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NAC is reported to restore mitochondrial GSH levels, respiration (Will et al.. 2000) 
and partially prevent both male and female abnormalities (Kumar et al., 2000). 
The GST -P enzyme has also been deleted in mice by gene targeting. Both GST -P 
heterozygote and homozygote null mice are normal throughout life and do not show 
compensatory increases in hepatic GSH content, yGCS or GS activity (Henderson et 
al., 1998). However, GST -P -/- mice develop significantly more skin papillomas than 
wild -type mice after treatment with either carcinogen 7,12 -dimethylbenz anthracene 
or 12- 0- tetradecanoylphorbol -13- acetate (Henderson et al., 1998). This suggests a 
direct role for GST -P in detoxification of these compounds, and is a good example of 
the insight that can be gained into gene function by gene targeting. 
Further to knockout models of GSH- enzymes, the SOD family have been subject to 
gene targeting. SOD2 codes for the mitochondrial form of the enzyme, Mn -SOD. 
SOD2 -/- disruption causes neonatal lethality at approximately 10 days. However, 
both SOD2 -/- mitochondrial structure and DNA mutation rates were 
indistinguishable from unaltered mice (Li et al., 1995). What appears to be 
accumulated lipid droplets were visible by electron microscopy in muscle and liver. 
Furthermore animals had an abnormal heart structure, whilst activities of the 
respiratory enzymes succinate dehydrogenase and aconitase are reportedly lower 
than found in wild -type mice (Li et al., 1995). Thus Mn -SOD appears necessary to 
maintain normal mitochondrial function. 
In contrast, deletion of SOD], the gene encoding Cu,Zn -SOD (the cytosolic enzyme 
which accounts for 80% of cellular SOD) surprisingly had no measurable impact 
upon development, growth or lipid peroxidation (Reaume et al., 1996). In 
comparison to wild -type mice, SODI -/- mice did however display neuromuscular 
pathologies (Flood et al., 1999) and retarded motor neuron survival post transection 
(Reaume et al., 1996). SODI -/- mice also have reduced numbers of corpora lutea and 
reduced fertility, in terms of offspring /litter and litters /month, compared to 
heterozygote mice (Matzuk et al., 1998). A possible reason for lack of more 
prominent effect of SOD] deactivation is the increased expression of the antioxidant 
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metal lotheionein proteins I and II, detected in livers of SODI -/- mice (Ghoshal et al., 
1999). However it is possible, as argued by Reaume et al, that MnSOD performs an 
essential neutralisation function of constantly produced mitochondrial radicals, 
whereas CuSOD, dispensable for normal physiological conditions, becomes 
important only in protecting against injury. Such contentions remain to be proved 
correct. The phenotypes of other antioxidant- related genes knocked out in mice are 
briefly detailed in table 6.2. 
In deciding which gene to target to model GSH dysfunction, there are six main 
options to consider. These include those enzymes directly involved in the GSH - 
cycle, namely the GST and GPx families, yGT, yGCS, GS and GR. The positive and 
negative aspects of these candidates are addressed individually. 
Removal of enzymes that use GSH as a co- factor in detoxification reactions is one 
possibility. However, the GST family comprises many members with overlapping 
substrate specificities (Hayes and McLellan, 1999) and deletion of one is unlikely to 
provide explicit information regarding the importance of GSH alone. Similarly the 
main value of excising a GPx isoenzyme is limited to understanding the function of 
that enzyme. Besides, loss of these enzymes would not reveal important functions of 
GSH that are not dependent upon catalysis. 
In contrast to enzymes that utilise GSH, enzymes that maintain intracellular levels of 
GSH are more appropriate targets for use in a gene targeting strategy. However, 
although deletion of GR would effectively block recycling of GSSG, production of 
GSH could continue unabated, and even become increased. Thus residual GSH is 
likely to be present in a GR -/- model, so GR is not an ideal choice to examine GSH 
function. yGT is a better candidate since this protein is usually required to import the 
constituent amino acids for GSH synthesis. There are known exceptions however, 
such as cells of the small intestine and kidney, that can import GSH from the 
extracellular melieu intact (Deneke and Fanburg, 1989). Therefore yGT is also not an 



































































































































































































































































































































































































































































































































































































































































































































































































































































This leaves the genes coding for GSH- synthetic enzymes, yGCS and GS. Deletion of 
either of these genes would permanently and completely halt GSH synthesis, and 
should therefore expose the normal role of GSH. Of the two enzymes yGCS is rate 
limiting in GSH production and the yGCS product, y- glutamyl -cysteine, is thought to 
have partial antioxidant activity itself (Deneke and Fanburg, 1989). Thus, of these 
two enzymes yGCS is the more attractive option to create a GSH- and GSH - 
precursor free model. To deactivate it completely, removal of the subunit containing 
the catalytic sites is the obvious choice. Thus, the yGCSh gene was selected for 
targeted deletion in this study. 
In an attempt to create an ES cell line with a deactivating mutation in 2,GCSh, >16kb 
novel mouse yGCSh cDNA and gene sequences were successfully isolated, cloned 
and characterised. This process yielded sufficient detail to permit construction a 
replacement -style targeting vector, pGCS -TV2. Electroporation of the final vector 
into ES cells, followed by selection in antibiotic -containing medium yielded resistant 
clones as expected. However, screening ES cell DNA by southern analysis failed to 
isolate a clone bearing the desired genetic modification. 
The approach successfully taken by Shi et al to delete yGCSh was subtly different. 
The total region of homology was slightly longer (approximately 0.7kb), but of 
possibly more note was the distribution of the homology. Shi and colleagues utilised 
a vector with roughly equal distribution (3.5/4.2 kb), whereas in this study the 
majority of homology resided the in the 5' arm (6/1 kb). Although this arrangement 
is thought less optimal by some (Thomas and Capecchi, 1987; Thomas et al., 1992), 
others report that as long as one arm is at least 0.8kb, it makes little difference how 
the homology is distributed (Hasty et al., 1991b; Torres and Kuhn, 1995). This 
discrepancy remains to be fully resolved and, as such, the distribution of homology 
in pGCS -TV2 could have potentially reduced recombination with the yGCSh gene. 
Shi and co- workers also employed southern analysis to screen antibiotic resistant 
clones. The band shift size expected and observed for a mutant allele was 2.95kb 
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(10.3 to 7.35), comparable to the 3.2kb (8 to 11.2) shift sought in this work. Both 
these strategies provide clear means to discern mutant and undisturbed alleles. 
Another difference was the use of neomycin transferase as a positive reporter. Shi 
incorporated a HPRT cassette into their vector, although again neo cassettes identical 
to that used in this work has been used extensively in previous targeting experiments 
(for examples, see table 6.1). Both the strategy presented here and that of Shi used 
gancyclovir to enrich for integration events that excluded tk incorporation. Therefore, 
selection cassette choice is an area not anticipated to impact negatively on the 
targeting frequency recorded in this work. 
The last difference between the published approach to deactivate yGCSh and that 
presented here is the strain of donor DNA and recipient cell line. The available 
information regarding this states '129/Sy' DNA was used for vector construction, 
electroporated into `AB2.1' ES cells. These ES cells belong to the `Steel' 129 /Sv 
substrain, as does the ? -library DNA used in this study to construct the targeting 
vector pGCSh -TV2. However, 129 /Sv is now recognised as a large family 
incorporating three parent strains and many distinct sub -strains (Simpson et al., 
1997). Consequently, it may be possible that the differences in targeting succes may 
have arisen as a consequence of subtle differences in the level of homology between 
targeting vector and targeting sequence, however the degree of any such difference is 
impossible to ascertain from the published data. 
Thus, from the information available, the only definite differences that can be 
asserted between the strategy of Shi et al and that pursued here relates to the 
cumulative effects of non -optimal distribution of homology. Refer to section 4.7 for 
a dedicated discussion of this topic. With the power of hindsight, recommendations 
for others embarking on a gene targeting project can be offered. These are (i) 
produce a targeting vector with a balanced homology size; (ii) ensure the similarity 
between DNA sequences of vector and target gene are as close as possible, and (iii) 
plan for laboratory assistance to isolate, expand and screen large quantities of clones. 
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Should a yGCSh heterozygote have been isolated as anticipated, the downstream 
experiments that would have been initiated fall into two categories. First, culture of 
yGCSh +/- ES cells in high concentration antibiotic (such as G418) to generate a 
yGCSh / line, a standard technique used to generate many null lines. Upon 
confirmation of a correct and stable karyotype (normal mice cells contain 40 
chromosomes), yGCSh -/- cells would be transferred to a dedicated departmental unit 
to generate yGCSh -/- chimeric mice via C57BL /6 blastocyst injection. By crossing 
these mice to Ola 129 mice we would identify those chimaeras with a gemuline 
contribution and so would generate heterozygous and subsequently homozygous null 
mice for yGCSh. 
Second, a series of ES cell culture assays would have been pursued in parallel as 
follows. To ascertain whether yGCSh +/- cells had diminished GSH levels and 
confirm yGCSh -/- ES cells contained negligible GSH, the GSH levels would be 
determined. Oxidants produced during normal metabolism or following exposure to 
xenobiotics may adversely affect maturation by causing DNA strand breaks, lipid 
peroxidation and protein degradation. Indeed, GSH appears critical in protecting 
early embryos from oxidative stress (Trocino et al., 1995; Ishibashi et al., 1996) - 
though no work to date has used a mammalian system devoid of GSH to 
conclusively examine this assertion. Thus, the ability of yGCSh +/- and yGCSh - ES 
cells to withstand oxidative insult would be tested and compared to genetically 
normal cells. Immediate and long term viability tests would reveal the extent of 
protection afforded by GSH to oxidative stress induced by MQ. Additionally, a lipid 
peroxidation assay would serve as a marker for the extent of oxidative damage 
sustained, which is expected to (a) be greater than in ES cells with GSH depletion 
induced by BSO, and (b) corroborate with viability data. 
The presence of GSH is thought, along with other factors, to influence gene 
expression by modulating the activity and binding of transcription factors to DNA 
(Schultz, 1993; Wasserman and Fahl, 1997; Rahman et al., 2001). This can adversely 
affect subsequent organogenesis (Beckman and Ames, 1997; Lopes et al., 1998). The 
RNase protection assay can probe for transcription of GSH -system enzymes and 
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other stress -response factors, such as p53 target genes - transactivation of which lead 
to apoptosis, or cell cycle arrest and DNA repair. Contrasting the band patterns 
obtained from yGCSh -/- and normal ES cells to MQ should reveal the spectrum of 
embryonic genes activated by oxidative stress, in comparison to a panel of house- 
keeping genes. Moreover, it would indicate whether the redox environment of a 
GSH -free cell alters the genetic responses to oxidative stress. 
Disruption of the intracellular redox equilibrium also affects the balance between cell 
death, proliferation and senescence (Powis et al., 1995; Wang et al., 1998b). For 
example, exposure of a neuronal cell line to H2O2 results in migration of cytoplsamic 
p53 to the nucleus, prior to caspase activation and apoptosis (Uberti et al., 1999). 
Dorsal apoptotic cell death is also purported to mediate neonatal lethality of yGCSh- 
I- mice (Shi et al., 2000). P53 cytospin tests in yGCSh -/- and wild -type ES cells 
would reveal if loss of GSH influences translocation of p53 to the nucleus, prior to 
MQ or H2O2- induced cell death. Others have shown the existence of a delayed 
apoptosis in ES cells, after exposure to UV light (Corbet et al., 1999). Therefore, the 
long -term apoptotic response would be examined with a time -course extending to 
cover 72 hours post stress, to estimate whether presence of GSH directly effects the 
existence and strength of a delayed p53- independent apoptosis. This should provide a 
fuller appreciation of the impact of GSH loss on the ability to engage apoptosis, a 
critical event in development. 
It is estimated that, due to damage, over 50% of human fertilisations are aborted 
early (Hall and Lane, 1997). Indeed, it would make good evolutionary sense to 
efficiently abort foetuses with DNA lesions, if failure to repair injuries resulted in 
progeny with compromised reproductive fitness (Janus et al., 1999). Quantifying the 
levels of oxidative damage, cell viability and cell death, along with gene expression 
in yGCSh -/- ES cells would together gauge the breadth of functions GSH plays in the 
early embryo. 
To prepare for the eventuality of analysing a yGCSh -/- ES cell line, the roles of GSH 
in the response of wild -type ES cells to oxidative injury were investigated. Since no 
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previous work examining this had been done, an in vitro wild -type model was 
successfully designed and optimised. This work first involved demonstrating that ES 
cells express yGCSh and contain GSH. Second, the base line tolerances of wild -type 
ES cells under diverse pro -oxidative stresses, including hydrogen peroxide, UV 
irradiation and aromatic quinones were established. Last, characterisation of the 
response to BSO, pre- incubation with which was shown to deplete GSH levels and 
further, that of the agents tested, the quinone menadione (MQ) was preferentially 
neutralised by GSH. 
MQ- generated ROS can cause single strand breaks in DNA and induce wild -type p53 
(Messmer et al., 1994; Upadhyay et al., 1995; Uberti et al., 1999). The GSH - 
dependent GPx enzyme is a transcriptional target of activated p53 (Tan et al., 1999). 
Therefore, subsequent assays measuring GSH levels, cellular viability and apoptosis 
performed on this model were replicated on a karyotypically normal p53 -/- ES cell 
line. 
This thesis presents data that shows wild -type ES cells are acutely sensitive to MQ- 
induced oxidative injury and respond by initiating a rapid, transient elevation of 
GSH. Pre -incubation with BSO blocked the GSH response and greatly enhanced 
MQ- cytotoxicity. Thus, the GSH response is interpreted as (a) performing a 
protective function at the cellular level and, (b) being mediated, at least in part, via 
an increase in de novo GSH synthesis. These conclusions are in agreement with data 
derived from a variety of cell systems in previous studies. Combination of this data 
with that derived from a yGCSh -/- embryonic cell line, subsequently generated by 
others (Shi et al., 2000), indicates that embryonic GSH is unnecessary for noinial 
growth in vitro but is necessary for the response against oxidative stress. 
A cluster of redox- regulation genes, including the GSH- dependent enzymes GPx and 
a GST have been identified as downstream effectors of p53 signalling (Tan et al., 
1999; Polyak et al., 1997). I therefore reasoned that p53 may have a role in the GSH 
response to oxidative stress, possibly via modulation of yGCS expression. However, 
the magnitude and duration of the MQ- induced GSH response was unaffected by p53 
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status. Consequently, it is highly probable that embryonic GSH levels are regulated 
through mechanisms distinct from p53. Candidate pathways include those that 
terminate in Nrf2, NF-Kf3 or AP -1 activation. 
However, a role for p53 in the global response was established as, in comparison to 
wild -type cells, p53 -/- ES cells had a decreased rate of apoptosis and increased 
viability immediately following oxidative stress. This implies the existence of 
distinct p53- dependent and independent death factors that mediate the deletion of 
damaged ES cells. Within the embryonic field, this result contributes to the view that 
p53 orchestrates complex dosage- and agent -specific responses to stress, and that 
broad simplifications of function do not hold. 
Prior depletion of GSH converted the MQ- induced apoptotic response of both 
genotypes to a non -apoptotic form of cell death. This finding is in line with results 
sourced from diverse cell types and pro- oxidants. BSO and GSH homologues (at 
high concentration) were also found to become cytotoxic under oxidative stress. 
These effects are likely to reflect a requirement for a critical GSH concentration band 
in ES cells to deal with oxidative injury: a proposition advanced for some types of 
differentiated cells (Mulier et al., 1998). It is tempting to speculate that on a low 
GSH background, oxidative damage inflicted is severe and overwhelms the ES cell 
response machinery, leading to catastrophic cell death. Further work out with the 
time limitations of this project are required to confirm this conjecture. 
Inhibition of the ephemeral GSH response was found to reduce the long -term 
replicative potential of both genotypes exposed to oxidative stress. Apoptosis is 
known to delete cells carrying a high degree of genetic damage. I propose that, in 
instances where the normal GSH response failed to protect against MQ- induced 
oxidative damage, ES cell apoptosis is triggered via multiple pathways (figure 6.1). 
In summary, these findings are consistent with the accepted broader role of (a) GSH 
as an inducible protective agent and, (b) p53 as an inducible transcription factor 



































































































































































































































































































































































































































































































































































































































































impact of p53 on clonogenic survival serves to underline the complex role played by 
p53 in embryogenesis. I propose that, in the absence of functional p53, MQ- induced 
DNA breaks accrue and activate alternative embryonic death pathways that prevent 
the persistence of genetic lesions in differentiated cells. This is in agreement with 
previous work which showed p53 -/- embryos, upon y- irradiation, display accentuated 
levels of delayed apoptosis compared to their wild type counterparts (Frenkel et al., 
1999). This is also consistent with the view that in development loss of cells is less 
detrimental to the organism than retention of damaged cells. 
These mechanisms are perhaps reliant upon other p53 family members, such as the 
homologues p63 and p73. GSH may serve to limit MQ- induced DNA damage and 
therefore indirectly prevent induction of both p53 dependent and independent death 
pathways. Thus the data indicate that p53 and GSH operate, through discrete 
mechanisms, to ensure that cellular integrity is not compromised by environmental 
oxidative stress during development. Investigation of pathways independent of p53 is 
clearly an area that may yield potential routes to limit developmental abnormalities 
induced by oxidative stress in utero. 
Since the yGCSh -/- phenotype is lethal, questions regarding the precise role of yGCS 
in the GSH response remain pertinent. One route to characterise this could be the 
generation of a conditional yGCSh mouse system, using cre -lox technology (outlined 
in section 4.3.2, and reviewed in (Lobe and Nagy, 1998). For example, introduction 
of a floxed yGCSh allele into yGCSh +/+ ES cells by replacement gene targeting of 
the wild type allele would make a yGCShfl°x /+ cell line. To test excision, addition of 
cre would lead to inactivation of the floxed yGCSh allele in vitro, which in this 
instance would create a heterozygous cell line. Chimeras derived from these ES cells 
could be used to generate mice heterozygous and ultimately homozygous for the 
floxed allele. Further rounds of intercrossing would then be used to introduce a cre 
transgene, the expression of which is under the control of a promoter only active in a 
particular tissue. This strategy would therefore ultimately yield progeny to permit 
analysis of the effect of GSH loss in a particular organ or cell type. 
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GSH is potentially critical in limiting redox imbalances caused by inhalation of 
environmental pollutants and the inflammatory response of lung pathologies, 
including idiopathic pulmonary fibrosis (IPF) and emphysema (reviewed in Rahman 
and MacNee, 2000). These conditions are also allied with an imbalance between 
proteases, such as elastase (sourced from neutrophils and other inflammatory cells), 
and ambient protease inhibitors (reviewed in (Sethi and Rochester, 2000). Both 
processes are thought to damage to the lung structure. It is generally anticipated that, 
due to interactions such as that of GSH with antiproteases and inflammatory 
cytokines, complex relationships between oxidative and proteolytic mechanisms of 
lung disorder exist (Morris and Bernard, 1994). 
Thus examination of the effect of local GSH deficiency in the lung under oxidative 
stress would be desirable. To delete yGCSh specifically in the lung requires the 
presence of cre limited to respiratory tissue. This could be achieved using a cre 
transgene driven by a lung- specific promoter, such as the surfactant gene SPC 
(surfactant protein C). Pulmonary surfactant is a compound of phospholipids and 
four unique proteins, SPA, SPB, SPC and SPD (Rooney et al., 1994), which prevents 
alveolar collapse via lowering of surface tension (Bernhard et al., 2001) and its anti - 
adhesive properties (Daniels and Orgeig, 2001). Whilst the lung is composed of over 
forty different cell types (Royce et al., 1996) murine SPC synthesis, as determined by 
a variety of techniques, is predominantly localised in distal bronchiolar and type II 
alveolar cells (Glasser et al., 1991; Glasser et al., 2000). This makes the 5' regulatory 
sequences of the SPC gene a plausible promoter to generate GSH- compromised 
respiratory epithelia. Indeed SPC has been used successfully to drive lung- specific 
expression of p53 (Morris et al., 1998), al- antitrypsin (Dhami et al., 1999), platelet - 
derived growth factor (Hoyle et al., 1999) and the adenovirus protein E3 -14.7K 
(Harrod et al., 1998) in mice. Cloned mouse SPC promoter was available within our 
laboratory, and SPC transgenic mice are under preparation (A. R. Clarke, personal 
communication). 
Crossing 'GCShfl'/- mice with transgenic SPC -Cre mice should result in 
deactivation of the remaining yGCSh allele specifically within the bronchiolar- 
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alveolar duct regions. If these mice survived to adulthood, it would be necessary to 
confirm that excision of yGCSh occurred in such animals, and was confined to the 
respiratory epithelia. This would be achieved by Southern blotting techniques on 
DNA extracted from alveolar and bronchial cells. Upon confirmation, this model 
would represent a powerful tool to investigate the role of GSH in respiratory 
disorders. Since there is evidence that GSH is connected with many aspects of lung 
function, including maintenance of a normal surfactant system (Martensson et al., 
1991; Li et al., 1998; Khalak et al., 1999), early lethality, or at least respiratory 
distress may be predicted. If so, an inducible model that allows for deletion of yGCSh 
in adult tissue represents an alternative avenue for exploration. 
To generate a conditional yGCSh model, I would propose a version of the promoter 
strategy of Zhang and co- workers, under development in this department. This 
approach requires fusion of cre with the ligand binding domain of a mutant oestrogen 
receptor (A), connected to the SPC promoter. This mutant receptor cannot bind 
oestradiols, but specifically recognises the anti -oestrogen drug, tamoxifen. Addition 
of tamoxifen to the culture medium of ES cells (Zhang et al., 1996) or neonatally to 
mature animals leads to efficient activation of the cre fusion protein, as measured by 
reporter genes (Fiel et al., 1996; Schwenk et al., 1998). Crossing yGCShfl°X /- females 
with males that bear a SPC -creA transgene can yield progeny with the potential for 
temporal control of gene excision. Injection of tamoxifan into the lung cavity would 
be predicted to initiate excision of the foxed yGCSh allele within the lower 
respiratory tract. 
Thus, this technique can permit analysis of the effect of complete yGCSh deficiency 
on respiratory tissue in mature animals. To study the function of GSH in the response 
to oxidative stress in this model, examination of GSH levels in different tissues must 
first be carried out to identify tissues with effectively deactivated yGCSh. Upon 
demonstration of success with either constitutive lung or inducible lung strategies an 
experimental program would be initiated. First, comparison of the LD50 values of 
wild -type and lung yGCSh -/- mice exposed to cigarette smoke would indicate the 
crude extent of reliance on the GSH system of the lower respiratory tract to limit 
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smoking- induced lung injury. This may be expected to be high, since GSH is 
normally a highly abundant antioxidant and is thought necessary to ameliorate 
oxidative damage to endogenous biomolecules (Cantin et al., 1987; Brown, 1994; 
Deneke, 2000). 
Second, to investigate the pathology of mice with yGCSh -/- lung to oxidative stress, 
tissues would be prepared for histological analysis. Morphologic evaluation of lung 
sections from wild -type and lung yGCSh -/- mice under light microscopy would 
assess any remodelling of lung architecture. In particular, fibrotic lesions and 
increased airspace permeability - phenomena associated with idiopathic pulmonary 
fibrosis and emphysema in man (MacNee and Rahman, 1995; Rahman and MacNee, 
2000). Airspace area would be measured by first capturing digital images under light 
microscopy, technology available in the imaging suite of the Pathology department. 
Following this, analysis with publically available NIH image software 
(http:rsb.info.nih.gov /nih- image /downloads.html), would be done as described 
(Hoyle et al., 1999). 
Third, lung sections would also be used to estimate apoptotic rates between 
genetically normal and lung- yGCSh -/- tissue, with and without oxidative stress. 
Apoptosis is potentially implicated in lung disorders (Morris and Bernard, 1994). If 
apoptotic rates significantly alter between lung genotypes, and correlate with the 
acquisition of histological features of respiratory disease, this result would flag 
apoptosis as an area worthy of further investigation. If not, it would suggest that 
dysregulated cell death is not a critical factor in development of inflammatory lung 
pathologies. 
Forth, to probe for mechanisms underlying pathologies recorded, lungs from both 
genotypes with and without smoking- induced oxidative stress would be perfused, the 
distal portions isolated, homogenated then divided into GSH, cytosolic and RNA 
samples. Others have shown GSH decreased 45% in lungs of rats exposed to 
cigarette smoke (Park et al., 1998). Therefore GSH levels, as well as the activities of 
SOD and other antioxidant enzymes from cytosolic fractions would be analysed. 
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This would indicate whether loss of yGCSh -/- results in complete ablation of 
pulmonary GSH, or whether secondary sources of GSH can re- supply lungs. 
Comparing the enzyme activities with northern blotting data for the same factors 
would suggest whether GSH deficiency leads to compensatory antioxidant responses, 
and whether alterations in activity concur with changes in gene expression. The 
former is likely since rats exposed to 90% oxygen for seven days demonstrated 
substantial increases in MnSOD (245 %), GPx (317 %), and GR (175 %) over controls 
(Kimball, 1976). 
Fifth, the ensuing inflammatory response is thought to exacerbate the initial injuries 
sustained, and represent an important phase in many types of lung disease. To 
examine the role of GSH in this response, it would be possible to investigate whether 
yGCS loss in the respiratory epithelium modified the number of accumulated lumenal 
macrophages, eosinophils or neutrophils. This could be achieved by 
immunohistochemistry on lung sections with murine monoclonal antibodies against 
such inflammatory cells, as used previously (Luna, 1968; Liu et al., 1996). 
Sixth, it would be interesting to determine the GSH content of the respiratory lining 
fluid (RLF) from yGCSh -/- and genetically normal mouse lung. This would indicate 
sources of lumenal GSH other than from the pulmonary tract, including net GSH 
exporters such as liver. RLF GSH pools are reduced in the respiratory disorders IPF 
(Cantin et al., 1989; Rahman et al., 1999) and acute respiratory distress syndrome 
(Bunnell and Pacht, 1993). However, in response to chronic smoking, GSH levels in 
RLF rise (Eiserich et al., 1995; Morrison et al., 1999). Examination of GSH levels 
found in RLF from yGCSh -/- lung exposed regularly to cigarette smoke would 
indicate whether this elevation was mediated predominantly, or not, by synthesis 
from within the respiratory epithelia. If so, strategies to modulate antioxidant gene 
expression in the pulmonary tract may represent a potential therapeutic target to 
augment RLF GSH levels. 
Seventh, to assess whether GSH loss in RLF affects antiprotease function. al- 
proteinase inhibitor (aiPI) previously isolated from the lungs of cigarette smokers 
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was found to have oxidised methionine residues and lower capacity to inhibit 
elastase (Carp et al., 1982; Hubbard et al., 1987). It would be instructive to know 
whether a1PI, recovered from smoking -damaged ),GCSh -/- lung, has lower activity 
and greater methionine oxidation than that of wild -type lung. If confirmed, this add 
weight to the theory that GSH plays a direct role in maintaining antiprotease 
function. 
Overall, the effect of lung 2GCSh loss on mice would be analysed by correlating 
induced oxidant /antioxidant or protease /antiprotease imbalances with anatomical and 
biochemical features of lung disease. This would clarify the roles of GSH in these 
paradigms and may open new areas for subsequent exploration, or refine 
experimental regimens to correct the low GSH levels associated with lung 
pathologies. Using the materials generated and the information presented in this 
thesis, it is hoped murine models to provide insights to these pertinent areas will be 
developed by others. 
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Appendix II: Solutions 
RNA Solutions 
DEPC treated water 
diethylpyrocarbonate (DEPC) in double distilled water 0.01% (w /v) 
Stand overnight at room temperature 
Autoclave solution prior to use 
5X First strand buffer 





Standard PCR 10X buffer 
Tris -HC1 pH8.0 20mM 
KC1 50mM 
MgC12 15mM 
Hi- Fidelity 50X polymerase buffer 
Glycerol 50% 




f3-mercaptoethanol 0.1 Mm 
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Hi- Fidelity 10X reaction buffer 




Agarose gel electrophoresis reagents 
Agarose gels 
0.8% w/v agarose in TBE buffer 
3% w/v agarose and 1% Nu 
For DNA fragments >500bp 
For DNA fragments <500bp 
buffer 
Tracking dye 
Bromophenol blue 0.1% 
EDTA 0.1M 
Glycerol 50% v/v 
TBE buffer 
Tris 0.89M 
Boric acid 0.89M 
EDTA 0.002M 
Plasmid isolation 
Antibiotic Luria Broth 
NaC1 1% (w /v) 
Bactotryptone 1% (w /v) 
Yeast extract 5% (w /v) 
Agar 2% (w /v) 
Sieve (Flowgen) in TBE 
Make up in dH2O, adjust to pH 7.0 with 5N NaOH. 
Autoclave, cool to 55 °C and add 50mg/ml of filter -sterilised ampicillin. 
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Resuspension Solution 
Tris.HC1 (pH=8.0) 50mM 
EDTA (pH =8.0) 10mM 
Autoclave and store at 4 °C 





Potassium Acetate (pH 5.5) 3M 
Equilibration buffer 
NaC1 750mM 
MOPS pH 7.0 50mM 
Isopropanol 15% 
Triton X -100 0.15% 
Wash buffer 
NaC1 1.0M 




MOPS pH 8.5 
Isopropanol 
TE Buffer 
Tris.Cl (pH =7.5) 








5X Sequenase Reaction buffer 
Tris -HC1, pH 7.5 200mM 
MgC12 100mM 
NaCl 250mM 
Enzyme dilution buffer 
Tris -HC1, pH 7.5 10mM 
DTT 5mM 
EDTA 0.1mM 
Acetylated BSA 0.5mg/m1 
Termination mixes 






In addition the `A' mix contains 8µM ddATP, the `C' mix 811M ddCTP etc. 
Stop solution 
Formamide 95% v/v 
EDTA 20mM 
Bromophenol Blue 0.5g /1 
Xylene cyanol FF 0.5g /1 
Gel solution 
Urea 250g 
19:1, 40% acrylamide stock 75m1s 
10X TBE 50mis 
dH2O 175m1s 
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Tris -HC1, pH 7.2 1M 
20 X SSC 
NaC1 3M 
Trisodium citrate 0.3M 
pH to 7.0 with 1M HCl 
High Prime 





5X reaction buffer in glycero150% (v /v) 
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Dextran sulphate solution 
Dissolve 50g dextran sulphate in 300mis of dH2O 
Pre -Hybridisation Solution 
SSC 15mis 20x 
SDS 5mls 10% 
Dextran sulphate solution 30mis 
Wash solutions, in order of ascending stringency 
I 2x SSC +1 %SDSindH2O 
II lx SSC + 1% SDS in dH2O 
III 0.5x SSC + 1% SDS in dH2O 
IV 0.25x SSC + 0.1% SDS in dH2O 
V 0.1x SSC + 0.1% SDS in dH2O 
Library plating 
LB ++ broth: 




Store at room temperature. 
1M MgSO4: 
Filter sterilize, store at room temperature. 
SM (per litre) 
NaC1 5.8g 
MgSO4.7H2O 2.0g 
Tris.Cl, pH7.5 1M50m1 
Autoclave, add 5m12% gelatin solution (autoclaved separately). 
Store at room temperature. 
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LB/MgSO4 plates: 
Prepare LB broth as described in section "Plasmid isolation" and add to a final 
concentration 
MgSO4 10mM 
Pour plates and store at 4 °C. 
LB /top agarose: 
Prepare LB as described above and add to a final concentration: 
MgSO4 
Agarose (7.2g/1), autoclave. 
Store at room temperature. 
10mM 
Maltose, 20% in H2O 
Filter sterilize, store at room temperature 
ES cell culture solutions 
Medium for ES cell culture 
BHK -21 G -MEM (Life Technologies) 500m1 
100x Non -Essential Amino Acids (Life Technologies) 5m1 
100x Sodium Pyruvate (100mM, Life Technologies) 5m 
100X L- Glutamine (200mM, Life Technologies) 5m1 
LIF (use at 1:500) 500µ1 
100mM ß mercaptoethanol solution 500µ1 
FBS/FCS serum for ES cells 50m1 
(25mls Fetal Calf Serum (Sigma): 25m1s Newborn Calf Serum (Life Technologies)) 
100mM J3-mercaptoethanol solution 
1000x13-mercaptoethanol (Sigma) 100µ1 
dH2O 14.1 mis 
Filter sterilise solution through 0.2µm filter. 
Store at 4 °C. 
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LIF was prepared by the transfection of Cos -7 cells and subsequent harvesting of the 






1X Trypsin -EDTA 
Trypsin 0.5g 
EDTA 2.0g 
(Made up to 11 with modified Puck's Saline A) 
Freeze Media (FM) 
Culture media 40% v/v 
Serum 50% v/v 
Dimethyl Sulphoxide 10% v/v 
ES Cell Lysis Buffer 




Proteinase K 1001.ig per ml 
Antibiotic supplements for selection 
For 500mis media 
5X Gancyclovir: 
200µg /ml 0418: 
5011,1 10,000X 
500µ1 of stock G418: Disslove 4.0g 0418 in 20mis 
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Abstract-We have investigated the roles of the antioxidant glutathione and p53 in the response of embryonic stem 
(ES) cells to oxidative stress. ES cells express yGCS, a critical enzyme in glutathione (GSH) biosynthesis. Treatment 
with the pro -oxidant menadione led to elevation of GSH, a strong apoptotic response and reduced clonogenic survival. 
Addition of BSO, a specific yGCS inhibitor depleted GSH pools and prevented the menadione- induced increase in GSH, 
sensitizing cells to oxidative insult. Although p53 status had no bearing on either the basal levels of GSH or the 
menadione- induced GSH response, the levels of menadione -induced apoptosis were reduced in the absence of p53. We 
conclude that the pathways involving p53 and GSH act independently to protect against the deleterious effects of 
oxidative damage. Furthermore, the presence of an intact p53 pathway confers a long -term growth advantage post 
oxidative stress. Thus, in the absence of p53 ES cells bearing genotoxic damage are less likely to be propagated, 
suggesting that p53- dependent apoptosis acts to limit the deleterious effects of oxidative stress during early 
development. © 2002 Elsevier Science Inc. 
Keywords -GSH, p53, Apoptosis, ROS, ES cells, Free radicals 
INTRODUCTION 
Oxidants produced during normal metabolism or follow- 
ing exposure to xenobiotics may adversely affect embry- 
ogenesis by causing DNA stránd breaks, lipid peroxida- 
tion, and protein degradation. Disruption of the 
intracellular redox equilibrium also affects the balance 
between cell death, proliferation, and senescence [1,2]. 
Cellular mechanisms to maintain redox homeostasis and 
curb injury inflicted by reactive oxygen species (ROS), 
the main source of oxidative stress, include a complex 
array of chemical and enzymatic ROS- scavengers, dam- 
age sensors, and response effectors. 
A key determinant in the maintenance of the redox 
equilibrium is the tripeptide glutathione (GSH). GSH is 
produced via a two -step pathway, the first of which is 
rate -limiting and catalyzed by gamma glutamylcysteine 
synthetase (yGCS). This enzyme is composed of two 
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subunits, a heavy subunit containing the active site 
(yGCSh) and a regulatory light subunit (yGCSI). GSH is 
the most abundant intracellular nonprotein thiol which 
affords protection against oxidative stress directly, via 
conjugation, or indirectly as a co- factor in repair reac- 
tions catalyzed by glutathione S- transferases (GST) and 
glutathione peroxidases (GPx) [3]. 
Several lines of evidence also point to a role for the 
stress -surveillance transcription factor, p53, in the re- 
sponse to oxidative stress [4,5]. In response to a variety 
of stress signals, p53 co- ordinates the cellular processes 
of cell cycle arrest, senescence, apoptosis [6 -8], and 
directly participates in DNA repair via the base excision 
repair (BER) pathway [9]. Considerable attention has 
also been focused on the contribution of p53 in embry- 
onic development. p53 is expressed at high levels in 
embryos up to day 11 post fertilization, and then levels 
rapidly decline, as reviewed [10]. As such, undifferenti- 
ated ES cells express high levels of p53 and respond to 
UV- induced damage by undergoing apoptosis, whereas 
differentiated cells have lower levels of p53 and are 
relatively UV resistant [11]. Furthermore, p53 levels and 
activity are modulated with the degree of differentiation 
100 . J. r. \.vE C{ CU. 
[11 -13], with expression throughout later gestation be- 
coming isolated to developing nervous tissue [13]. 
Although p53 null mice were found to be viable, an 
increased incidence of exencephaly and associated de- 
fects in neural tube development suggests a role for p53 
in neural tube closure [14,15]. Embryos deficient for a 
negative regulator of p53, mdm2, are non -viable at an 
early stage. However, viability of mdm2 null mice is 
fully restored in the absence of p53, suggesting that 
regulation of p53 activity is critical for embryogenesis 
and its overexpression is detrimental to development 
[ 16]. 
Several studies have attributed the cause of drug- 
induced birth defects to oxidative DNA damage [17,18]. 
A role for p53 as a teratological suppressor was sug- 
gested on the basis of the ability of p53 to inhibit the 
effects of the pro-oxidant and teratogen benzo[a]pyrene 
on mouse embryonic development, possibly by protec- 
tion against ROS- induced DNA damage [17 -19]. 
A large body of evidence also implicates ROS in the 
induction of apoptosis [20 -22], and p53 activation 
[5,23]. Intriguingly, many of the early transcripts in- 
duced by p53 prior to the onset of apoptosis are involved 
in the regulation of ROS and are thought to increase ROS 
formation [24]. Since antioxidants, including GSH, can 
rescue cells from apoptosis, ROS have been implicated 
as downstream effectors in the execution phase of cell 
death [25 -27]. Furthermore, the gene encoding GPx was 
found to be transactivated by p53 [28], linking the p53- 
signaling pathway with the regulation of antioxidants. 
The majority of studies investigating the toxicity of 
oxidative stress have utilized the culture of primary or 
transformed cell lines for limited periods of time. ES 
cells, the pluripotent progenitors of all subsequent devel- 
opment, proliferate continuously in culture. However, ES 
cells are nontransformed and exhibit normal growth and 
responses to damage characteristic of that in vivo. These 
traits permit analysis of the immediate and long -term 
effects of oxidative stress on healthy mammalian cells. 
Such experiments have not, to the author's knowledge, 
been used before with ES or other cell types. 
We used ES cells to investigate the role of GSH and 
p53 in the response to oxidative stress induced by the 
pro -oxidant and chemotherapy quinone, menadione 
(MQ) [29,30]. MQ can diffuse across the plasma mem- 
brane and initiate a toxic "redox cycle" with molecular 
oxygen, a reaction that can generate ROS including 
H202, 102, 02-, and, in the presence of metal ions, the 
highly unstable and deleterious hydroxyl radical, OH'. 
MQ can also react directly with protein sulfhydryl (SH) 
groups. This ability of MQ to arylate protein SH- groups 
to form MQ- protein conjugates, an event not dependent 
upon the presence of iron, is well documented [31]. 
Thus, metabolism of MQ can exert oxidative stress by 
two routes: arylation or oxidation. 
MQ can introduce single strand breaks in DNA, 
though this damage has been dissociated from immediate 
cell death in hepatocytes [32] and fibroblasts [5]. In 
embryonic development, however, such damage to DNA 
propagated through successive rounds of replication may 
accumulate to the detriment of the organism. 
We present evidence that suggests p53 and GSH, 
through discrete mechanisms, modulate the immediate 
and long -term viability of ES cells under oxidative stress. 
This alteration in viability is mediated, at least in part, by 
p53- dependent and -independent signaling pathways that 
delete damaged embryonic cells. 
MATERIALS AND METHODS 
ES cell culture and experimental treatments 
ES cells were maintained in GMEM BHK -21 supple- 
mented with nonessential amino acids, sodium pyruvate, 
L- glutamine, 10% fetal calf serum (Life Technologies, 
Paisley, UK), 3- mercaptoethanol (Sigma Chemical Co., 
St. Louis, MO, USA), and leukemia inhibitory factor. 
0.3 X 106 cells /well were seeded in gelatinized 6 well 
plates (Greiner Laboratories, Solingen, Germany) and 
propagated at 37 °C in 5% CO2. 
Three hours after seeding the medium was replaced 
with normal medium, or media containing 100 µM BSO 
(Sigma) and incubated for 16 h. At the end of the 16 h 
pretreatment the medium was discarded and the cells 
rinsed once with warm PBS. Subsequently, cells were 
incubated with serum -free media with or without 35 AM 
MQ (Sigma) for 90 min. 35 µM MQ was selected on the 
basis of baseline kill experiments indicating that, at this 
dose, BSO optimally reduced ES cell viability (data not 
shown). Following MQ exposure, cells were rinsed twice 
with warm PBS and incubated with complete media until 
analysis. 
Derivation of p53 -null embryonic stem cells by high 
G418 selection 
The p53 -/- ES cell line HG287 was derived from 
the hemizygous line R72 by high G418 selection [33]. 
R72 cells were previously derived from E14 [34] by 
targeting the p53 locus with a neomycin resistance cas- 
sette [7]. 
yGCS RT-PCR 
RNA was isolated from subconfluent ES cells with 
TRIzol Reagent (Life Technologies) and total RNA re- 
verse transcribed using Superscript II (Life Technolo- 
1267bp 

















Fig. 1. ES cells express yGCSh transcripts. RT -PCR strategy to detect 
the presence of yGCS mRNA in ES cells. (A) Dashed lines represent 
PCR products, solid line cDNA. yGCSh exonic primers F2 + R2 
generate a 139bp product, F2+ R4 a 1267bp product. (B) Agarose gel 
electrophoresis of RT -PCR performed on total RNA isolated from 
subconfluent ES cells. Lane 1: PCR with F2 + R2, lane 2: F2 + R4, 
lane 3: positive control amplifying the housekeeping gene encoding 
g -actin (450 bp product), lane 4: negative control. 
gies) according to the manufacturer's instructions. To 
detect yGCS mRNA, PCR was performed on ES cell 
cDNA. Oligonucleotide primers were designed on the 
basis of the published sequence of yGCSh cDNA [35], 
and the housekeeping gene, )3-actin (Stratagene, La Jolla, 
CA, USA). yGCSh primer sequences (5' -3'); 
F2: AGGAGAAAAGGTTGTCATCAATG, 
R2: CAAATCCCATGGCATCCATGTA 
R4: CAAGTAACTCTGGGCATTCACA (Fig. 1A). 
PCR was run in a Hybaid Omnigene cycler as follows: 
94 °C, 45 s: 56 °C, 30 s: 72 °C; 60 s, for 30 cycles. PCR 
products were analyzed on a 4% agarose gel. 
MTT assay 
ES cell viability was determined by the modified 
tetrazolium salt 3- (4- 5- dimethylthiazoyl -2 -yl) 2-5- diphe- 
nyl-tetrazolium bromide (MTT) assay as described [36]. 
Briefly, 600 µl of MTT (5 mg/ml in PBS) was added to 
each well after treatment. Samples were incubated for 3 h 
at 37 °C, washed once with PBS and left to dry, prior to 
the addition of 1.5 ml dimethyl formamide (DMSO). The 
optical densities at 590 nm were measured using a 96 
well multiscanner autoreader (Dynatech MR 5000), with 
DMSO as a blank. 
Clonogenic survival assay 
Cells were plated in triplicate at a range of cell den- 
sities and treated with MQ and BSO as described above. 
Plates were maintained for 10 days, then fixed in 70% 
ethanol for 10 min and stained with 10% Giemsa prior to 
counting clones. 
Quantification of apoptosis by direct counts of acridine 
orange stained cells 
Cells were trypsinized, washed in PBS and fixed in 
90% ethanol: 10% formalin. Fixed single cell suspen- 
sions were stained with acridine orange solution (10 
µg/ml) and observed under fluorescence microscopy. 
Apoptotic ES cells were identified by their condensed 
chromatin, fragmented nuclei and smaller size [37]. The 
number of apoptotic cells in relation to total cell number 
was scored in triplicate. In total, 600 cells were counted 
for each sample. 
Intracellular GSH levels 
GSH levels were measured according to the method 
of Tietze et al. [38]. Briefly, cells were trypsinized, 
washed in PBS and stored at -70 °C. Pellets were thawed 
slowly on ice before addition of 0.5 ml ice -cold 0.6% 
sulfosalicyclic acid/0.01% Triton X -100. The cells were 
lysed by freeze -thawing and repeated vortexing. Samples 
were pelleted at 4 °C and the supernatant stored at 
-70 °C. 
Assays were performed in triplicate. Samples (10 µl) 
were incubated at room temperature with 8 units /ml 
glutathione reductase in the presence of 0.4 mg/ml 
DTNB (5, 5' dithiobis- 2- nitrobenzoic acid). Following 
addition of 0.4 mg /ml NADPH ((3- nicotinamide adenine 
dinucleotide phosphate) the change in absorbance at 412 
nm was recorded using a Dynex -TC Multiplate reader. A 
standard curve was established for each plate using GSH 
in the range of 0.167 -2.5 nmoles. Results were expressed 
per mg of total protein. Sample protein concentration 
was determined by the Bio -Rad assay, using BSA as a 
standard. 
Statistical analysis 
All data sets were analyzed using the software pack- 
age SigmaStat version 2.03 (SPSS, Chicago, IL, USA). 
When comparing two groups Normality and Equal Vari- 
ance are automatically tested. Where these criteria are 
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Table 1. Levels of GSH in Different Cell Types 
Cell type Basal [GSH] 
Human alveolar carcinoma, A549 
Human hepatocarcinoma, HepG2 
Bovine arterial endothelium 
Rat lung epithelial, L2 
Mouse embryonic epithelial: 
BDC -1 (wild type) 
GCS -1 (yGCSh -/ -) 
Mouse embryonic stem, ES: 
HM -1 (wild -type) 
HG287 (p53 -/ -) 
Rat embryo 

























Illustrates the GSH level of ES cells in comparison to levels of intracellular GSH detected in other tissues. All GSH values are expressed as nmollmg 
protein except values marked *, expressed as pmol/embryo. ND = no detectable level of GSH. 
met parametric (unpaired t) tests were applied, where 
these criteria were not met nonparametric (Mann -Whit- 
ney rank sum) tests were applied. 
RESULTS 
ES cells synthesize yGCS transcipts 
We wished to characterize the response of ES cells to 
oxidative stress. To detect the presence of a GSH- depen- 
dent antioxidant system in ES cells, we tested for the 
expression of yGCS, which catalyses the rate -limiting 
step in de novo glutathione biosynthesis. yGCSh tran- 
scripts were detected by RT -PCR performed on ES cell 
lysates (Fig. 1). 
Partial GSH depletion does not affect ES cell viability 
Having established the presence of yGCS transcripts 
in ES cells, the intracellular levels of free GSH in wild - 
type (HM -1) and p53 -/- (HG287) ES cells were mea- 
sured as described. GSH levels in ES cells are compa- 
rable with levels found in the early embryo (Table 1). 
We measured ES cell GSH levels following treatment 
with the GSH -modulating agent BSO (DL- buthionine- 
(S,R)-sulfoximine). BSO, a specific and irreversible in- 
hibitor of yGCS [46], has been shown to reduce the 
levels of GSH in many cell types. ES cells GSH levels 
were measured after incubation with a range of BSO 
concentrations. BSO lowered GSH levels, although the 
reduction was similar for all BSO concentrations within 
the 25 -250 µM range employed (Fig. 2). For subsequent 
experiments concentrations of 100 µM BSO were used, 
which gave approximately 70% GSH depletion. 
In order to estimate the tolerance of wild -type and 
p53 -/- ES cells to low GSH, we analyzed the conse- 
quences of BSO on cellular viability. We estimated vi- 
ability by the MTT assay, which measures mitochondrial 
dehydrogenase activity. 100 pM BSO had no effect on 
the MTT index (Table 2), even when incubated for 
periods up to 48 h (data not shown). 
MQ reduces viability in a GSH- and p53- dependent 
manner 
Next, we analyzed the immediate response of ES cells 
to MQ- induced oxidative stress, with viability scored 
through the MTT assay. Figure 3 shows that the viability 
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Fig. 2. Effect of BSO on ES cell GSH levels. GSH content of wild -type 
ES cells after incubation for 16 h with a gradient of BSO concentrations 
or without BSO. Results are mean SEM values from three independent 
experiments. The corresponding values for p53 -/- cells were indis- 
tinguishable (data not shown). 
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Table 2. Toxicity of BSO Towards Wild -type and p53 -/- ES Cells 
Genotype Treatment n 
GSH 





Wild -type Untreated 18 16.1 -± 1.5 0 100 
BSO 100 µM 9 4.93 ± 0.45 69.82 ± 2.10* 102.5 ± 1.26 
p53 -/- Untreated 9 16.01 ± 1.9 0 100 
BSO 100 µM 9 4.54 ± 0.7 70.4 ± 2.81t 98.8 ± 2.35 
ES cells were treated for 16 h with 100 µM BSO in full media. Immediately after treatment, cytosolic extracts were prepared by freeze- thawing 
and ultrasound. Samples were stored at -20 °C until analysis of GSH levels via the Tietze method. Cell viability 24 h post BSO exposure was 
evaluated using the MTT assay. Data are mean ± SEM values from at least nine independent experiments performed in triplicate. GSH reduction: 
* and $, t -test p = .001 vs. untreated value. 
raised following exposure to 35 µM MQ. Wild -type cells 
displayed a sustained decrease in viability in the period 
post treatment, dropping to 34% of control values at 7 h. 
Pretreatment with BSO augmented MQ cytotoxicity, re- 
ducing viability to less than 5% of control levels at 7 h. 
Following exposure to MQ with or without BSO pre- 
treatment, p53 -/- ES cells displayed a considerably 
higher viability than their wild -type counterparts up to 
48 h post exposure to MQ. 
MQ induces p53 -independent modulation of free GSH 
levels 
In order to assess any alteration in the level of GSH 
subsequent to oxidative stress, GSH levels were moni- 
p53 +MQ -wild -type +MQ 
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Fig. 3. Effect of BSO on MQ- induced cytotoxicity in wild -type and 
p53 -/- ES cells. Cell viability at various time points immediately post 
35 µM MQ exposure was evaluated by the KM' assay. Error bars 
represent SEM of three independent experiments. * and $ indicate the 
difference in comparison to wild -type ES cells treated with MQ only 
(p = < .001 t -test) and with MQ + BSO (p = < .001 t- test), 
respectively. 
tored in ES cells at different time points post exposure to 
MQ. Following a 90 min incubation with 35 µM MQ, 
wild -type ES cells showed a rapid elevation of free GSH 
levels, peaking at 24 h post exposure before subsiding to 
basal levels 48 h post exposure (Fig. 4). The fluctuation 
of GSH levels seen in untreated controls is consistent 
with the degree of confluency, as reported for culture for 
other cell types. 
Time post treatment (h) 
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Fig. 4. GSH response of ES cells to oxidative stress. Total free GSH 
levels in wild -type (top panel) and p53 -/- ES cells (lower panel) post 
35 µM MQ and BSO treatment. Cells received either no pretreatment 
(solid lines), or BSO pretreatment (dashed lines). Subsequently, cells 
were transiently incubated in serum free media with 35 µM MQ (solid 
boxes) or without MQ (open triangles). Time at 0 h = end of the MQ 
treatment. Error bars represent SEM values of three independent ex- 
periments. *Indicates the difference in comparison to MQ- treated 
p53 -/- ES cells (p = 1.0 t- test), and $ signifies the difference 
compared to untreated wild -type cells (p = .005 t- test). 
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Control BSO MQ Control BSO MQ 
Treatment 
Fig. 5. Effect of BSO or MQ on the induction of apoptosis. ES cells 
were treated with 100 µM BSO or 35 µM MQ treatment and the rate 
of apoptosis examined. Shaded bars represent percentage of intact cells, 
solid bars percentage of apoptotic cells. Cell death was examined 7 h 
post removal of 35 p,M MQ and the percentage apoptosis occurring in 
each experiment was assessed directly, using morphological criteria. 
Error bars represent SEM values from three independent experiments. 
Statistical indicators are shown as: §, (p = .001 t -test) vs. untreated 
wild -type ES cells; t, (p 0.026 t -test) vs. untreated p53 -/- ES cells, 
and *, (p = .001 t -test) vs. wild -type ES cells exposed to MQ. 
Next, we examined the response of ES cells to BSO 
removal. When incubated with fresh media, ES cells 
depleted of GSH recovered basal levels by 24 h. How- 
ever, ES cells preincubated with BSO failed to induce an 
elevation in GSH when treated with 35 µM MQ. Fur- 
thermore, GSH levels remained suppressed, with recov- 
ery to control levels only achieved at 48 h. 
Though basal levels of GSH were unaffected by p53 
status, p53 has been shown to transactivate a number of 
other genes implicated in ROS regulation [23,26]. Con- 
sequently, we postulated p53 may play a role in the 
GSH -mediated response to oxidative stress. We therefore 
analyzed GSH levels in p53 -/- ES cells following 
oxidative stress (Fig. 4). However, in response to MQ, 
GSH levels did not differ between wild -type and 
p53 -/- cells at 6 h (Mann Whitney Rank Sum Test p = 
.2) or 24 h (t -test p = 1). 
MQ induces apoptosis in wild -type and p53 -/- ES 
cells 
As MIT does not distinguish between growth arrest 
and cell death, we investigated the mechanism underly- 
ing the reduction in cellular viability associated with 
exposure to MQ. The mode of cell death was determined 
directly using morphological criteria after staining with 
acridine orange (Fig. 5) [35]. No difference in the rate of 
apoptosis was detected between untreated and BSO- 
treated cell cultures, consistent with analogous MTT 
indices. A considerable proportion (52.47% ± 3.73) of 
wild -type ES cells exposed to MQ had entered apoptosis 
6 h following MQ removal (t -test p = .001), concordant 
with the observed reduction in the MIT index at this 
time. p53 -/- ES cells also exhibited an apoptotic re- 
sponse (15.88% -F 3.57, t -test p = .026). However, the 
incidence was considerably reduced in comparison to 
wild -type cells (t -test p = .001), consistent with a large 
population of p53 -/- cells remaining viable at 48 h post 
MQ exposure. 
MQ treatment reduces clonogenic survival, a 
phenomenon accentuated by p53 deficiency 
In comparison to wild -type ES cells, p53 -/- ES cells 
are refractory to apoptosis at 6 h after exposure to MQ 
and display an immediate survival advantage over wild - 
type cells, manifested up to 48 h post exposure. To 
ascertain whether loss of p53 conferred a continued 
growth advantage over an extended period, we compared 
the clonogenic survival of wild -type and p53 -/- ES 
cells after exposure to MQ. A difference in plating effi- 
ciency was observed, with wild -type cells showing a 
plating efficiency of 85.4% compared to p53 -/- cells. 
To control for this difference, all data was calculated 
relative to untreated controls of the respective genotype. 
Remarkably, following treatment with 35 µM MQ, the 
long -term ability of p53 -/- ES cells to form clones was 
found to be significantly lower than wild -type ES cells 
(Fig. 6, t -test p < .006). Reduction of GSH with BSO 
prior to MQ exposure served to exacerbate the disparity 
between genotypes (t -test p = .029). 
DISCUSSION 
We investigated the influence of GSH and p53 on the 
immediate apoptotic response and long -term clonogenic 
survival of ES cells following oxidative stress. We show 
that yGCSh is constitutively expressed and GSH present 
in ES cells, the earliest embryonic lineage. BSO, a spe- 
cific and irreversible inhibitor of yGCS, depleted GSH 
levels by an extent broadly consistent with that obtained 
for the culture of other mammalian tissues with BSO, 
which ranges from < 75% [47] to > 90% [48]. 
ROS can cause single strand breaks in DNA, initiate 
nuclear translocation and activation of wild -type p53 
[23,49]. We show that ES cells are sensitive to oxidative 
challenge and respond by initiating apoptosis, a process 
widely regarded as important in normal development. 
The ES cell response also entails a rapid and transient 
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Fig. 6. Clonogenic survival of ES cells following exposure to oxidative 
stress. The long -term viability of ES cells after exposure to 35 µM MQ 
with or without prior 100 pM BSO treatment was determined. Wild - 
type ES cells are represented as solid bars and p53 -/- cells as striped 
bars. Error bars represent SEM values of three independent experi- 
ments. *Indicates the statistical significance in comparison to wild -type 
ES cells treated with MQ only (p = < .006 t- test), and # represents the 
significance in comparison to wild -type ES cells treated with MQ + 
BSO (p = .029 t- test). 
elevation of GSH. This phenomenon parallels studies 
exposing a variety of cell types to MQ, and is thought to 
perform a protective function against oxidative damage 
[44,50]. 
However, an initial fall in GSH levels, evident in 
other cell types, was not observed in ES cells. The Tietze 
method used in this study measures total glutathione 
levels, reduced and oxidized. However GSH- conjugates 
such as PrSSG, formed by arylation reactions, are not 
detected and their formation would register as a loss of 
glutathione. It is therefore probable that GSH scavenges 
MQ- generated ROS, and that arylation reactions are not 
predominant in ES cells. Indeed, raised GSSG levels are 
commonly detected in other cell lines treated with MQ or 
other modes of oxidative stress [39,51]. Thus oxidation 
of GSH to GSSG, coupled with rapid GSH synthesis, 
could account for the lack of a preliminary fall in total 
GSH levels. 
The generation of a yGCSh -/- embryonic cell line 
has revealed GSH is not required for normal growth in 
culture [43]. In this study, we show GSH deficiency 
augmented MQ cytotoxicity in both wild -type and 
p53 -/- ES cells, reflecting a protective role of GSH. 
That BSO prevented the elevation in GSH indicates this 
response is normally mediated by an amplified rate of 
GSH synthesis. Together, this data indicates ES cells 
have a functional GSH- dependent detoxification system, 
which although dispensable for growth under normal 
conditions becomes necessary in the response against 
oxidative stress. 
Conversely, p53 -/- ES cells display an immediate 
survival advantage compared to wild -type cells. A bat- 
tery of redox -regulation genes, including GPx, GST, and 
oxidoreductases have been identified as downstream ef- 
fectors of p53 signaling [24,28]. We therefore reasoned 
that p53 may have a role in the GSH response to oxida- 
tive stress, possibly through modulation of yGCS expres- 
sion. We found that the steady state levels of GSH in 
wild -type and p53 -/- ES cells were identical. This 
makes a role for p53 in basal transcription of yGCSh or 
related enzymes unlikely, and is consistent with the 
notion that p53 transcribes target genes only when acti- 
vated by cellular injury. However, the GSH response 
profiles of wild -type and p53 -/- ES cells under oxida- 
tive stress were statistically indistinguishable . This is 
strong evidence that oxidative stress induces GSH via a 
mechanism independent of p53. Candidate mechanisms 
include other redox -sensitive transcription factors, such 
as NF -KB and AP -1. These have been shown to elevate 
GSH in a variety of cell types, coincident with an up- 
regulation of yGCSh [51 -54]. 
Whilst MQ initiates apoptosis in both p53 -/- and 
wild -type ES cell lines, the immediate apoptotic response 
was significantly reduced in p53 -/- ES cells. This 
indicates the presence of distinct p53- dependent and 
-independent apoptotic pathways. Others have shown 
p53 is necessary for inducing apoptosis in response to 
oxidative stress [55]. However, Aladjem et al. observed 
only p53- independent apoptosis in response to ribonu- 
cleotide depletion and DNA damage, whilst Corbet et al. 
showed both p53- dependent and delayed p53- indepen- 
dent apoptosis in response to UV [37,56]. These findings 
serve to underline the complex role played by p53 in the 
apoptotic response of embryonic cells to damage. 
The lower incidence of apoptosis observed in 
p53 -/- ES cells at 6 h does not necessarily imply an 
attenuated p53 -/- apoptotic response. Others have re- 
vealed, with extended time courses, the presence of a 
delayed wave of p53- independent apoptosis [57 -59]. 
Thus the lower apoptotic index observed at 6 h post MQ 
treatment is interpreted as a kinetic shift, rather than a 
reduced response per se. This is also in agreement with 
the "primed to die" function where, even in the absence 
of p53, ES cells recognize injury and activate a death 
pathway. Because ROS act as downstream mediators in 
some apoptotic pathways it is possible that MQ, via ROS 
generation, may directly activate apoptotic factors in the 
absence of the p53 protein [60]. 
It should be noted that, as well as DNA damage 
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inflicted by MQ and the subsequent induction of apopto- 
sis, the embryonic toxicity of MQ may manifest via a 
subtle reprogramming of gene expression. Such alter- 
ations are difficult to monitor in vitro and could effect 
cellular changes not detected within this study. 
We observed the immediate growth advantage and 
reduced apoptotic response of p53 -/- ES cells exposed 
to MQ translated into a lower clonogenic survival than 
wild -type cells in the long -term. This is consistent with a 
role for p53 as teratological suppressor, originally pro- 
posed due to the ability of p53 to limit the teratogolic 
effects of benzo[a]pyrene [19], and later cyclophospha- 
mide, on mouse embryonic development [61]. However, 
there are exceptions. While fetal lethality in wild -type 
mice embryos exposed to irradiation was greater than in 
p53 -/- mice, p53 -/- mice showed more lesions [62]. 
Moreover, Wubah and colleagues demonstrated the 
genotoxic agent 2- chloro -2- deoxyadenosine caused a 
73% incidence of eye abnormalities in wild -type em- 
bryos, compared with 52% and 2% in p53 + /- and 
p53 -/- embryos, respectively [63]. Clearly further 
work is required to resolve these apparent differences in 
p53 functionality. 
In the absence of p53 (although immediate survival is 
higher) surviving ES cells are very likely to carry a high 
level of cellular damage. Normally this injury would be 
repaired through p53- dependent DNA mechanisms, such 
as BER, and failure to repair would trigger p53- depen- 
dent cell death. In the absence of p53, we hypothesize 
this level of damage is sufficient to initiate delayed 
p53- independent mechanisms that prevent propagation, 
leading to reduced long term survival. These mecha- 
nisms may include p53- independent apoptosis and per- 
manent withdrawal from the cell cycle. This is in agree- 
ment with the conclusions reached by Frenkel et al., who 
showed p53 -/- embryos, upon irradiation, display not 
only altered patterns of apoptosis but accentuated levels 
of delayed death compared to their wild -type counter- 
parts [59]. This is also consistent with the view that in 
development loss of cells is less detrimental to the or- 
ganism than retention of damaged cells. It should be 
remembered that these results reflect early organogenesis 
(< 10 d post fertilization) and may not be the case for 
later development, where p53 levels decrease with dif- 
ferentiation. 
In conclusion, we propose that in the absence of 
functional p53, MQ- induced DNA breaks accrue and 
activate alternative embryonic death pathways that pre- 
vent. the persistence of genetic lesions in differentiated 
cells. These mechanisms are perhaps reliant upon other 
p53 family members, such as the homologues p63 and 
p73. GSH may serve to limit MQ- induced DNA damage 
and therefore indirectly prevent induction of both p53- 
dependent and -independent death pathways. Investiga- 
tion of pathways and independent of p53 is clearly an 
area that may yield a greater understanding of develop- 
mental abnormalities induced by oxidative stress in 
utero. 
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ABBREVIATIONS 
BSO- DL- buthionine- [S,R]- sulphoximine 
ES- embryonic stem 
yGCS -gamma glutamylcysteine synthetase 
yGCSh -yGCS heavy subunit 
yGCSI -yGCS light subunit 
GPx- glutathione peroxidase 
GSH- reduced glutathione 
GSSG- oxidized glutathione 
GST- glutathione transferases 
MQ- menadione 
ROS- reactive oxygen species 
